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Preface
Mrs. P.D., a seventy-year-old who had always enjoyed good health, visits her GP with 
defecation problems. She has suffered from constipation for quite some time, but blood 
tests, an ultrasound scan and a colonoscopy in the past year showed no abnormalities. The 
GP, therefore, has prescribed her laxatives for a number of weeks now, and these appear to 
be helping her.
Well over a year after that, Mrs. P.D. revisits her GP. She mentions that her right shoulder is 
troubling her considerably. The past few months, she has had to cancel tennis appointments 
more and more often because she cannot manage to throw the ball for her service. Carrying 
a heavy shopping bag is also beyond her possibilities. Her energetic spouse encouraged her 
to go and see her GP. After a physical examination, showing clear indications of a frozen 
shoulder, the GP decides to refer Mrs. P.D. to an orthopedic surgeon, who treats her with 
corticosteroid injections several times. These appear to be providing some alleviation.
Another year later, Mrs. P.D. visits her GP again, this time because she feels down and has 
difficulty concentrating. At home she cannot be bothered to do anything. Her housekeeping 
is a burden to her. She has lost a lot of weight for lack of appetite. She has quit her tennis 
because it was all taking too much out of her. Her spouse has gradually taken over more and 
more of her tasks: he does the cooking and the shopping as his wife tends to forget more and 
more things on the list. Suspecting her of having a depression, the GP consults a psychiatrist. 
The psychiatrist finds Mrs. P.D. absent-minded and confused and suspects her of being in the 
early stages of dementia.
Six months later, Mrs. P.D. visits the general practice again with her spouse. While she walks 
from the waiting room to the consulting room, the GP notices that she barely lifts her feet 
and walks hunched over. Besides her old complaints of constipation, stiffness in the right 
shoulder, and gloominess, Mrs. P.D. is trembling increasingly, to the point where her old 
tennis friends were wondering whether she was nervous. Things are also getting tougher 
on her spouse. The GP has the feeling there is something more going on. The physical 
examination shows rigidity and tremor on the right-hand side. The GP explains to Mrs. P.D. 
and her spouse that he is thinking of Parkinson’s disease and proposes referring her to a 
neurologist.
After her visit to the neurologist and almost three years after her initial complaints started, 
the GP’s suspicion is confirmed: Mrs. P.D. has Parkinson’s disease.  
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Chapter 1 | General introduction
Background
Exactly 200 years ago, in 1817, the British surgeon James Parkinson wrote his Essay on the 
Shaking Palsy and defined it as ‘Involuntary tremulous motion, with lessened muscular 
power, in parts not in action and even when supported; with a propensity to bend the trunk 
forwards, and to pass from a walking to a running pace: the senses and intellects being 
uninjured’.1 At that time, his essay drew little attention. Half a century later, the French 
neurologist Jean-Martin Charcot acknowledged Parkinson’s observations and named the 
disorder that he believed was characterized by bradykinesia, tremor at rest, rigidity, facial 
immobility and disturbances of gait and posture maladie de Parkinson.2 It took until the 20th 
century before degeneration of dopamine-producing cells in the substantia nigra of the brain 
was recognized as the cause of the disease and pharmacological treatment for Parkinson’s 
disease (PD) was introduced.3 
Although the diagnosis of PD still requires the clinical presence of bradykinesia and muscular 
rigidity, a 4-6 Hz resting tremor or postural instability, our understanding of the symptom 
complex of PD has grown since the 1800s.4 Nowadays, PD is recognized as a multisystem 
disorder consisting of both motor and non-motor symptoms.5 The non-motor symptoms vary 
from autonomic disturbance (i.e. orthostatic hypotension, constipation, urinary incontinence 
and sexual dysfunction) to sleep disorders, pain, olfactory dysfunction and neuropsychiatric 
disorders such as depression, anxiety, hallucinations and cognitive impairment.6 The clinical 
expression of the motor and non-motor symptoms, in addition, varies between patients, and 
patients’ perceptions of the most troublesome symptoms differ as well.7-9 It is because of this 
complexity that a multidisciplinary approach to care, with the patient’s active participation, 
is recommended.10
Above all, there is one health care provider involved in the care of PD patients from the first 
symptom to advanced-stage PD: the general practitioner (GP). Therefore, this thesis focuses 
on the role of primary care in Parkinson’s disease.
Towards the diagnosis of Parkinson’s disease
PD is known to have an insidious onset. Years before patients are being diagnosed, they may 
already be suffering from symptoms related to the disease.11, 12 Nevertheless, many hurdles 
have to be cleared to get from the first symptom to the moment of diagnosis. Patients, 
for example, do not always recognize that their symptoms require medical attention, and 
consultation of a health care provider does not guarantee an instant diagnosis.
Patients
Bodily changes do not immediately lead to symptoms. Patients first need to pay attention 
to and become aware of physical and mental sensations. As a next step, the sensations they 
experience need to be interpreted as symptoms that must be evaluated for their perceived 
health threat.13, 14 The representations patients make of their illness determine their coping 
Processed on: 18-4-2017
509581-L-bw-plouvier
14
Parkinson’s disease in primary care | A joint journey of patients and general practitioners
strategies, including the decision to seek medical attention and the actual act of doing so.15 
Breen et al. already found that PD patients need time to recognize their motor symptoms and 
to realize that medical attention is required.16 In addition, there are substantial differences 
between individuals in frequency of and reasons for contacting their GP, irrespective of PD 
signs and symptoms.17 Research in patients with cancer and diabetes mellitus has shown 
that a number of factors influence the pathway from the first recognizable symptom to the 
diagnosis. These factors include the nature of the symptoms and the patients’ emotional 
response to them, knowledge of the disease, the consultation of significant others and 
concurrent problems in patients’ personal lives.18, 19 Knowledge of the factors influencing the 
course of the diagnostic pathway of PD, however, is scarce. 
Patients’ experiences during the diagnostic process do not only influence their feelings 
about the pathway itself. Studies amongst cancer patients found that patients tend to lose 
confidence and trust in their GP if they need to pay multiple visits to the general practice 
before being referred.20-22 Patients may interpret the need for repeatedly consulting their GP 
as lack of responsiveness and, therefore, as diagnostic delay, resulting in dissatisfaction and 
worse long-term care experiences.23 In addition, patients suffering from cancer types that are 
difficult to recognize, such as ovarian cancer, are known to change over to another general 
practice more often than patients with cancer types that are easier to recognize.24 PD may 
be difficult to recognize as well, and the diagnostic pathway can be lengthy and uncertain. It 
is reasonable, therefore, to expect a negative influence of patients’ diagnostic experiences 
on their satisfaction, confidence and trust and, hence, on the patient-doctor relationship.16, 25 
Nonetheless, we do not know how PD patients evaluate their diagnostic pathway.
General practitioners
Symptoms already present before the onset of the typical motor signs of PD are known 
as prodromal symptoms.11 Prodromal symptoms include, for example, shoulder pain and 
restrictions in movement, olfactorary dysfunction and rapid eye movement sleep behavior 
disorders.5, 12 Most prodromal symptoms of PD are not disease-specific.12 In the Netherlands, 
patients generally first present their symptoms to their GP. As the gatekeepers to specialist 
care, GPs need to discriminate the prodromal symptoms of PD from symptoms related 
to other causes and subsequently decide on referral.26, 27 Although PD is the second most 
common neurodegenerative disorder after Alzheimer’s disease, it is rather uncommon in 
general practice in the Netherlands with an incidence varying from 0.3 per 1,000 person-
years in subjects aged 55-65 years to 4.4 per 1,000 person-years for subjects aged ≥85 years 
and a prevalence of 1.3%.28, 29
Recognizing PD as the cause of the presented prodromal symptoms, therefore, can be 
challenging.25 Adding to the diagnostic difficulties is the fact that earlier studies on prodromal 
symptoms are mainly hospital based and focus on patients referred to neurologists. When 
patients consult their GP, symptoms are often still limited and embedded in clinical uncertainty, 
while referral to the neurologist takes place at a later point in the disease trajectory.26, 27, 30-33 
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As GPs play a crucial role in PD recognition, we need to increase our knowledge of the way 
prodromal symptoms of PD are presented in general practice. 
Changes in care after the diagnosis of Parkinson’s disease
Once the diagnosis is set, Parkinson’s disease continues to have an influence on the lives of 
patients and their relatives. Physical, emotional and psychosocial aspects of life are affected 
by PD.34, 35 The fluctuating expression of symptoms, which may vary on a daily basis, add to 
the impact of the disease.34, 35 Progression of PD, in addition, will confront patients and their 
relatives with new disabilities and limitations.36 In some cases, the support or medical care 
that is offered to patients needs to be changed to cope with these disabilities and limitations. 
As 80% off all PD patients in the Netherlands continue to live at home during the course 
of their disease, it is likely that GPs can play a role in offering support during these changes 
in care.37 
Patients
PD patients are likely to experience a variety of changes in care. So far, research on changes 
in care has mainly focused on transitional care from one health care setting to another or to 
home.38-42 Such changes jeopardize continuity of care and challenge both the patients’ and 
the health care providers’ communication skills as there is a need for clarity in preferences, 
expectations and roles in care.40, 43 Studies among patients with prevalent chronic conditions 
such as heart failure, chronic obstructive pulmonary disease (COPD) and cancer show that 
patients feel they lack control when being discharged from hospital to home. In addition, 
they feel uncertain, unprepared, inadequately guided and not involved in care-taking 
decisions.41, 42 Changes in care may also be more closely related to patients’ personal context, 
such as changes in the help they receive from a relative or adjustments made to their living 
situation. Although these changes might be experienced without the direct involvement of 
health care providers, patients may still benefit from support. For this reason, we wonder 
what changes in care PD patients actually experience and how they cope with them, yet 
information on this topic is limited.
General practitioners
GPs are important health care providers to offer support during changes in care. In the 
Netherlands, all citizens are registered with a general practice.44 This structure supports 
Dutch GPs in their role as family doctors, who are informed about the physical and mental 
state of all family members and the contextual circumstances that influence their well-being. 
Amongst other tasks, GPs play an important role in disease-specific care for prevalent chronic 
conditions such as COPD and diabetes.45, 46 Knowledge of their patients’ personal context 
facilitates and enhances the quality of such care.47 The long-term patient-doctor relationship, 
in addition, facilitates the GPs’ understanding of their patients’ ability to cope. The GPs’ 
knowledge of their patients’ contextual circumstances enables them to offer personalized 
support during changes in care.
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However, for a complex chronic condition such as PD - a condition with a versatile presentation 
and a complicated treatment regimen - disease-specific care is usually best offered by 
specialized health care providers with expert knowledge and skills.36, 47 Although GPs are 
aware of the impact the disease and possible changes in care may have on the patients’ 
context, they are not involved in disease-specific care. Nevertheless, the GPs’ experience in 
offering support during changes in care may be valuable for PD patients as well. In order to 
know if GPs can offer this support to PD patients, we need to increase our understanding of 
the role of GPs in PD care.
Rationale of this thesis
Specialized health care providers now agree that PD patients benefit from early intervention 
and treatment, taking into account the patients’ personal situation and care preferences and 
discussing the benefits of intervention on the one hand and the risk of side effects on the 
other. Research has shown that early intervention is likely to result in maintenance of quality 
of life, slowdown of clinical progression and reduction of mortality.48-50 However, before 
interventions can be discussed, the disease has to be diagnosed. In order to allow patients 
and health care providers to take time to discuss referral and treatment steps, delay in the 
diagnostic pathway should be addressed whenever possible and preferred by patients.
Therefore, we need to understand the factors that influence the course of the experienced 
diagnostic pathway of PD according to patients. Moreover, a trusting therapeutic relationship 
between patients and health care providers is indispensable for genuine shared decision-
making.51 As patients and GPs each have a share in establishing such a relationship, we need 
to improve our understanding of factors that pose a risk to such a relationship by contributing 
to patients’ dissatisfaction with the diagnostic pathway. To facilitate early recognition by GPs, 
moreover, we need to learn more about the way prodromal PD is presented to GPs.
In addition, for a progressive disease with an extended impact on the lives of patients and 
their relatives, remarkably little is known about PD patients’ (health care) needs during 
changes in care.  Increasing our knowledge of patients’ experiences and their expectations 
of the GP allows for more customized support. In-depth understanding of the difficulties GPs 
experience in choosing their position in PD care, furthermore, may highlight areas that need 
attention in order for GPs to provide patient-centered quality care.
Objectives of this thesis
The aim of this thesis is to contribute to patient-centered quality care for community-
dwelling patients with PD from the first recognizable symptoms to advanced-stage disease 
by gaining insight into patients’ experiences before, during and after the diagnosis and the 
challenges GPs are confronted with in providing care to these patients. This thesis, therefore, 
will address the following objectives:
1. To gain insight into patient experiences of the diagnostic pathway of PD and to describe 
the factors that influence it.
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2. To gain insight into factors influencing patient dissatisfaction with the diagnostic 
pathway of PD.
3. To characterize the prodromal symptoms of PD presented in general practice.
4. To gain insight into patient experiences and coping with changes in care encountered 
during the course of PD.
5. To clarify the role community-dwelling PD patients see for their GP in PD care and to 
clarify the role GPs see for themselves.  
Outline of this thesis
Towards the diagnosis of Parkinson’s disease
The patient’s perspective
Based on a qualitative study of patient essays, Chapter 2 describes the patients’ views on the 
pathway from the first recognizable symptoms to the diagnosis of PD, dividing the pathway 
into three time intervals: recognizing the symptoms; deciding to seek help; and the process 
of diagnosing PD. 
In Chapter 3, we present data from a quantitative analysis of the above-mentioned patient 
essays that helps us understand the factors that influence patient dissatisfaction with the 
diagnostic pathway of PD.
The general practitioner’s perspective
Chapter 4 contains a nested case-control study of the prodromal symptoms of PD presented 
to GPs in four general practices participating in the Continuous Morbidity Registration (CMR) 
of the Radboud university medical center in Nijmegen, the Netherlands. 
Changes in care after the diagnosis of Parkinson’s disease
In Chapter 5, we provide the protocol of a longitudinal mixed methods study on changes in 
care of community-dwelling PD patients using video diaries and in-depth interviews with 
patients and their GPs.
The patient’s perspective
Chapter 6 describes a qualitative analysis of community-dwelling PD patients’ experiences 
and coping with the changes in care they encountered.
The general practitioner’s perspective
In Chapter 7, we compare the perspectives of community-dwelling PD patients and their GPs 
on the role of the GP in PD care, based on the results of a qualitative analysis.
Reflections and recommendations
Chapter 8 provides a critical review of the presented results and the set-up of 
the studies. In addition, it makes recommendations for clinical practice, education and 
future research.
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Abstract 
Objective: To explore patients’ views on their pathway to the diagnosis of Parkinson’s 
disease (PD). 
Methods: A qualitative study of 52 essays written by patients with PD, using comparative 
content analysis. 
 
Results: Patients divide their diagnostic pathway into three time intervals: recognition of 
the symptoms; the decision to seek help; and the process of diagnosing PD. Patients have 
difficulties recognizing the prodromal symptoms of PD (their knowledge is based on public 
figures with advanced PD) and mention their general practitioners do as well. The decision to 
seek help is influenced by the patient’s attitude towards health care and by their significant 
others. More than half of the patients believe their diagnosis was delayed. However, the 
majority of all patients are satisfied with their diagnostic trajectory. 
Conclusion: The pathway to diagnosing PD is an iterative process influenced by patient-, 
health care provider- and disease-related factors. Despite possible delay in diagnosis, 
patients are content with their pathway. 
Practice implications: In order to facilitate earlier diagnosis and timely therapeutic 
intervention (in particular with regard to future possibilities for disease-modifying therapy), 
effort is required to increase the recognition of prodromal symptoms of PD by patients, their 
significant others and health care providers. 
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Introduction
Parkinson’s disease (PD) is now recognized as a multisystem disorder with motor and non-
motor features.1 Some motor and non-motor features are prodromal symptoms: symptoms 
that are already present before the onset of the typical motor signs of PD.2 Patients seem 
to have prodromal symptoms years before they are diagnosed with PD.2-4 As physical 
abnormalities do not immediately lead to symptoms, the process is influenced by attention, 
awareness, interpretation and attribution of the patient.5, 6 The illness representations, 
which patients form of a perceived health threat, influence coping strategies including 
help-seeking behavior.7, 8 Earlier research has shown that it takes patients more time to 
recognize their motor symptoms and to realize they need medical attention, than it takes 
the general practitioner (GP) to diagnose PD.9 On the other hand, it is not uncommon that a 
patient needs to visit a number of health care providers before the diagnosis of PD is made.10 
When it comes to women and patients with young onset PD, health care providers seem 
to require more time to diagnose PD.11, 12 However, patients can benefit a lot from an early 
diagnosis of PD. Early recognition of symptoms allows patients and health care providers 
to discuss the benefits of timely therapeutic intervention on the one hand and the risk of 
side effects on the other. They can then make a shared decision on a customized balance 
between advantages and disadvantages, taking into account the patient’s personal situation 
and preferences. This is likely to result in maintenance of quality of life, slowdown of clinical 
progression and reduced mortality.13-15
Research in patients with cancer has shown that the pathway from the first recognizable 
symptoms to the diagnosis can be influenced by a number of factors such as the nature 
of the symptoms and the emotional response to them, knowledge of the disease and the 
consultation of significant others.16 In chronic diseases with a less threatening outcome, such 
as diabetes mellitus, the same factors are of importance.17 For PD it is unknown which factors 
influence the diagnostic pathway and how patients reflect on their pathway. However, more 
insight into the patients’ views could lead to interventions that facilitate an earlier diagnosis 
by avoiding as much delay as possible in the diagnostic pathway. In this study we aim to gain 
insight into the patients’ views on their diagnostic pathway and the factors that influence it. 
Furthermore, we want to know how patients reflect on their pathway.  
Methods
Recruitment
This study is part of a larger study on the prodromal symptoms of PD and the patients’ views 
on the trajectory towards the diagnosis. For this reason, all patient members of the Dutch 
Parkinson’s Disease Association whose email addresses were known (n = 4717) received an 
email, in which the study was explained and they were asked to participate. In case patients 
were willing to participate a digital essay format was sent. Digital essays rather than individual 
interviews were chosen to assure easily accessible, anonymous participation and to enable 
patients to reflect in their own pace. Participation was voluntarily and one-time only. 
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Patients were provided with contact information in case of questions, concerns or hesitations 
about participation. After completion of the essay format, patients had to agree with 
submission of the format. This step was assessed as informed consent. 
Data collection
Patients were asked for their demographic characteristics at the time of diagnosis: sex, age, 
level of education, employment status and civil status. To help them formulate their essay, a 
number of questions, based on literature and expert opinion, were developed in a small pilot 
study. The final questions are shown in Table 1.
Of all the patients who received an email, 27% (n = 1251) started writing an essay. Essays were 
completed by 21% (n = 974) of the patients: 689 patients responded before the reminder, 
285 afterwards. Patients with a different diagnosis than idiopathic PD were excluded (n = 74). 
Finally 900 essays remained (Figure 1). 
Question 
1. Can you describe your first complaint(s) that eventually turned out to be a  
 forerunner sign of PD? What did you do when you experienced this/these  
 complaint(s)?
2. Can you describe what happened next, until the moment you were diagnosed  
 with PD?
3. Did people in your surroundings influence the pathway to diagnosis? If so, in  
 what way?
4. Do you think, in your case, it would have been possible to diagnose PD earlier?  
 If so, at what time and why do you think so? What were the consequences for  
 you and your family?
Table 1. Subject questions included in digital essay format
4717 members were approached (100%) 3466 members did not respond to approach (73%)
277 members did not finish their essay (6%)
74 essays (2%) were excluded because member 
had a different diagnosis than Parkinson’s disease
purposive sampling
1251 members started an essay (27%)
974 members finished their essay (21%)
900 essays included in the study
52 essays coded and analyzed Figure 1. Selection of essays
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Data analysis
A purposive sample of 26 essays was entered into ATLAS.ti 7, a software program for detailed 
coding in qualitative data analysis. Purposive sampling, based on the collected demographic 
data, was used to increase the external validity and to provide a wide range of patients’ 
experiences. Level of education was divided into two categories: low and high. Finishing 
elementary school or vocational education was considered a low level of education. 
Finishing high school, higher professional education or university was considered a high 
level. The qualitative data analysis was an iterative process by two independent researchers 
(AP, LB), using the principles of comparative content analysis.18 The two researchers read the 
26 essays several times to familiarize themselves with the data. They independently applied 
codes to meaningful words and sentences in the essays. These codes were discussed and 
refined in consensus meetings with the supervisors (ToH, AL). New codes, arising from the 
discussion, were applied to the essays. After analysis of the 26 essays no significant new codes 
emerged (saturation). Codes were then grouped into themes, final themes were agreed upon 
with the supervisors (ToH, AL). These themes were structured in Figure 2. In order to verify 
the figure and the position of the themes within it, another purposive sample of 26 essays 
was analyzed. 
Figure 2. Stimulating and impeding factors on the pathway to diagnosis of Parkinson’s 
disease (PD); divided into the three time intervals of the pathway to diagnosis and related 
to factors concerning the patient, the health care provider and the disease
Time intervals in the 
pathway to diagnosis of 
Parkinson’s disease
Recognition of the 
symptoms
Decision to seek help
Iterative process
The process of diagnosing 
PD
Influencing 
factors on 
the process
Patient 
related
Knowledge of PD  
Alternative explanation
for the symptoms
 Assessment of the severity of the symptoms
 Influence of family, friends and colleagues 
        Attitude toward health care
        Adaptation of lifestyle
        Influence of the symptoms on  
        daily life
        Fear for the diagnosis
    Doctor-patient communication
        Recognition by the health  
        care provider
        Referral to the neurologist
       Alternation of the symptoms
Health care 
provider 
related
Disease 
related
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Results
Characteristics of the study population
About half of the participants were women (54%) (Table 2). The mean age at the time of 
diagnosis was 56 years (SD 14.5), varying between 32 and 84 years. The majority of the 
patients was employed (62%) and lived with a partner and/or children (75%) at the time 
of diagnosis. 
Male
Female
56.3 (14.5)
High
Low
Employee
Self-employed
Retired
Receive sickness benefit
Unemployed
Combination of employments
With partner/family
Single* 
Single* with children
n = 52 
24
28
26
26
25
2
12
4
4
5
35
13
4
Demographic variable  
Sex
Mean age in years (SD)
Level of education
Employment
Civil status 
*Including widowed and divorced
Table 2 Sample characteristics at the time of diagnosing Parkinson’s disease
Diagnostic process
We could distinguish three time intervals in the individual pathways to diagnosis, as 
described by patients: recognition of the symptoms, the decision to seek help from health 
care providers and the process of diagnosing PD (Figure 2). Each of these intervals will be 
further explored beneath. 
Recognition of the symptoms
Many patients stressed the importance of recognizing the first symptoms. The majority 
did not immediately recognize that their symptoms could be part of a disease. Rather, 
they described they realized something was abnormal. Family, friends or colleagues were 
described to be of influence in the recognition. 
Back from holiday, I thought that the handlebar of my folding bike was loose - it wobbled 
quite a bit. Perhaps a few days later, I thought the wheel of my regular bicycle wobbled as 
well. This could not be a coincidence; it had to be me. (Female, 53 years)
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[…] I took part in a walking event that spanned four evenings. One of my friends noticed my 
right arm did not swing while I was walking. (Female, 32 years)
Many patients described they initially found an alternative explanation for their symptoms, 
sometimes influenced by previous experiences or by family and friends.
I experienced difficulties with writing, which I noticed when writing many Christmas cards 
in December […]. I blamed increased computer use being the reason I was no longer 
accustomed to handwriting a lot. (Female, 47 years) 
I had some difficulties washing my hair. The right side was slower than the left side. When I 
said something about it, my children responded: mother you are getting older. (Female, 54 
years)
A few patients mentioned that they only knew what advanced PD looked like, based on 
information from books or television. That was the reason they had not taken PD into 
consideration.  
For me at that time, the image of Parkinson’s disease was defined by Prince Claus [member 
of the Dutch royal family] and the Pope [John Paul II], not knowing they already had an 
advanced stage of Parkinson’s disease. (Female, 47 years)
However, a few patients instantly identified their symptoms as a disease or even as PD. 
In February […] my leg started to shake and I knew I had Parkinson’s disease (my sister has it 
too and an acquaintance as well). (Female, 68 years)
Decision to seek help from health care providers
After recognizing that the symptoms were abnormal, patients indicated that they needed to 
make a decision whether to consult their GP or not. Several patients decided to seek help 
right after detecting the symptom(s), sometimes stimulated by family, friends or colleagues. 
However, a few patients seemed to have difficulties assessing the severity of their symptoms. 
They mentioned they were afraid what the health care provider might think of them and 
feared that their symptoms were due to dramatizing, or that they were wasting the health 
care provider’s time.
I visited the GP for a diagnosis when the thought occurred to me: there is really something 
physically wrong with me, this is not all in my head or the consequence of being alone with 
two kids making everything difficult, difficult, difficult. (Female, 49 years)
I remember that I felt guilty for taking his time, and I felt uncomfortable in the waiting room 
among the ‘real patients’. (Female, 47 years)
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The patient’s attitude towards health care appeared to be of importance. Patients think 
differently about consulting health care providers. Previous negative experiences in the 
communication with health care providers might influence the decision to return to the 
doctor with symptoms.
I grew up in an environment that favors alternative medicine, and thus did not seek help from 
mainstream medicine until later on. (Female, 70 years)
[…] Pain in my right leg and the lower back. Physical therapy. […] Still tired. Sometimes a seve-
re cramping around my heart. […] In June […] extensive testing, diagnosis of angina pectoris. 
Walking becomes more difficult: dizziness, my handwriting becomes spidery. Now and then 
blood tests, the results are always normal. My GP: “There is nothing wrong with you.” But 
where does this fatigue come from then? GP: ”Well, I’m not sure. But you’re not that young 
anymore!” I felt really tired lately, especially in the morning when getting out of bed. I get 
depressed. (Female, 84 years)  
Some patients described they adapted their lifestyle or made adjustments in order to relieve 
the symptoms.  
My left hand started to shake in more and more situations, it was especially bad in the choir; 
new sheet music in my hands, reading music and lyrics, and singing at the same time. […] 
At the December concert, I sang with a home-made brace to control my hand. (Female, 53 
years)
Patients indicated that they altered their decision to seek help when the symptoms got 
worse, new symptoms appeared or symptoms did not recover spontaneously. The restrictive 
influence of symptoms on the patient’s daily life was also mentioned as a reason to visit a 
health care provider.
After a good holiday with my family, the tremor still continued, so I visited the GP again. 
(Male, 32 years)
At one point, I became tired very easily, I lost strength in my arms. I was a production worker 
and noticed I had more and more trouble with my motor skills, then I went to the GP. (Male, 
42 years) 
A few patients actively decided not to seek help yet, because of fear for the diagnosis.
The first symptom was a tremor of the right hand, which came about suddenly. Furthermore, 
my husband and friends noticed that I did everything slower. For me, the worst part was the 
feelings of depression; that was not my nature. I had everything I ever wanted, but I could 
not enjoy it, it was horrible. My handwriting had changed as well, it became very small. 
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I struggled with it for two years, but deep in my heart I knew it was not good and that I 
probably had Parkinson’s disease. (Female, 61 years)
The process of diagnosing PD
Some patients described the GP immediately noticed that their symptoms could be signs of 
PD and referred them to the neurologist, who instantly diagnosed the disease. However, more 
than half of the patients mentioned their GP did not recognize the symptoms, sometimes 
not even when the patient specifically asked if it could signal PD. Other patients described 
they were referred to the physical therapist or orthopedic surgeon without a clarified 
diagnosis. Some patients mention their neurologist seemed to have difficulties recognizing 
the symptoms. 
My fingers no longer cooperated. I could not hold a pen and had constipation. Then I visited 
the GP. The GP did not recognize it as PD. He said the problems were caused by aging. (Male, 
69 years)
 
I had shoulder complaints. I went to the GP, who referred me to the orthopedic surgeon. He 
told me I had bursitis, which was treated by injections in my shoulder. I had to come back 
every 6 weeks […]. I was treated for 2 years like this. (Male, 52 years)
Reflecting on the pathway
Patients reflected differently on their diagnostic pathway. Nearly half of the patients believed 
they could not have been diagnosed earlier. 
I do not think I could have been diagnosed faster. My complaints are always taken seriously, 
even when they were ‘vague’. Some can, retrospectively, be attributed to PD. (Male, 83 years)
However, the majority of the patients did believe their diagnosis was delayed. A few patients 
felt this was the result of their own help-seeking behavior. Others described that they 
believed the health care provider did not recognize their symptoms in time or postponed 
referral to a neurologist. Nevertheless, most patients were satisfied with the trajectory 
towards diagnosis. A few discontent patients described difficulties in the communication 
with their doctor.
If I look back, then the diagnosis probably could have been made earlier, but this was my 
doing. But I do not regret the path I took and that I only took action after 2 years. (Female, 
61 years) 
If I had gone to the GP earlier, and the GP had known more about PD, then some things could 
have been detected faster. If the diagnosis was made earlier, I could have felt better about it 
emotionally. (Male, 53 years)
Processed on: 18-4-2017
509581-L-bw-plouvier
30
Parkinson’s disease in primary care | A joint journey of patients and general practitioners
Discussion and conclusion
Discussion
To the best of our knowledge, this is the first study that explores the pathway to the diagnosis 
of PD from the patients’ viewpoint. The pathway to the diagnosis of PD, as described by 
patients, can be divided into three time intervals: recognition of the symptoms, the decision 
to seek help and the process of diagnosing PD. Impeding and stimulating factors concerning 
the patient, the health care provider and the disease itself can influence each of these time 
intervals. Although more than half of the patients believed their diagnosis was delayed, the 
majority of all patients were satisfied with the trajectory towards diagnosis.
Earlier studies have shown that the pathway to the diagnosis of a disease can be divided into 
several stages in which delay can appear. Safer et al. proposed a model of three stages of 
delay in seeking care at a medical clinic.19 Andersen et al. and Walter et al. have built further 
on this, resulting in the model of Walter that contains four intervals with clearly defined 
start and end-points: the appraisal interval (from detection of bodily change(s) to perceiving 
a reason to discuss symptoms with a GP); the help-seeking interval (from perceiving a 
reason to visit the GP to the first consultation with a GP); the diagnostic interval (from the 
first appointment to the diagnosis); and the pre-treatment interval (the time between the 
diagnosis and initiation of treatment).20, 21 With the exception of the pre-treatment interval, 
this model seems very well applicable to our results.
According to the model of Walter et al.21, the intervals of the pathway to diagnosis are 
influenced by patient -, health care provider- and disease-related factors. Most influencing 
factors found in our study are patient-related and can be stimulating as well as impeding. These 
include (lack of) knowledge of PD, alternative explanations for the symptoms, assessment 
of the severity of the symptoms (and possible interpretation as common illnesses), the 
influence of family, friends and colleagues, adaptations in lifestyle to relieve the hinder and 
the restrictive influence on daily life. These results are in line with the factors found to be 
of influence in studies on cancer and diabetes.16, 17, 22 However, our study reveals that the 
media play an important role as well on the diagnostic pathway of PD. Books and television 
paint a classic picture of PD, thereby limiting the knowledge of the disease and influencing 
the assessment of severity. Furthermore, our findings reveal that fear for the diagnosis can 
hold-back patients from seeking help. Although this fear is described in cancer research as 
well, fear for cancer might be difficult to compare to fear for PD. Patients associate cancer 
with painful treatments and death22 while they might not have such explicit ideas about PD. 
Since most prodromal symptoms of PD are not acute or life threatening, patients can decide 
to postpone seeking help. Our study showed that the patient’s attitude towards health care 
providers, sometimes prompted by earlier experiences, can also influence the decision to 
seek help. Some patients mention they are hesitant to present their non-specific symptoms 
to their GP, afraid they might be seen as somatizers. This is in line with earlier research that 
showed that patients carefully consider when to consult their GP and are concerned about 
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going with non-specific symptoms.16, 17, 22, 23 Research in epilepsy also showed that patients 
might postpone seeking help because they are not ready to accept the diagnosis of a chronic 
disease.24 The same might be true for patients with PD. 
A number of health care provider-related factors influence the diagnostic pathway as well. 
Health care providers need to recognize the (prodromal) symptoms and suspect PD. The 
importance of educating physicians to consider the possibility of prodromal PD is already 
expressed in earlier research.25 However communication also seems to be an important 
factor influencing patients’ contentment with their diagnostic pathway.26 It is desirable that 
patients are provided with customized information concerning the suspected diagnosis 
and treatment options. They should be encouraged to participate in the decision-making 
process on referral to a movement disorder specialist and on therapy.14, 27 For this, physicians 
need to persuade patients to ask questions, articulate their expectations and voice 
their preferences.28
Finally, disease-related factors are of influence on the diagnostic pathway, in particular on 
the decision to seek help. In line with literature16, 17, 22, we found that patients are more 
inclined to seek help when their symptoms become worse or do not recover spontaneously. 
However, this requires patients who are aware of bodily changes and are capable to carefully 
monitor their symptoms.19 In addition, the general population should be more aware of 
symptoms that can be highly relevant for the early detection of PD.25
The pathway to diagnosis is a dynamic and iterative process in which patients may not 
experience a linear passage through the intervals, and in which steps can be repeated until 
PD is diagnosed. This is also shown in the model of Walter et al.21 Based on that model 
we developed a figure that summarizes all the influencing factors found in this study, as 
discussed above (Figure 2).  
Asking patients to retrospectively describe their diagnostic pathway inevitably leads to 
limitations. Patients may find it difficult to remember precisely what took place prior to the 
diagnosis, at what time and in which order, especially since for some patients it is years ago 
since they were diagnosed. Therefore, recall bias cannot be ruled out. However, with the 
use of a digital essay format we gave patients the opportunity to go back in time and recall 
the pathway, while supporting the arrangement of their memories. The format with open 
questions led to essays of comparable structure, at the same time maintaining the possibility 
for the patients to individualize their answers. Unfortunately, the time frame in the essays is 
not always clear. Therefore there are limitations in comparing the time frame of each interval 
with other studies.9, 26 
The preset questions and the approach via internet have other disadvantages. The extent 
of details found in the essays is limited; in-depth interviews could have given more detailed 
Processed on: 18-4-2017
509581-L-bw-plouvier
32
Parkinson’s disease in primary care | A joint journey of patients and general practitioners
information on the diagnostic pathway. Moreover, it is estimated that less than 25% of all 
patients with PD in the Netherlands is a member of the Dutch Parkinson’s Disease Association. 
Furthermore, only a selection of the patient members of the Association is reached with the 
approach through email and the use of a digital essay format. Members who are unable 
to use a computer or feel uncomfortable with it are left out. Although information on the 
demographic variables of the non-responders and the reasons why they did not take part 
is lacking, the inability or undesirability to use the computer may be the explanation that 
the respondents, whose essays are included in the analysis, are relatively young and well 
educated despite the application of purposive sampling. It cannot be ruled out that the 
results of our study are influenced by this, since it is known that health literacy is influenced 
by the patient’s level of education and lifestyle commitments.29, 30 However, we included a 
highly variable sample of respondents and achieved saturation in the analysis. Moreover 
we verified the figure and the position of the themes within it with the analysis of a second 
sample of essays. Therefore we feel confident that our results hold sufficient external validity. 
Conclusion
The pathway to the diagnosis of PD is a dynamic and an iterative process. As described by 
patients, both patients and GPs have difficulties in recognizing the early symptoms of PD.
Patients often have a limited perception of PD, based on public figures with an advanced 
stage of PD. More than half of the patients believed they could have been diagnosed earlier. 
At the same time, the majority of all patients are content with their pathway. Nevertheless, 
patients can benefit a lot from an early diagnosis and timely therapeutic intervention, taking 
into account the patient’s personal situation and preferences. Therefore it is important that 
patients, their significant others and GPs learn to recognize the early symptoms of PD and 
act accordingly.
Practice implications
In order to facilitate an earlier diagnosis of PD, which enables shared decision-making 
between patients and health care providers, educating the general population on possible 
prodromal symptoms of PD should be considered. The image of PD, as it is spread by the 
media, has to be modified from the classic image of the old man with advanced symptoms to 
a more complete representation of the disease. 
It is necessary to explore whether the patient’s view on possible lack of knowledge of the GP 
is underlined by the health care providers themselves. The GP has a central role in putting 
together all pieces of the puzzle which a patient has presented over time, in order to signal PD. 
Furthermore, he/she is the gatekeeper to care, who has to refer to a neurologist. Therefore, 
it seems without debate that knowledge on the prodromal symptoms of PD is essential. A 
subsequent quantitative analysis of all 900 collected essays of patients with PD is necessary 
and will give us more insight into the prodromal symptoms of PD that are experienced by 
patients and reported spontaneously by them. 
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Finally, we would strongly advise to no longer use ‘stage(s) of delay’ in the conversation 
concerning a diagnostic process. Delay has a negative connotation and does not appreciate 
the autonomy of the patient, who might decide to hold-back help-seeking for a number of 
reasons. Furthermore, our results show that most patients are content with the pathway 
they experienced, although objectively spoken delay might have taken place. In other 
literature the term ‘time interval’ is suggested as an alternative for ‘stage of delay’.21 We believe 
this term accurately describes a stage (the time between two events) and, most importantly, 
does not criticize the decisions made by patients, alone or together with their health 
care providers. 
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The diagnostic pathway of Parkinson’s disease: a cross-sectional 
survey study of factors influencing patient dissatisfaction
I could have been diagnosed earlier if my GP had made the referral earlier. The advice of our 
GP to put Parkinson’s out of our heads was especially upsetting; my husband and I [...] were 
extremely overwhelmed by the diagnosis of the neurologist. Because of this, we felt anger 
towards the GP [...], and our trust in her has been damaged. (Female, 58 years)
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Abstract
Background: The diagnostic pathway of Parkinson’s disease (PD) is often complicated. 
Experiences during this pathway can affect patients’ satisfaction and their confidence and 
trust in health care providers. Although health care providers cannot influence the impact of 
the diagnosis, they can influence how patients experience the pathway. This study, therefore, 
aims to provide insight into PD patients’ dissatisfaction with the diagnostic pathway and to 
describe the factors that influence it. 
Methods: We carried out a cross-sectional survey study among 902 patient members of the 
Dutch Parkinson’s Disease Association, who were each asked to write an essay about their 
diagnostic pathway. A coding format was developed to examine the content of these essays. 
Inter-observer agreement on coding patient dissatisfaction was calculated using Cohen’s 
kappa. The chi-square test and a multivariate logistic regression analysis were performed 
to assess the relation between dissatisfaction and sex, level of education, duration of the 
pathway, communication with the general practitioner (GP) and the neurologist, the number 
of health care providers involved, whether or not a second opinion had taken place (including 
the person who initiated it) and diagnostic delay (taking into consideration who caused the 
delay according to the patient). A subgroup analysis was performed to gain insight into sex-
related differences.
Results: Of all patients, 16.4% explicitly described they were dissatisfied with the diagnostic 
pathway, whereas 4.8% were very satisfied. The inter-observer agreement on coding 
dissatisfaction was κ = 0.82. The chance of dissatisfaction increased with a lower level of 
education, the involvement of more than one additional health care provider, a second 
opinion initiated by the patient and delay caused by a health care provider. When only the 
GP and the neurologist were involved, women were more likely to be dissatisfied than men.
Conclusions: PD patients’ dissatisfaction with the diagnostic pathway is related to a lower 
level of education, a second opinion initiated by the patient and experienced diagnostic 
delay. GPs can positively influence patients’ experiences if they are aware of these risk 
factors for dissatisfaction and pay extra attention to communication and shared decision-
making. This will contribute to a trusting therapeutic relationship that is indispensable with 
progression of the disease. 
Processed on: 18-4-2017
509581-L-bw-plouvier
39
3
Chapter 3 | The diagnostic pathway of Parkinson’s disease: a cross-sectional 
survey study of factors influencing patient dissatisfaction
Background
Patients’ experiences during the pathway to a diagnosis can influence long-term care. 
Research in cancer patients shows that patients tend to lose confidence and trust in their 
general practitioner (GP) if the nature of the presented symptoms is not immediately 
recognized by the GP and if multiple visits to the GP are necessary before referral takes 
place.1-3 Moreover, patients may interpret the need to consult their GP repeatedly as lack of 
responsiveness and thus as delay caused by the GP, resulting in patient dissatisfaction.4
Diagnosis timing issues may induce patients to change general practice.5 The importance 
of timeliness of diagnosis related to patient dissatisfaction emerges from a study amongst 
cancer patients, showing that patients suffering from cancer types that are difficult to 
recognize, such as ovarian cancer and multiple myeloma, are more likely to change practice 
than patients with types of cancer that are easier to recognize, such as melanoma and breast 
cancer.5 In addition, long-term care experiences of cancer patients are worse for those who 
visited their GP several times before they were referred than for those who were referred 
instantly.2
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that can be difficult to 
diagnose.6 Classic symptoms such as muscular rigidity and tremor are not always present and 
may be preceded by a variety of motor and non-motor symptoms that are not necessarily 
disease-specific.7-10 When patients consult their GP, symptoms are often still limited and 
embedded in clinical uncertainty, while referral to the neurologist takes place later in the 
disease trajectory.10-12 This may explain the difficulties GPs encounter in recognizing PD as the 
common cause of these symptoms and in referring accordingly.10, 12 As a consequence, the 
pathway to the diagnosis of PD can be lengthy and uncertain and, unless well explained, it 
is reasonable to expect a negative influence on patient confidence, trust and satisfaction.6, 13
Although the impact of a PD diagnosis cannot be taken away completely, health care 
providers can have an influence on how patients experience the diagnostic pathway. It is 
known that PD patients’ dissatisfaction with the way the diagnosis of PD is explained to them 
has an impact on health-related quality of life.14 Lack of involvement in therapy decisions 
is also negatively related to satisfaction and compliance with therapy.15 However, research 
into patient experiences of the diagnostic pathway of PD is limited and does not provide 
any insight into factors influencing patient dissatisfaction.13, 16 Patients will benefit from a 
sustained trusting relationship with their GPs, in which they have confidence in the personal 
care provided by the GP, as progression of the disease will inevitably cause health problems 
that require the GP’s involvement.17 In order to optimize patients’ experiences of the pathway 
to the diagnosis of PD and, hence, to contribute to a trusting patient-doctor relationship, this 
study aims to improve our understanding of PD patients’ dissatisfaction with the diagnostic 
pathway and to describe the factors influencing it.
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Methods
Recruitment and data collection
We conducted a cross-sectional survey study among patient members of the Dutch 
Parkinson’s Disease Association. All members with a known email address (n = 4717) 
were approached digitally to enlist their participation. Patients were asked to fill in their 
demographic characteristics at the time of diagnosis: sex, age, highest level of education 
finished, employment status and civil status. They were also asked to describe their 
experiences of the pathway from the first recognizable symptom(s) to the diagnosis of PD. 
To facilitate patients in formulating their essay, we provided them with a number of guiding 
questions that were based on the literature and expert opinion and had been tested in a pilot 
study (Table 1). 
In case patients had questions, concerns or hesitations, they could contact the researcher 
(AP). After finishing their essays, patients had to agree to submission, a step that was 
assessed as informed consent. Participation was one-time only, voluntarily and anonymous. 
The research ethics committee of the Radboud university medical center examined the 
protocol of the study and concluded that the study could be carried out in the Netherlands 
without needing approval by the regional research ethics committee.
A qualitative analysis of a purposive sample of 52 essays preceded this study. We refer to the 
paper describing this analysis for more detailed information on recruitment, data collection 
and results.16 The qualitative analysis results were used to create a format to examine the 
content of all essays. Details on the coding format are described in Additional file 1.
Though patient dissatisfaction with the diagnostic pathway was the main focus of the current 
study, patients were not explicitly asked for their satisfaction or dissatisfaction. Rather, 
we encouraged them to describe their feelings about the timing of the diagnosis and the 
consequences of this timing in order to gain insight into patients’ spontaneous reporting 
of the diagnostic pathway (Table 1). We only applied codes if patients spontaneously and 
unmistakably expressed their satisfaction or dissatisfaction: ‘satisfied’ was coded when 
Question 
1. Can you describe the first symptom(s) that eventually turned out to be a forerunner  
 sign of PD? What did you do when you experienced this symptom or these  
 symptoms?
2. Can you describe what happened next, until the moment you were  
 diagnosed with PD?
3. What role was there for people in your surroundings during the diagnostic  
 pathway?
4. Looking back on the diagnostic pathway, how do you feel about the timing of the   
 diagnosis? Can you describe the consequences of this timing for you and    
 your family?
Table 1. Questions guiding patients to describe their experiences of the diagnostic pathway of Parkinson’s disease
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patients were clearly positive, and ‘dissatisfied’ was coded when patients explicitly mentioned 
problems or made negative remarks. All other cases were coded ‘neutral’. To enable the 
researchers to interpret satisfaction and dissatisfaction with the diagnostic pathway, it was 
defined as ‘the overall feeling a patient expressed about the diagnostic pathway in his/her 
essay’, and it was independently coded by two researchers (AP, OdB) in a random sample of 
225 essays (25%) to enable calculation of inter-observer agreement.
The same researchers also independently coded 154 essays (17.1%) completely, initially to 
create consensus on the coding method, and later to discuss doubts in coding. The other 
748 essays were coded by one researcher (OdB). Codes were only applied if patients in their 
essay explicitly described the duration of the pathway, communication with the GP or the 
neurologist, the number of different health care providers involved, a second opinion or 
experienced delay. 
Data analysis
Statistical analyses were conducted using SPSS 22.0. Descriptive statistics were calculated. 
As patient dissatisfaction was the main focus of our analysis, the expressed feelings were 
divided into two categories: dissatisfied and neutral/satisfied. Cohen’s kappa was used to 
calculate inter-observer agreement. 
The chi-square test was used to assess the relation between dissatisfaction with the 
diagnostic pathway and factors that may have been of influence. These factors included the 
demographic variables sex and level of education, the latter divided into low (primary school/
vocational education), medium (secondary school) and high (higher professional education/
university). Moreover, we assessed the relation between dissatisfaction and duration of 
the diagnostic pathway (divided into unknown, <2 years or ≥2 years on the basis of the 
literature6, 8, 9); communication with the GP or the neurologist (negative, neutral/positive); 
and the number of different health care providers involved (0, 1, 2, ≥3). As guidelines in the 
Netherlands describe the involvement of a GP and a neurologist as usual care in the pathway 
to the diagnosis of PD, these health care providers were excluded from the number of health 
care providers involved.11, 18
In addition, we performed the chi-square test to assess the relation between dissatisfaction 
and second opinion. Second opinion was defined as ‘the involvement of a second neurologist 
during the pathway towards the diagnosis of PD’ and was categorized into: no second opinion/
not mentioned; second opinion on the patient’s initiative (including the combined initiative 
of patient and health care provider); and second opinion on the health care provider’s 
initiative. We also assessed the relation between dissatisfaction and experienced diagnostic 
delay, taking into consideration who caused the delay according to the patient. Delay was 
divided into: no delay; not (clearly) mentioned; caused by the patient (including caused by 
both the patient and the health care provider); caused by the health care provider(s); and 
unknown who caused it.
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A multivariate logistic regression analysis was performed to assess the independent 
association between dissatisfaction and sex, level of education, duration of the diagnostic 
pathway, the number of different health care providers involved, second opinion and 
experienced delay. As only few patients explicitly described their communication with the GP 
and the neurologist, this factor was excluded from the regression analysis. We also excluded 
second opinions if it was unknown on whose initiative they had taken place. As the literature 
shows that female patients tend to be more dissatisfied with care than male patients19, we 
also performed a subgroup analysis to gain insight into possible sex-related differences. 
Therefore, we added interaction terms of sex with the other variables to the multivariate 
regression model. A P-value less than 0.05 was considered statistically significant. 
Results and discussion
Characteristics of the study population
Of all patient members who received an email, 27% started and 21% finished the essay. 
Seventy-two essays were excluded due to incorrect or uncertain diagnosis of PD or a complete 
lack of information. Finally, 902 essays were included in this study (Figure 1). More men than 
women participated, and most patients had a high level of education (Table 2). Mean age at 
the time of diagnosis was 60 years (SD 9.9).
Figure 1. From recruitment of patient members of the Dutch 
Parkinson’s Disease Association to essays included
4717 members were approached (100%) 3466 members did not respond to approach (73%)
277 members did not finish their essay (6%)
72 essays (2%) were excluded because:
- members had a different diagnosis than 
Parkinson’s disease or the diagnosis was uncertain
- the essay contained no information at all
1251 members started an essay (27%)
974 members finished their essay (21%)
902 essays included in the study (19%)
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Patient dissatisfaction with the diagnostic pathway
The inter-observer agreement of the two researchers (AP, OdB) on coding patient 
dissatisfaction with the diagnostic pathway was κ = 0.82 (95% CI 0.72-0.91).
More than one in seven patients (n = 148; 16.4%) explicitly described they were dissatisfied 
with the experienced diagnostic pathway. Most patients (n = 711; 78.8%) did not clearly 
express their opinion, while less than five per cent (n = 43; 4.8%) mentioned they 
were satisfied. 
Dissatisfaction was significantly associated with several factors. Female sex (P < 0.01), 
duration of the pathway (P < 0.001), communication with the GP or the neurologist (P < 0.001 
and P < 0.01, respectively), the number of health care providers involved (P < 0.001), second 
opinion (P < 0.001) and experienced delay (P < 0.001) increased the chance of dissatisfaction 
(Table 3).
Male
Female
60.1 (9.9)
Low
Medium
High
Employed
Self-employed
Retired
Recipient of sickness benefits
Unemployed
Combination of employments/other
Single*
With partner
With family (including partner)
Other
n = 902 (100%) 
550 (61.0%)
352 (39.0%)
250 (27.7%)
284 (31.5%)
368 (40.8%)
352 (39.0%)
71 (7.9%)
307 (34.0%)
18 (2.0%)
86 (9.5%)
68 (7.5%)
80 (8.9%)
596 (66.1%)
217 (24.1%)
9 (1.0%)
Demographic variable 
Sex
Mean age in years (SD)
Level of education
Employment
Civil status 
*Including widowed and divorced
Table 2 Included PD patients’ characteristics at the time of diagnosis
Processed on: 18-4-2017
509581-L-bw-plouvier
44
Parkinson’s disease in primary care | A joint journey of patients and general practitioners
The multivariate analysis showed that low-educated patients were more likely to be 
dissatisfied than medium and high-educated patients (OR 0.45; CI 0.2-0.9 and OR 0.46; 
CI 0.2-0.9, respectively). The chance of dissatisfaction was also significantly higher when 
more than one additional health care provider was involved. With the involvement of two 
extra health care providers, the odds ratio for patient dissatisfaction was 2.53 (CI 1.2-5.3) 
compared to a situation in which only the GP and the neurologist were involved. If three or 
more additional health care providers were involved, the odds ratio for dissatisfaction was 
even higher (OR 3.92; CI 1.4-10.7). A second opinion on the patient’s initiative increased the 
chance of dissatisfaction compared to cases without a second opinion (OR 5.04; CI 2.3-10.9). 
In addition, when patients experienced delay caused by a health care provider, they were 
significantly more likely to be dissatisfied than patients who did not experience delay (OR 
38.78; CI 20.0-75.0) (Table 4).
Variable 
Sex (n = 902)
 - Male
 - Female
Level of education (n = 902)
 - Low
 - Medium
 - High
Duration of the diagnostic pathway (n = 902)
 - Unknown
 - <2 years
 - ≥ 2 years
Communication with the general practitioner (n = 77)
 - Negative
 - Neutral/positive
Communication with the neurologist (n = 78)
 - Negative
 - Neutral/positive
Number of health care providers involved (n = 902)a
 - 0
 - 1
 - 2
 - ≥3
Second opinion (n = 856)b
 - No/not mentioned
 - Yes, on the patient’s initiative
 - Yes, on the health care provider’s initiative
Experienced delay (n = 902)
 - No delay
 - Not (clearly) mentioned
 - Yes, caused by the patient
 - Yes, caused by a health care provider
 - Yes, unknown who caused it
*Statistically significant, P < 0.05
aExcluding GP and neurologist 
bExcluding second opinion, initiative unknown 
Patient 
dissatisfaction
n (%)
74 (13.5%)
74 (21.0%)
49 (19.6%)
40 (14.1%)
59 (16.0%)
54 (13.3%)
28 (12.1%)
66 (25.0%)
40 (69.0%)
2 (10.5%)
41 (62.1%)
1 (8.3%)
43 (8.2%)
52 (21.3%)
31 (34.8%)
22 (52.4%)
93 (12.5%)
29 (45.3%)
12 (24.5%)
15 (3.2%)
9 (6.8%)
2 (2.6%)
111 (61.0%)
11 (26.2%)
Patient 
satisfaction/neutral
n (%)
476 (86.5%)
278 (79.9%)
201 (80.4%)
244 (85.9%)
309 (84.0%)
352 (86.7%)
204 (87.9%)
198 (75.0%)
18 (31.0%)
17 (89.5%)
25 (37.9%)
11 (91.7%)
484 (91.8%)
192 (78.7%)
58 (65.2%)
20 (47.6%)
650 (87.5%)
35 (54.7%)
37 (75.5%)
454 (96.8%)
124 (93.2%)
74 (97.4%)
71 (39.0%)
31 (73.8%)
P-value
<0.01*
0.22
<0.001*
<0.001*
<0.01*
<0.001*
<0.001*
<0.001*
Table 3. Univariate analysis of factors influencing patient dissatisfaction with 
the diagnostic pathway of Parkinson’s disease 
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Variable (n = 856)b
Sex 
 - Male
 - Female
Level of education 
 - Low
 - Medium
 - High
Duration of the diagnostic pathway 
 - Unknown
 - <2 years
 - ≥ 2 years
Number of health care providers involveda 
 - 0
 - 1
 - 2
 - ≥3
Second opinion
 - No/not mentioned
 - Yes, on the patient’s initiative
 - Yes, on the health care provider’s initiative
Experienced delay 
 - No delay
 - Not (clearly) mentioned
 - Yes, caused by the patient
 - Yes, caused by a health care provider
 - Yes, unknown who caused it
*Statistically significant, P < 0.05
aExcluding GP and neurologist 
bExcluding second opinion, initiative unknown 
Odds ratio 
(OR) for 
dissatisfaction
Reference
1.50
Reference
0.45
0.46
Reference
1.20
1.43
Reference
1.66
2.53
3.92
Reference
5.04
2.11
Reference
1.85
0.84
38.78
7.14
95% Confidence 
Interval (CI)
0.9-2.5
0.2-0.9
0.2-0.9
0.6-2.4
0.8-2.5
0.9-3.0
1.2-5.3
1.4-10.7
2.3-10.9
0.8-5.4
0.7-4.6
0.2-4.0
20.0-75.0
2.7-19.0
P-value
0.12
0.12
0.02*
0.02*
0.01*
0.47
0.61
0.22
0.01*
0.09
0.01*
<0.01*
<0.001*
<0.001*
0.12
<0.001*
0.19
0.83
<0.001*
<0.001*
Table 4. Multivariate logistic regression of factors influencing patient 
dissatisfaction with the diagnostic pathway of Parkinson’s disease 
Men and women significantly differed in the relation between dissatisfaction with the 
diagnostic pathway and the number of health care providers involved during this pathway. 
If no health care providers were involved, female patients were more likely to be dissatisfied 
than male patients (OR 3.11; CI 1.4-7.0). There were no significant differences between men 
and women in the chance of dissatisfaction with the involvement of one or more additional 
health care provider(s) (OR 0.58; CI 0.2-1.4 with one, OR 1.63; CI 0.4-5.8 with two, and OR 
1.92; CI 0.3-12.1 with three or more health care providers involved). No interaction effects 
were found for any other variables (results provided in Additional file 2).
Discussion
Most patients in our study do not describe dissatisfaction with the diagnostic pathway 
of PD. However, more than one in seven patients is explicitly dissatisfied. The chance of 
dissatisfaction is increased with a lower level of education, the involvement of more than 
one additional health care provider, a second opinion on the patient’s initiative and delay 
caused by the health care provider. In addition, if only the GP and neurologist have been 
involved in the diagnostic pathway, women are more likely to be dissatisfied than men.
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Although dissatisfaction with the diagnostic pathway of PD appears to be playing a 
limited role in quantitative terms, dissatisfaction with the initial diagnostic process can 
have an impact on long-term care, stressing the importance of paying attention to it: 
cognitions formed at an early stage tend to determine care experiences during the further 
treatment episode.2, 5, 20
Our study shows that it is not the duration of the diagnostic pathway of PD on its own that 
leads to patient dissatisfaction, but that other factors appear to be important as well. In 
line with the literature, the women in our study are more likely to be dissatisfied than the 
men.5, 19 Contrary to what we expected, however, the chance of dissatisfaction is highest 
for low-educated patients.5, 19 As only few patients in our study explicitly mention their 
communicative experiences with the GP and the neurologist, we could not demonstrate an 
independent association between dissatisfaction and communication. It is likely, though, 
that communication at least partly explains the finding that low-educated patients are more 
often dissatisfied than patients with higher education as low-educated PD patients are 
known to have a lower level of health literacy than high-educated patients and a low level of 
health literacy negatively influences patients’ ability to obtain and understand information 
about a disease.21, 22
In the case of PD, the complexity and abstractness of the process in the brain that causes 
the complaints and the varying expression of the disease can be difficult for a doctor to 
explain understandably and challenging for a patient to grasp fully. An earlier study shows 
that the way the diagnosis of PD is communicated to a patient is very important.13 Moreover, 
the difficulty for GPs to recognize PD and the fact that a diagnosis is not 100% certain until 
autopsy is performed are likely to influence patients’ experiences of the diagnostic pathway 
of PD as well.10, 17 Cancer patients, for example, mention they feel uncertain and anxious 
if referral is not explained carefully, and patients with amyotrophic lateral sclerosis report 
falsely raised hopes after every negative investigation.20, 23 Our study shows that patients 
who feel that their health care provider is responsible for delay in the diagnostic pathway are 
more likely to be dissatisfied than patients who do not describe delay.
Lack of communication during the diagnostic pathway is also known to have a long-term impact 
on the patient-doctor relationship, a relationship that depends on patients’ satisfaction and 
their confidence and trust in the health care provider - with the risk of disappointment as the 
distinguishing feature between the latter two: in a situation of trust one is more likely to be 
disappointed-.20, 24 In our study, patient dissatisfaction is related to a second opinion on the 
patient’s initiative. Although we do not know whether dissatisfaction is the cause or the result 
of the patient’s request for a second opinion, earlier research shows that dissatisfaction is 
negatively associated with trust and that trust limits the tendency for patients to request for 
a second opinion.24 Physicians who listen carefully, behave empathically and communicate 
clearly are more likely to be trusted by their patients.24, 25 Moreover, trust is further enhanced 
if patients feel they are treated as equal partners.24, 25 
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Though the negative impact of being diagnosed with PD cannot be ruled out, GPs can 
contribute to their patients’ experiences of the diagnostic pathway of PD in a positive way by 
using their central role in symptom recognition and referral to communicate openly about 
the clinical uncertainty involved in PD diagnosis and about the expectations of referral, 
while taking into account a patient’s level of health literacy and offering scope for questions, 
hesitations and emotions. This is how GPs and patients can go through the diagnostic pathway 
of PD together and make shared decisions whenever possible or desirable. It is likely that 
such an experience will contribute to patient satisfaction with the pathway and will help 
to maintain a trusting therapeutic relationship that is indispensable with progression of 
the disease.17 
Strengths and limitations of the study
To the best of our knowledge, this is the first study that reports on patient dissatisfaction 
with the diagnostic pathway of PD and factors that might be of influence. We included a large 
number of essays. Moreover, we used an original approach to mixed methods research.26 
Our data are based on patients’ spontaneous reporting, thus reflecting what matters most to 
them, rather than reflecting their recognition of pre-determined items.
We used a coding format that was based on the results of our preceding qualitative study, and 
a considerable part of all essays was independently coded by two researchers, who reached 
consensus in case of coding disagreement.16 The strength of the inter-observer agreement 
on coding dissatisfaction can be considered ‘almost perfect’, confirming our opinion that 
we used a reliable method to extract the content of the essays.27 We feel confident that the 
results of our study provide valuable new information that can be used to improve patient 
experiences of the diagnostic pathway of PD.
Nevertheless, there are limitations to consider when interpreting the results of this study. 
As patients described their experiences retrospectively, recall bias cannot be ruled out. 
In addition, this study used the diagnostic pathway of PD as a starting-point, yet patients 
are likely to have had previous care experiences with their GPs, and their satisfaction or 
dissatisfaction with these earlier care episodes may have influenced their experiences with 
the diagnostic pathway of PD as well as their description of it. In addition, dissatisfaction with 
the pathway cannot solely be interpreted as dissatisfaction with the GP, as more health care 
providers have likely been involved in the diagnostic process. The spontaneous reporting 
method does not allow for interpretation of causality and if information on a second opinion 
is lacking, for example, it may not have been performed or it may not have been reported.
For practical reasons, we chose to approach only those PD patients in the Netherlands who are 
members of the Dutch Parkinson’s Disease Association, and not all patients we approached 
finalized their essay. As information on the non-responders and the patients who did not 
finish their essay is lacking, selection bias cannot be ruled out. As a possible result of our 
decision to use a digital approach, the patients included in our study are relatively young, 
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and it cannot be ruled out that this unequal distribution has influenced the results as well, as 
younger patients are generally known to be less satisfied.19 
Conclusions
The diagnostic pathway of PD can be lengthy and uncertain, and more than one in seven PD 
patients is clearly dissatisfied with it. This study shows that patient dissatisfaction is related 
to a lower level of education, a second opinion on the patient’s initiative and delay that is 
caused by the health care provider according to the patient. GPs can positively influence 
their patients’ experiences if they are more aware of these risk factors for dissatisfaction 
and pay extra attention to open communication on the clinical uncertainties of the early 
symptoms of PD and on shared decision-making on referral. This is likely to contribute to a 
trusting relationship between PD patients and their GPs, a relationship that is essential at all 
stages of the disease. 
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Additional files
Additional file 1 
Coding format to examine patients’ essay contents; only variables included in the analysis 
have been incorporated
Variable
Sex
Year of birth
Year of diagnosis
Age at the time of diagnosis
Highest level of education finished
Employment status at the time of 
diagnosis
Civil status at the time of diagnosis
Duration of the diagnostic pathway
Communication with the GP during the 
diagnostic pathway 
Communication with the neurologist 
during the diagnostic pathway 
Health care providers involved in the 
diagnostic pathway 
Second opinion
Experienced delay during the diagnostic 
pathway
Satisfaction with the diagnostic pathway 
Values
1 = Male
2 = Female
Year
Year
Age in years
Low = Primary school/Vocational education 
Medium = Secondary school
High = Higher professional education/university 
1 = Employed
2 = Self-employed
3 = Retired
4 = Recipient of sickness benefits
5 = Unemployed
99 = Combination of employments/other
1 = Single (including widowed and divorced)
2 = With partner
3 = With family (including partner)
99 = Other
0 = unknown
1 < 2 years
2 ≥ 2 years 
0 = Not mentioned/unknown
1 = Negative
2 = Neutral/Positive
0 = Not mentioned/unknown
1 = Negative
2 = Neutral/Positive
Each health care provider as a separate variable
0 = Not involved/not mentioned
1 = Involved
0 = No/not mentioned
1 = Yes, on the initiative of the patient or patient and health care 
provider(s)
2 = Yes on the initiative of health care provider(s)
99 = Yes, initiative unknown 
0 = No
1 = Not (clearly) mentioned
2 = Yes, caused by the patient or by both patient and health care 
provider(s)
3 = Yes, caused by health care provider(s)
4 = Yes, unknown who caused it
1 = Explicitly dissatisfied
2 = Neutral
3 = Explicitly satisfied
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Additional file 2 
Multivariate logistic regression of factors influencing patient dissatisfaction with the 
diagnostic pathway of Parkinson’s disease, including interaction terms of sex with 
other variables  
Variable (n = 856)b
Sex 
 - Male
 - Female
Level of education 
 - Low
 - Medium
 - High
Duration of the diagnostic pathway 
 - Unknown
 - <2 years
 - ≥ 2 years
Number of health care providers involveda 
 - 0
 - 1
 - 2
 - ≥3
Second opinion
 - No/not mentioned
 - Yes, on the patient’s initiative
 - Yes, on the health care provider’s initiative
Experienced delay 
 - No delay
 - Not (clearly) mentioned
 - Yes, caused by the patient
 - Yes, caused by a health care provider
 - Yes, unknown who caused it
Level of Education x Sex
 - Low x Male
 - Medium x Male
 - High x Male
Duration of the diagnostic pathway x Sex 
 - Unknown x Male
 - <2 years x Male
 - ≥ 2 years x Male
Number of health care providers involveda x Sex
 - 0 x Male
 - 1 x Male
 - 2 x Male
 - ≥3 x Male
Second opinion x Sex
 - No/not mentioned x Male
 - Yes, on the patient’s initiative x Male
 - Yes, on the health care provider’s initiative x Male
Experienced delay x Sex
 - No delay x Male
 - Not (clearly) mentioned x Male
 - Yes, caused by the patient x Male
 - Yes, caused by a health care provider x Male
 - Yes, unknown who caused it x Male
Odds ratio 
(OR) for 
dissatisfaction
Reference
2.63
Reference
0.41
0.34
Reference
1.17
1.13
Reference
3.86
3.59
5.40
Reference
7.44
3.72
Reference
2.15
1.49
50.78
1.74
Reference
0.95
1.74
Reference
1.13
1.99
Reference
0.16
0.40
0.51
Reference
0.56
0.10
Reference
0.89
0.41
0.79
9.25
95% Confidence 
Interval (CI)
0.6-11.6
0.2-1.1
0.1-0.9
0.4-3.2
0.5-2.5
1.7-9.0
1.3-9.8
1.3-21.9
2.3-24.5
1.0-13.8
0.6-8.2
0.2-13.2
19.4-133.0
0.2-16.4
0.2-3.8
0.5-6.4
0.3-4.8
0.6-6.6
0.0-0.6
0.1-2.0
0.1-4.0
0.1-2.8
0.0-1.4
0.1-5.8
0.0-9.6
0.2-3.2
0.7-125.8
P-value
0.20
0.20
0.07
0.08
0.02*
0.94
0.76
0.77
<0.01*
<0.01*
0.01*
0.02*
<0.01*
<0.01*
<0.05*
<0.001*
0.26
0.72
<0.001*
0.63
0.59
0.94
0.40
0.51
0.87
0.26
0.04*
<0.01*
0.26
0.52
0.22
0.48
0.18
0.38
0.90
0.58
0.74
0.10
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*Statistically significant, P < 0.05
aExcluding GP and neurologist 
bExcluding second opinion, initiative unknown 
x Sex: interaction term of sex with variable (male = reference group)
Number of health care providers involveda x Sex is significant, meaning that there is a significant difference 
between men and women for the relationship between patient dissatisfaction and the number of health care 
providers involved. 
In order to calculate the odds ratios for dissatisfaction with the involvement of 0, 1, 2 or ≥3 health care providers 
for women compared to men, we subsequently used a reduced model, excluding the non-significant interaction 
terms of sex with level of education, duration of the diagnostic pathway, second opinion and experienced delay.    
Variable (n = 856)b
Sex 
 - Male
 - Female
Level of education 
 - Low
 - Medium
 - High
Duration of the diagnostic pathway 
 - Unknown
 - <2 years
 - ≥ 2 years
Number of health care providers involveda 
 - 0
 - 1
 - 2
 - ≥3
Second opinion
 - No/not mentioned
 - Yes, on the patient’s initiative
 - Yes, on the health care provider’s initiative
Experienced delay 
 - No delay
 - Not (clearly) mentioned
 - Yes, caused by the patient
 - Yes, caused by a health care provider
 - Yes, unknown who caused it
Number of health care providers involveda x Sex
 - 0 x Male
 - 1 x Male
 - 2 x Male
 - ≥3 x Male
Odds ratio 
(OR) for 
dissatisfaction
Reference
3.11
Reference
0.41
0.44
Reference
1.19
1.45
Reference
3.59
3.39
4.91
Reference
5.26
2.03
Reference
1.98
0.89
42.18
7.20
Reference
0.19
0.52
0.62
95% Confidence 
Interval (CI)
1.4-7.0
0.2-0.8
0.2-0.8
0.6-2.4
0.8-2.6
1.6-8.1
1.3-8.9
1.3-19.1
2.5-11.2
0.8-5.4
0.8-5.0
0.2-4.4
21.4-83.2
2.7-19.3
0.1-0.6
0.1-2.4
0.1-4.5
P-value
<0.01*
0.01*
<0.01*
0.01*
0.44
0.63
0.20
<0.01*
<0.01*
0.01*
0.02*
<0.001*
<0.001*
0.16
<0.001*
0.15
0.88
<0.001*
<0.001*
0.05
<0.01*
0.40
0.64
*Statistically significant, P < 0.05
aExcluding GP and neurologist 
bExcluding second opinion, initiative unknown   
x Sex: interaction term of sex with variable (male = reference group)
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Number of health care providers involveda
 - 0
 - 1
 - 2
 - ≥3
aExcluding GP and neurologist
Odds ratio (OR)
for dissatisfaction, female 
compared to male
3.11
0.58
1.63
1.92
95% Confidence
Interval (CI)
1.4-7.0
0.2-1.4
0.4-5.8
0.3-12.1
P-value
<0.01*
0.23
0.45
0.49
Using this reduced model we calculated the odds ratio (OR) for dissatisfaction per number of involved health care 
providers, female compared to male.
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Abstract
Background: Timely diagnosis of Parkinson’s disease (PD), facilitating early intervention, 
depends largely on the GP’s awareness of early symptomatology. For general practice, it is 
unknown which prodromal symptoms (symptoms preceding the typical motor symptoms of 
PD) demand the GP’s alertness.  
Objective: To assess prodromal symptoms that should alert the GP to the possibility of PD in 
primary care patients.
Methods: A nested case-control study was caried out in a population of approximately 
12 000 patients registered in the Continuous Morbidity Registration database affiliated with 
the University of Nijmegen in the Netherlands. The database pools subject data from four 
primary care practices. The subjects comprised all 86 patients diagnosed with PD between 
1972 and 2007, and 78 controls, matched by sex, age, socioeconomic status and primary care 
practice. The primary measures of outcome were the prodromal symptoms presenting in the 
2 years prior to the diagnosis of PD. The number (and type) of referrals and diagnostic tests 
were also assessed.
Results: In the 2-year period prior to diagnosis, PD patients more often presented with 
functional somatic symptoms, constipation, hyperhidrosis and sleep disorders than controls. 
Patients also more frequently experienced more than one prodromal symptom and were 
more often referred within the primary care team or to a medical specialist.
Conclusion: Prodromal symptoms of PD are encountered in general practice. GPs should be 
alert when patients present with multiple prodromal symptoms in a 2-year period, especially 
considering the benefits of early intervention, and the future possibilities for disease-
modifying therapy.
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Background
Parkinson’s disease (PD) is a common neurodegenerative disorder that has a severe impact 
on the patient’s daily life.1 Multiple caregivers are involved in the course of the disease.2 
The diagnosis of PD requires the presence of bradykinesia, combined with other motor 
symptoms such as muscular rigidity, a 4-6 Hz resting tremor or postural instability (UK Brain 
Bank Clinical Diagnostic Criteria).3 However, it is becoming clear that non-motor symptoms 
such as autonomic dysfunction, depression, anxiety and cognitive decline are also part of 
the PD symptom complex.4-6 Moreover, some motor and non-motor symptoms, including 
olfactory dysfunction and rapid eye movement (REM) sleep behavior disorder are prodromal 
symptoms; symptoms that are already present before the onset of the typical motor signs of 
PD.4-7 Patients seem to be hindered by individual prodromal symptoms or combinations of 
them8, 9 as they consult GPs and medical specialists with increasing frequency in the 10-year 
period before they are diagnosed with PD.9
Recognition of prodromal symptoms and increase in consultation frequency are essential for 
timely referral and early intervention, aiming to maintain the best quality of life for patients 
with PD.3, 10-12 GPs play an important role in this, as patients will generally first present their 
symptoms to their GP, and not, for example, to a neurologist. Knowledge and awareness of 
the prodromal symptoms of PD are therefore crucial for GPs.6 
Earlier studies of prodromal symtoms are mainly hospital-based and focus on patients referred 
to neurologists4, 5, 7, 13; only few studies are performed focussing on the population typically 
presented to a GP.9 An Australian study showed there are deficits in the GP’s knowledge of 
motor and non-motor aspects of PD. Knowledge of the prodromal symptoms of PD was not 
assessed.14 However, given the low prevalence of PD in individual family practices, it seems 
likely that there are also deficiencies in the GP’s knowledge of the prodromal symptoms.  
  
This study therefore aims to characterize the prodromal symptoms of PD presenting in 
general practice and to give insight into referral rates in the 2 years prior to the diagnosis, in 
order to increase the GP’s alertness for symptoms of PD. 
Methods
Continuous Morbidity Registration database
We conducted a nested case-control study using data from the Continuous Morbidity 
Registration (CMR) database affiliated with the University of Nijmegen in the Netherlands. 
The recording in the database is anchored in the Dutch health care system where all citizens 
are registered with a personal GP, whether they consult the GP or not. Since 1971, all health 
problems are monitored in a population of approximately 12 000 patients from four general 
practices, representative of the Dutch population with regard to age and sex. In addition 
to health problems, sex, age, socioeconomic status (SES; low, middle and high) and marital 
status are registered.15, 16 
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All episodes of illness seen by or reported to the GP are registered as soon as they are 
established, using an adapted version of the E-list.17 Monthly meetings are held with all 
participating GPs to discuss classification problems, monitor the application of diagnostic 
criteria and discuss coding problems in real and hypothetical cases. When necessary, 
diagnoses and codes are corrected. The validity of the CMR has been established 
repeatedly15 and more than 65 papers based on CMR data have been published in 
international peer-reviewed journals between 1992 and 2012.16 
Patients with PD
We selected all patients from the CMR database who were diagnosed with PD between 1972 
and 2007. From 1972 to 1980, PD was diagnosed by a GP and from 1980 to 2007, by a 
neurologist. Patients must have been registered with the general practice for at least 2 years 
before their diagnosis. For a 2-year period prior to the diagnosis, the following variables 
were collected: sociodemographic characteristics; data on four major comorbid conditions 
(diabetes mellitus, cardiovascular diseases, COPD, rheumatoid arthritis); prodromal 
symptoms; and data on referrals and diagnostic tests. Based on a literature study, a selection 
of prodromal symptoms was studied: functional somatic symptoms; (autonomic) dysfunction, 
such as constipation, hyperhidrosis, olfactory dysfunction, orthostatic hypotension, urinary 
incontinence, swallowing difficulty, and sleep disorders; musculoskeletal complaints; 
neuropsychiatric disorders, such as anxiety, dementia, and depression; and traumata, such 
as fractures, laxations and distorsions.4, 5, 7-9, 13 Functional somatic symptoms were defined 
as physical symptoms, appearing in patients with presumed psychosocial problems or 
psychological distress, that remain medically unexplained after adequate examination.18 
Referrals were divided into three categories: somatic within the primary care team (physical 
therapist, social worker, occupational health officer, speech therapist, dietician and district 
nurse), somatic medical (all medical specialists except for a psychiatrist), and mental health 
(psychiatrist, psychologist and ambulatory mental health care). Diagnostic tests included 
hematological tests, X-ray examinations and ultrasonography. 
Data on prodromal symptoms were obtained directly from the medical records, except for 
data on clear diagnoses and information about referrals and diagnostic tests. These data 
were derived from the CMR database. A patient was assumed to experience a prodromal 
symptom when a note was made in the medical record or when a diagnosis was coded in 
the database.
Controls
For each patient with PD, a matched control was drawn from the CMR population. The 
control matched the patient in sex, age, SES and primary care practice at the date the patient 
was diagnosed with PD. Furthermore, the match must have been registered at the same 
practice as the patient for a minimum of 2 years. The only exclusion criterion in the control 
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group was the diagnosis of PD. For controls, the same information as described for patients 
with PD was obtained.
Statistical methods
Statistical analyses were conducted using SPSS 20. Descriptive statistics were calculated. The 
chi-square test was used to assess the relationship between PD and the presence of the 
selected comorbid conditions. Conditional logistic regression was used in this nested case-
control study to investigate the relationship between PD and the prodromal symptoms. The 
criteria for the matched sets were sex, age category (≤69 years, 70 to 80 years, ≥81 years), 
SES and practice. The numbers of cases and controls in the matched sets were uneven. In 
case a prodromal symptom did not present in the control group, a Fisher’s exact test was 
used. In order to reveal patterns in the combined presentation of prodromal symptoms, all 
presented combinations of prodromal symptoms were scored. The chi-square test was used 
to assess the relationship between PD and the number of prodromal symptoms presented. 
Conditional logistic regression was used to investigate the relationship between PD and the 
number of referrals and diagnostic tests. The criteria for the matched sets were sex, age 
category (≤69 years, 70 to 80 years, ≥81 years), SES and practice. The number of referrals 
and diagnostic tests were divided into categories of frequency (0, 1, ≥2). There were varying 
numbers of cases and controls in the matched sets. The chi-square test was used to explore 
the relationship between PD and the number of referrals and diagnostic tests per individual 
(categories: 0, 1, ≥2). 
A P-value less than 0.05 was considered statistically significant. 
Results
Characteristics of subjects
We included 86 consecutive patients with PD and 78 controls (Table 1). There were no 
suitable controls for eight patients. The patient group consisted of 57% men, the mean age 
was 72.3 years (SD 8.8). Patients were of low, medium and high SES in 44.2%, 50.0% and 5.8% 
of the cases, respectively. Significantly more PD patients than controls had a cardiovascular 
disease (P 0.018; Table 1).  
Characteristics
Sex (% male)
Mean age (years)
Socioeconomic status
 - Low, n (%)
 - Middle, n (%)
 - High, n (%) 
Comorbidity
 - Diabetes mellitus, n (%)
 - Cardiovascular diseases, n (%)
 - COPD, n (%)
 - Rheumatoid arthritis, n (%)
*P < 0.05, statistically significant.
Patients (n = 86)
49 (57.0%)
72.3 (SD 8.8)
38 (44.2%)
43 (50.0%)
 5 (5.8%)
8 (9.3%)
36 (41.9%)
12 (14.0%)
1 (1.2%)
Controls (n = 78)
42 (53.8%)
70.6 (SD 8.9)
34 (43.6%)
39 (50.0%)
5 (6.4%)
4 (5.1%)
19 (24.4%)
9 (11.5%)
1 (1.3%)
P-value
0.305
0.018*
0.644
0.945
Table 1. Characteristics of patients with Parkinson’s disease and matched controls
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Prodromal symptoms presented to the GP 
Several symptoms presented by PD patients to the GP with higher frequency in the 2 years 
prior to the diagnosis, compared to matched controls (Table 2). There was a significant 
difference in functional somatic symptoms (OR 2.45; P 0.014), constipation (OR 3.32; P 0.039) 
and sleep disorders (OR 6.98; P 0.002) presented. Hyperhidrosis was only reported in the 
patient group (9.3% versus 0%; P 0.007). For all other symptoms, including musculoskeletal 
complaints, there was no significant difference between the PD patients and the controls. 
Symptoms
Functional somatic symptoms
(Autonomic) dysfunction:
 - Constipation
 - Hyperhidrosis
 - Olfactory dysfunction
 - Orthostatic hypotension
 - Urinary incontinence
 - Swallowing difficulty 
 - Sleep disorders
Musculoskeletal complaints
Neuropsychiatric disorders:
 - Anxiety 
 - Dementia
 - Depression
Traumata
a P-value Fisher’s exact test
*P < 0.05, statistically significant
Patients
(n = 86)
33 (38.4%)
16 (18.6%)
8 (9.3%)
1 (1.2%)
2 (2.3%)
9 (10.5%)
4 (4.7%)
22 (25.6%)
51 (59.3%)
0
2 (2.3%)
3 (3.5%)
3 (3.5%)
Controls 
(n = 78)
17 (21.8%)
4 (5.1%)
0
0
0
4 (5.1%)
1 (1.3%)
3 (3.9%)
37 (47.4%)
0
2 (2.6%)
0
7(9.0%)
Odds ratio 
(OR)
2.45
3.32
-
-
-
3.21
2.23
6.98
1.60
-
0.65
-
0.33
95%  CI
1.2-5.1
1.1-10.4
-
-
-
0.8-13.2
0.2-22.2
2.0-24.3
0.8-3.2
-
0.1-5.3
-
0.1-1.4
P-value
0.014*
0.039*
0.007*a
1.000a
0.498a
0.106
0.493
0.002*
0.171
-
0.688
0.247a
0.123
Table 2. Symptoms presented to the GP in the 2 years prior to the diagnosis 
Parkinson’s disease; patients compared to matched controls
Figure 1. Number of prodromal symptoms presented to the GP in the 2 years prior to 
the diagnosis Parkinson’s disease; patients compared to matched controls
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Of all the PD patients, 53.4% presented with multiple prodromal symptoms in the 2-year 
period prior to the diagnosis, versus 25.6% of the controls (Figure 1) (OR 3.37; P < 0.001). 
We did not find any salient patterns in the combined presentation of prodromal symptoms 
(results not shown). 
Referrals and diagnostic tests 
Patients were referred more frequently than controls (Table 3). There was a significant 
difference in referral within the primary care team (OR 3.28; P 0.007). There was also 
a significant difference in referrals to a medical specialist; 46.5% of the PD patients were 
referred to a medical specialist at least once (OR 4.26; P 0.002), compared to 20.5% of the 
controls (OR 2.69; P 0.088). Referral to a psychologist or psychiatrist was very low.  
More diagnostic tests were performed in the patient group than in the control group, but the 
results were not statistically significant.
Referrals/diagnostic tests
Somatic within the primary care 
team
 - 0
 - 1
 - ≥2
Somatic medical
 - 0
 - 1
 - ≥2
Mental health
 - 0
 - 1
 - ≥2
Diagnostic tests
 - 0
 - 1
 - ≥2
*P < 0.05, statistically significant
Patients
(n = 86)
59 (68.6%)
23 (26.7%)
4 (4.7%)
46 (53.5%)
26 (30.2%)
14 (16.3%)
77 (98.8%)
1 (1.2%)
0
37 (43.0%)
30 (34.9%)
19 (22.1%)
Controls 
(n = 78)
69 (88.5%)
9 (11.5%)
0
62 (79.5%)
10 (12.8%)
6 (7.7%)
85 (98.7%)
1 (1.3%)
0
46 (59.0%)
19 (24.4%)
13 (16.7%)
Odds ratio 
(OR)
3.28
-
4.26
2.69
-
-
1.94
1.99
95%  CI
1.4-7.8
-
1.7-10.9
0.9-8.4
-
-
0.9-4.0
0.8-4.8
P-value
0.007*
-
0.002*
0.088
-
-
0.077
0.126
Table 3. Number of individuals with 0, 1 or ≥2 referrals or diagnostic tests in the 2 years prior 
to the diagnosis Parkinson’s disease; patients compared to matched controls. 
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Conclusions
Summary of the main findings
We identified that in primary care, PD patients more frequently experience prodromal 
symptoms in the 2 years prior to the diagnosis compared to controls. These prodromal 
symptoms include functional somatic symptoms, constipation, hyperhidrosis and sleep 
disorders. Over 50% of the PD patients presented more than one prodromal symptom. 
However, specific combinations of presented prodromal symptoms could not be found. 
Referrals within the primary care team and to medical specialists occured more often in 
the patient group, whereas referral for mental health was low and comparable to controls. 
Diagnostic tests were requested equally for PD patients and controls.  
Comparison with existing literature
We found that several prodromal symptoms, corresponding with those reported in the 
literature, were presented to the GP. Studies have shown that autonomic dysfunction and 
REM sleep behavior disorder can be present in the prodromal phase of PD.4, 5, 8, 9, 19 Although 
we did not specify the nature of the sleeping disorders studied, it is likely that these included 
REM sleep behavior disorder. 
Functional somatic symptoms diagnosed in the prodromal phase of PD might in fact be 
early autonomic symptoms of PD that are misdiagnosed, interpreted and registered by 
GPs as functional somatic symptoms. However, a recent study suggested a link between 
the pathophysiology of PD and a higher susceptibility of PD patients to functional somatic 
symptoms in the course of the disease.20 In our study, functional somatic symptoms were 
recorded more frequently in PD patients than in controls. It is therefore possible that the 
higher susceptibility to functional somatic symptoms is already present in the years before 
PD is diagnosed. Regardless of the reason, GPs should be aware that the presentation of 
functional somatic symptoms could in fact be the presentation of the prodromal phase of PD. 
In contrast to earlier studies 8, 9, we did not find a significant difference in musculoskeletal 
symptoms between PD patients and controls. Since these symptoms already have high 
prevalence in the age group in which PD is mostly diagnosed, they seem to be of little value 
for GPs as distinctive signs of early PD. 
Although the prodromal symptoms studied may not individually be specific enough to 
indicate early PD6, our results show that two or more prodromal symptoms presenting in a 
2-year period could be an indicator of early PD. 
Our results demostrating the increased number of referrals in the patient group support 
results from earlier research.9, 11 One study suggested that the increase in referrals reflects 
the variable non-motor symptoms that may present early or precede the motor phase of 
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PD.11 Our study is in line with this, in that it showed that the increase in referral rate is not 
solely due to referrals to a neurologist. 
Strengths and limitations of the study
The strength of this study is the use of a well-documented database (eliminating the risk of 
recall bias) to study the symptoms presented to the GP, the referrals and diagnostic tests in 
a 2-year period before the diagnosis of PD. Another strength is the inclusion of unselected 
cases of PD, in the early stage of their disease development. The database made it possible 
to recruit controls from the general population and, as a consequence, the findings hold 
external validity for PD diagnosis in primary care. 
However, some methodological issues merit consideration. First of all, as for every 
longitudinal research, the number of patients included and the duration of the observation 
period are inversely proportional to each other. We chose a study period of 2 years prior 
to the diagnosis of PD, since for this period information could be retrieved for a substantial 
number of patients and controls. It cannot be excluded that a longer study period would lead 
to different results. 
Secondly, we used a pre-selected list of prodromal symptoms, based on literature4, 5, 7-9, 13 
and supported by expert opinion. Because the main focus of our research was to extend the 
knowledge of GPs in order to increase their alertness, we studied known prodromal symptoms 
that were presented in general practice. The pre-selected list of prodromal symptoms was 
not intended to be comprehensive. It is therefore possible that some symptoms that occur 
in the early phase of PD, known or unknown at the time, were not included. An interesting 
target for future research could be identifying novel prodromal symptoms of PD by studying 
all symptoms presented in general practice by patients later diagnosed with PD.
A third point of attention is that only symptoms registered in the patient’s medical record 
were included in this study. The results may therefore be an underestimation of the actual 
prevalence of prodromal symptoms, due to lack of presentation by the patient or lack of 
reporting by the GP. However, relying on symptoms captured in the medical health record of 
the patient closely resembles everyday clinical practice. Furthermore, by focussing on these 
symptoms, the analysis was based on symptoms significant enough for patients to consult 
and seek help from their GP.
Fourthly, attention needs to be given to the age categories designated for the conditional 
logistic regression. The age group of ≤69 years may seem too heterogeneous to form one 
group. However, this group consisted of a range of PD patients aged 52-69 years, with one 
outlier of 39 years. Since matching was also done by age, the distribution of age in the control 
group is comparable to the patient group. We therefore believe this heterogeneity has no 
noteworthy influence on the results. 
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A fifth point of attention is the possibility of confounding factors. The difference in the number 
of referrals might be partly explained by the difference in comorbidity between the group of 
PD patients and the control group. The presentation of adverse effects of medication could, 
in some cases, be similar with the presentation of some of the prodromal symptoms studied. 
Smoking habits and alcohol consumption could have also influenced the results.  
Finally, our study did not comprehensively assess the prodromal symptoms of PD in general 
practice. It is therefore not possible to calculate the predictive values of these symptoms. 
However, the Dutch CMR database, with its large sample size, longitudinal design and proven 
validity 15 provided an important insight into the early phase of PD, suggesting that the first 
disabling symptoms of the disorder can be seen in general practice. Given the relatively low 
prevalence of PD in general practices, the results of this study can offer valuable support in 
handling the uncertainty around diagnosis, as is the case for other low-prevalence diseases.21 
In conclusion
Prodromal symptoms are a reality in general practice. The therapeutic benefit of early 
intervention3, 12 and the future possibilities for disease-modifying therapies, emphasize 
the importance of recognizing prodromal symptoms of PD leading to early diagnosis. This 
falls into the primary care domain and the role of GPs: awareness that functional somatic 
symptoms, constipation, hyperhidrosis, sleep disorders, and an increase in referrals may 
signal PD, leading to an early diagnosis. 
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Abstract
Introduction: Parkinson’s disease (PD) affects many aspects of the lives of patients and 
relatives. Patients must adapt continuously to disabilities that necessitate changes in 
(medical) support, such as domestic adjustments, involvement of (non) professional 
caregivers or admission to hospital. Such changes mark a transition: a transfer of a patient 
between levels or locations of care. Transitions are likely to be multifold and complex, given 
that PD care extends across all echelons of health care. Patients and relatives are vulnerable 
during a transition, which imposes risks for their safety and quality of life. Guidance by the 
general practitioner (GP), who knows the preferences of the patient, can help to overcome 
challenges associated with a transition. However, patient-centered primary care requires 
insight into the transitions PD patients encounter. We aim to examine these transitions and 
the way patients, relatives and GPs experience them and cope with them. Moreover, we 
will study the patients’ expectations of their GP during a transition and the GPs’ views on 
their role. 
Methods and analysis: A longitudinal mixed methods study will be conducted, using 
qualitative research methods combined with quantitative data as a validated questionnaire 
on quality of life. Patients will be asked to make a video diary every 2 weeks for a period 
of 1 year. Once they encounter a transition, patients and their GPs will be interviewed to 
identify causes and consequences of the transition. The verbatim transcripts of the videos 
and interviews will be analyzed according to the principles of constant comparative analysis. 
Ethics and dissemination: Ethical approval was not needed according to Dutch legislation. 
Informed consent of patients, relatives and GPs will be obtained. We will disseminate the 
results in peer-reviewed journals, at research conferences and on the website of the Dutch 
Parkinson’s Disease Association. 
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Introduction
Parkinson’s disease (PD) is a neurodegenerative, disabling disease characterized by motor 
symptoms and a wide variety of non-motor symptoms.1 It affects physical, emotional and 
psychosocial aspects of the lives of patients and their relatives.2, 3 The clinical presentation 
and rate of progression of PD vary considerably among patients4, 5, as does the perception of 
the most troublesome problems.6, 7 The complexity of the disease requires a multidisciplinary 
approach with active participation of the patient.8 However, due to progression of PD and 
daily fluctuations of the symptoms, patients and relatives are forced to adapt continuously 
to new disabilities and limitations in daily life.3, 9 Some of these disabilities and limitations 
necessitate changes in the support or medical care that is offered to a patient. Such changes 
mark a transition: a transfer of a patient between different levels of (non) professional care 
within the same location or between different locations of care.10 Commonly encountered 
transitions are the need for domestic adjustments or specific tools for the patient, 
modification of pharmacotherapy, alternation in the involvement of (non) professional 
caregivers, adaptation of working hours or type of work and/or admission to specialized day 
care or hospital. Transitions are likely to be multifold and complex, given that PD care typically 
extends across all echelons of health care.9, 11 They pose challenges to the communication 
skills and coping competencies of patients and professionals, since transitions emphasize the 
need for clarity in the preferences, expectations and roles of everyone involved. Moreover, 
transfers between different locations of care jeopardize continuity of care.12, 13 Patients and 
relatives are particularly vulnerable and might feel overwhelmed by a transition, that is often 
unforeseen.14 Safety and quality of life of patients and relatives are at risk.12, 13 
The challenges associated with a transition can be partly overcome by a health care 
professional who is well aware of the care preferences of patients and relatives and who could 
guide them during a transition, if patients and relatives feel this need.12, 15 In the Netherlands, 
the general practitioner (GP) is the preferred health care professional to fulfill this role as 
all patients are registered with a general practice; the GP coordinates access to specialized 
care16. This structure supports Dutch GPs to function as a family doctor, with insight into the 
physical and mental state of all family members and the contextual factors that influence 
the well-being. Furthermore, the GP has a long-term professional relationship with the 
patients and their relatives. No more than 20% of all patients with PD in the Netherlands 
are admitted to a nursing home somewhere in the course of their disease.17 Over time, the 
vast majority of patients will, therefore, consult their GP with all sorts of health questions, 
thereby providing several occasions to discuss the expectations and preferences of the 
patient and the relatives.18 Earlier research in the Netherlands showed that patients with a 
chronic disease (such as PD) appreciate a long-term relationship with their GP and his/her 
coordinating role.19 Moreover, GPs have been shown to be aware of the need for customized, 
preferably proactive, care for chronically ill patients.15 
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Such proactive patient-centered primary care requires more insight into the transitions that 
patients with PD and their relatives encounter during the course of the disease. Therefore, 
this study aims to answer the following questions:
1. What transitions do patients with PD encounter? How do patients, relatives and GPs 
experience and cope with these transitions and what is the impact on patients’ lives?
2. What are signs and symptoms of an upcoming transition?
3. What do patients with PD expect from their GP during a transition? Do GPs agree with 
these expectations?
Methods and analysis
Study design
A longitudinal mixed methods study20 will be performed, using qualitative research methods 
as video diaries and in-depth interviews and quantitative data as a validated questionnaire 
on quality of life and ratings for the neurological signs of PD.
Participants
General practitioners
A purposive sample of general practices surrounding Nijmegen, the Netherlands, will be 
approached to participate. Purposive sampling will be used to increase the external validity 
and to provide a wide range of opinions. Based on expert experience and literature, we 
consider the following characteristics to be relevant for purposive sampling: geographical 
location of the practice (city vs. rural area); practice organization (group practice vs. solo 
practice); age, gender and working experience of the GP. GPs will be approached to participate 
until saturation in data analysis is reached.   
  
Patients 
The patient population will consist of patients with PD. In order to participate, patients need 
to meet the following inclusion criteria:
 - The diagnosis of PD is confirmed by a neurologist, according to established guidelines.21
 - The patient lives independently, possibly with help from (non) professional caregivers.
 - The patient does not have a form of cognitive dysfunction (according to the GP) and is  
 therefore, mentally capable of remembering what happened in the past weeks/months.
 - The patient is capable of handling a simple video camera with clear instructions   
 (possibly with help of a partner or significant other). 
For each participating patient, the partner or a significant other will be asked to participate 
as well. Inclusion of patients (preferably with diversity in gender, age and Hoehn-Yahr stage 
of PD), data collection and data analysis will continue iteratively until saturation is reached.
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Recruitment
General practitioners
GPs will be personally approached to participate. Subsequently, an email will be sent in 
which the aim of the study is explained briefly and more information is given to inform 
the GP what participation means for the GP, for the patient and for the partner/ 
significant other. Once a GP confirms to participate, he/she will search the computerized 
patient files of the general practice to identify patients with PD that fit the inclusion criteria.
 
Patients
Patients that fit the inclusion criteria described above will initially be approached by their 
GP. The GP will give a brief explanation of the study and will ask if the patient is willing to be 
approached by the researcher. If so, the GP will inform the researcher and the researcher will 
contact the patient in order to send an information letter. A week later, the researcher will 
approach the patient again and will ask for questions regarding the study. When a patient (and 
possibly the partner/significant other) agrees to participate, an appointment will be made 
with the researcher in order to give more detailed information on the study and to explain 
the use of the camera. Moreover, this appointment will serve to ask the patient (and possibly 
the partner/significant other) for informed consent. Patients consenting participation can be 
included even when their partner/significant other does not consent to participate.
Data collection
Video diaries
Patients will be asked to make a video message of 5-10 minutes every 2 weeks for a period 
of 1 year. A pilot study already proved the feasibility of this method. Patients will use a 
basic video camera (JVC Pics 10, Sony MHS-FS1 or Panasonic HC-V110) that is provided to 
them for the purpose of this study. Patients will make the videos themselves in their own 
home, supported by an instruction manual. This manual includes an instruction on the use 
of the video camera and instructions regarding the content of every video message. A video 
message has to contain the following items:
 - The name of the patient and the date of the recording.
 - A grade between 0 and 10 (0 being the worst imaginable, 10 the best), reflecting the   
 way the patient felt in the 2 weeks before the recording.
 - Two tests for neurological signs of PD:
• Finger tapping test, executed to conform to ‘3.4 Finger tapping’ of the Movement  
 Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating   
 Scale (MDS-UPDRS)22: 40 times with the left hand and 40 times with the    
 right hand.
• Arising from the chair, executed to conform to ‘3.9 Arising from chair’ of the 
 MDS-UPDRS22.
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 - A description of three situations, that happened in the 2 weeks before the recording:
• A situation that went very well, despite the fact that the patient has PD. What was  
 the reason this went well?
• A situation that did not work out the way the patient expected it to because of PD.  
 What was the reason for it?
• A situation in which the patient got help because of PD. Why was help necessary?  
 Was the help asked for or offered? How did the patient experience the need for   
 help and how did the patient experience the help itself?
When the patient’s partner/significant other has agreed to participate in the study as well, 
he/she will be asked for a subsequent video message (following the recording of the patient) 
containing:
 - A description of a situation, that happened in the 2 weeks before the recording, in   
 which the partner/significant other gave help to the patient with PD. Did he/she offer to  
 help or did the patient ask for it? How did it feel to help? And in general, how does   
 it feel to be a caregiver? 
Once a month, a research assistant will collect the video diaries. The assistant and the patient 
will also fill in the PDQ39, (a validated Dutch version of) a questionnaire on the quality of life 
of patients with PD.23-25 Furthermore, the research assistant will explore whether a transition 
has taken place in the last month, using a short questionnaire in which the patient will be 
asked if any of the transitions, which are the focus in this study, have taken place. 
Identification of a transition
A transition is defined as the transfer of a patient between different levels of (non) 
professional care within the same location or between different locations of care.10 For this 
study, we will focus on a number of specific transfers, given they occur as a consequence 
of PD: 
 - A change in the extent of domestic help that is provided.
 - A change in the extent of help that is necessary for personal care.
 - A domestic adjustment (such as a bracket on the toilet or shower).
 - The purchase of a specific tool (such as a walker or adapted cutlery).
 - A modification of pharmacotherapy.
 - The involvement of a health care provider (including, eg, the physical therapist and   
 speech therapist), who was not involved before.
 - Consultation of the GP or medical specialist, if not part of a routine follow-up.
 - Adaptation of working hours or type of work.
 - Admission to specialized day care or hospital.
In-depth interviews 
Once a patient encounters a transition, he/she will be contacted to participate in an in-depth 
interview. The interviewer will stimulate the patient to tell more about the transition and the 
way the patient handled it. A brief topic list will be made to guide the interviewer, possible 
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topics are the patient’s view on forerunner signs and causes of the transition, the role of 
caregivers during the transition and the impact of the transition on the life of the patient 
and his/her partner. As data collection and analysis will proceed as an iterative process, 
relevant and new topics will be added to the topic list after a preliminary analysis of every 
interview. In this way, ideas and thoughts that emerge in primary stages of the analysis will 
be brought forward in subsequent interviews as the study proceeds, in order to reach a 
deeper understanding of the relevant topics and themes. 
The patient’s GP will be approached for an in-depth interview on the transition as well. A 
different topic list will be used for the interviews with GPs, focusing on forerunner signs 
and causes of the transition, the role of the GP and the patient’s prognosis concerning 
transitions due to PD. This topic list will also be modified according to the iterative process 
described above. GPs will be asked verbally (recorded on tape) for informed consent prior to 
the interview. 
All interviews will be recorded on tape for the purpose of transcription.
Data analysis
The researcher will watch all recorded videos. Once a transition has taken place, the 
researcher will review the last four videos of the patient involved for cues of an upcoming 
transition and for specific details to be discussed in the interviews. The reviewed videos will 
be transcribed verbatim for analysis, ensuring the anonymity of the patient. Speech, facial 
expression, finger tapping and arising from the chair will be scored according to the MDS-
UPDRS points 3.1, 3.2, 3.4 and 3.9, respectively.22 PDQ-39 will be scored using the sum score 
of all subscores.25 These sum scores will be plotted in a graph, that expresses the sum score 
per patient per month and the moment a transition has taken place. 
All recorded in-depth interviews will be transcribed verbatim anonymously for analysis 
as well. 
Analysis
The transcripts of the video diaries and in-depth interviews will be entered into 
ATLAS.ti 7, a software program for detailed coding in qualitative data analysis. In order to 
refine and focus the interview topic guides, analysis of the videos and in-depth interviews 
will start the moment the first transition has taken place and the videos and interviews have 
been transcribed. The analysis will be according to the principles of constant comparative 
analysis.26 Two researchers will read all transcripts several times to familiarize themselves 
with the data. They will independently apply codes to meaningful words and sentences in 
the transcripts. These codes will be discussed, seeking agreement for their content. In case 
of disagreement, the opinion of a third researcher will be sought. Codes will then be grouped 
into themes that represent important and relevant aspects of transitions, as formulated 
in the research questions. Themes will be used to refine the interview topic guides and 
to progressively focus and explore the data in-depth. Analysis will continue until saturation 
is reached. 
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Ethics and dissemination
Longitudinal research with chronically ill patients poses several ethical issues.27 One of these 
concerns the consent to participate. Patients will be asked for their written consent before 
they are included in the study. However, unforeseen circumstances and progression of the 
disease might change a patient’s opinion. Consent will therefore be verified verbally before 
each interview. Moreover, when the researcher or research assistant suspects diminishing 
enthusiasm to participate, this will be brought up and the patient will be reminded that 
participation is voluntarily and can be ended (preliminary) at any time.
Furthermore, continuity in staff is a key element of longitudinal research. Therefore, we aim 
to assign one researcher, who will be responsible for watching all videos and performing 
the in-depth interviews. Moreover, this researcher will be part of the analyzing team. We 
also aim to make sure that the same research assistant will visit the participating patients 
every month. 
The results of this study will be disseminated in peer-reviewed journals and at research 
conferences. Results will also be published on the website and in the magazine of the Dutch 
Parkinson’s Disease Association. Moreover, the patients, relatives and GPs participating in 
the study will be informed about the results.
Discussion
In this study we will focus on transitions in PD in patients living at home. We will explore 
the transitions that patients encounter in the course of their disease and examine the 
way patients, their partners/significant others and their GPs experience these transitions. 
Moreover, our results will facilitate the anticipation of upcoming transitions. Finally, this 
study will offer the opportunity to compare the patients’ expectations of their GP during a 
transition and the GPs’ views on their role in a transition. Therefore, this study will provide 
insight into crucial elements of transitions in the course of PD, such as the extent to which 
patients want their GP to be involved during a transition and how this could influence their 
experiences. Moreover, this could give insight into the most ideal moment to offer primary 
care during a transition. This will enable improvement of (proactive) primary care for patients 
with PD, in a patient-centered way.
Recruitment challenges
Recruiting patients with a chronic disease to participate in longitudinal qualitative research 
poses difficulties.27 Furthermore, recruitment of GPs and patients in primary care can 
be challenging.28 In this study we expect that the challenges at the GP’s level include 
willingness to participate and to fulfill all requests associated with participation: searching 
the computerized patient files for patients that fit the inclusion criteria, approaching 
suitable patients, informing the researcher when a patient is willing to be approached, and 
participating in an in-depth interview. 
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Moreover, there are possible challenges at the level of the patient. The number of patients 
with PD in each general practice is about four29 and only a selection of these patients will fit 
the inclusion criteria. One could also argue that the patients that do fit the inclusion criteria 
are relatively independent patients with PD. It is very well possible that this group of patients 
will encounter different transitions than patients with more advanced PD. However, the GP is 
the main caregiver for patients with PD who still live at home; therefore we specifically aim 
to study this relatively independent group. If the present approach is successful, future work 
should address the transitions in more advanced PD. Apart from this, patients might find 
it difficult to agree with participation for a period of 1 year, as they are uncertain what the 
next year will bring to them. Unforeseen circumstances could force the patient to stop his/
her participation preliminary. Furthermore, participating patients might have difficulties in 
handling the video camera or describing useful situations in their video recordings. However, 
a pilot study suggested that patients with PD are able to make useful video recordings 
themselves by following the instruction manual provided to them. 
Challenges at the level of the relative could also influence recruitment, such as the inability 
to handle an additional, non-essential, task besides care giving or their opinion that 
participation in a study might not be good for the patient.  
Strengths and limitations 
The home setting, in which the videos will be recorded, might comfort patients and partners 
to freely express symptoms and difficulties they experience in daily life, even those they 
might interpret as too unimportant to consult the GP for although these might have a 
significant impact on the quality of life. 
The longitudinal qualitative design of this study provides other unique opportunities.27 For 
example, it will be possible to interview patients and their GPs at turning points in life rather 
than at fixed moments. Furthermore, the information from the video diaries combined with 
the iterative process of data analysis enables refinement and customization of the topic guide 
for each interview. This will give a deeper understanding of the transitions encountered in 
the course of PD, and the causes and consequences of these over time. In addition, the 
results of the in-depth interviews with the patients and their GPs enables comparison 
between the patient’s views and expectations and those of the GP, providing insight into 
possible discrepancies. Moreover, the video diaries allow for within-patient comparison of 
the results, since progression of the disease and the constant adaptation to new disabilities 
or limitations might influence the experiences and preferences patients express over time. 
Finally, the use of multiple qualitative research methods, supported by quantitative data, 
offers valuable opportunities for data triangulation.20 The constant comparative content 
analysis, applied until saturation is reached, adds further to the robustness and validity of 
the results.26 
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However, qualitative research methods have disadvantages as well. Qualitative research 
has neither the goal nor is the suited method to quantify variables or to generalize results 
from a small sample to a larger population. Therefore, the results of this study will need to 
be interpreted in the light of the studied sample of patients and GPs, and the context and 
culture of the Dutch health care system. 
Ethical approval
The research ethics committee of the Radboud university medical center was consulted 
and decided approval was not needed according to the Dutch legislation (correspondence 
date December 11th 2013). Patients, partners/significant others and GPs will be asked for 
informed consent.
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Abstract
Background: Chronically ill patients will face and have to cope with changes in care. Research 
so far has focused on the experiences and coping of patients with prevalent diseases for 
which the general practitioner (GP) offers care. We lack knowledge of changes in care of 
patients with low-prevalent diseases such as Parkinson’s disease (PD), for which care is 
usually offered by medical specialists. 
Objectives: To improve knowledge of PD patients’ experiences and coping with changes 
in care. 
Methods: A qualitative interview study with a purposive sample of 16 community-dwelling 
PD patients in the Netherlands. Semi-structured interviews were analyzed using an inductive 
approach to comparative content analysis.
Results: Patients mentioned a variety of changes in care such as changes in the level of unpaid 
care, the purchase of tools, modification of pharmacotherapy or admission to hospital. Three 
themes had a great influence on patients’ experiences and their acceptance of impairments 
afterwards: anticipating change; self-managing change; and managing expectations. Self-
management was facilitated by patients’ ability to anticipate change. Patients preferred to 
self-manage change as this gave them a feeling of control. Self-management was also related 
to realistic expectations and acceptance of the post-change situation. 
Conclusion: Self-management support for PD patients can be offered by GPs, as the changes 
in care patients experience are likely to be the cumulated result of disease-related and 
patient-related factors GPs are familiar with.
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Introduction
Chronically ill patients will face changes in care at some point in the course of their disease. 
Patients with Parkinson’s disease (PD), for example, suffer from motor symptoms and a wide 
variety of non-motor symptoms, and the fluctuating expression and progression of this 
disease frequently force PD patients to adapt to new impairments and disabilities.1 Some of 
these disabilities will necessitate changes in care.2
Changes in care may include changes in home help services, the purchase of a tool or 
modification of pharmacotherapy.3 So far, however, research has mainly focused on transitional 
care from one health care setting to another or to home.3-7 Studies among patients with 
prevalent chronic conditions such as heart failure, chronic obstructive pulmonary disease 
(COPD) and cancer show that patients feel they lack control when discharged from hospital. 
Moreover, they feel insecure, unprepared, inadequately guided and not involved in care-
taking decisions at those moments.6, 7
Offering support to prepare patients to handle changes in care can contribute to patients’ 
well-being.8 The insight is growing that patients’ health care needs to deal with the challenges 
of a chronic disease are defined not only by the disease itself, but also – and perhaps even 
more so – by patients’ ability to cope.9 As general practitioners (GPs) offer disease-specific 
care to patients with prevalent conditions such as COPD and diabetes mellitus and are 
familiar with patients’ personal context and ability to cope, GPs are the most appropriate 
health care providers to offer medical and mental support to patients with COPD and 
diabetes experiencing changes in care.
In the case of a less prevalent disease such as PD, however, it is not clear who should be 
offering this support, as the neurologist offers disease-specific care, while the GP is familiar 
with patients’ personal circumstances. In order to offer PD patients customized support in 
handling changes in care, we need to improve our understanding. In this study, therefore, we 
aim to increase our knowledge of community-dwelling PD patients’ experiences and coping 
with the changes in care they face in the course of their disease.
Methods
Study design
We performed an exploratory qualitative study using semi-structured interviews with 
community-dwelling PD patients in the Netherlands. A qualitative research design and 
purposive sampling of patients were chosen to gain wide and in-depth knowledge of patient 
experiences and coping.  
The research ethics committee of the Radboud university medical center examined the 
study protocol and concluded that the study could be carried out in the Netherlands without 
requiring approval by the accredited regional research ethics committee (December 11th 
2013). Written informed consent was obtained from all participating patients. 
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Selection of study subjects
Between September 2013 and November 2014, nine GPs working in and around Nijmegen 
(The Netherlands) were asked to select patients that met the following criteria: a diagnosis 
of PD (established by a neurologist according to accepted criteria); community-dwelling; no 
apparent cognitive dysfunction; and capable of handling a video camera with instructions. A 
purposive sample of patients - based on age, gender and severity of PD according to Hoehn 
and Yahr (H&Y)10 - was approached by their GP. 
When a patient agreed to participate, the researcher AP (a medical doctor with experience 
in qualitative research) gave more detailed information and asked the patient for informed 
consent. Initially patients were asked to participate for a period of 1 year. After inclusion of 
eight patients, we reduced the study period to 6 months because patients mentioned that 1 
year was rather too long. The final number of included patients was determined by the point 
of data saturation. Data collection ended in June 2015. 
Data collection
Supported by an instruction manual, patients made a video once a fortnight to give a verbal 
and non-verbal impression of their physical and mental state.11 Once a month, a research 
assistant collected these videos and explored whether a change in care was experienced. 
Special interest was paid to changes that may occur in the course of PD.11 
If patients had experienced a change in care, they were interviewed face-to-face by researcher 
AP in their own home. A brief topic guide with core questions and optional prompts was 
available, which was customized using specific individual information from the patients’ 
videos (Table 1). Interviews were recorded and fully transcribed.
More detailed information on recruitment and data collection can be found in the study 
protocol.11
Questions
Can you describe the change in care that took place?
Can you tell me about your experiences with this change in care?
 - How did you experience it?
 - Can you describe if anything or anyone had an influence on your   
 experience? And if so, how did this influence your experience? 
Can you tell me about your coping with this change in care?
 - How did you cope with this change in care?
 - Why did you cope with it this way? Can you describe your considerations?
 - Can you describe if anything or anyone had an influence on your coping? 
 - And if so, how did this influence your coping? 
Table 1. Semi-structured interview topic guide (original version)
Topic
A
B
C
Processed on: 18-4-2017
509581-L-bw-plouvier
83
6
Chapter 6 | Being in control of Parkinson’s disease: a qualitative study of patient experiences
Data analysis
ATLAS.ti 7, a computer program for qualitative data analysis, was used for coding. Analysis of 
the anonymous transcripts started as soon as the first interviews had been transcribed and 
was an iterative process using an inductive approach to comparative content analysis.12, 13 
Two researchers (AP, AvL) independently read all transcripts and applied codes to meaningful 
words or sentences. Codes were discussed, seeking agreement for their content. New codes 
arising from these discussions were applied to the transcripts. Codes were grouped into 
themes, and final themes were agreed upon with the supervisory committee (all authors). 
Themes were used to adapt the interview topic guide and to progressively focus and explore 
data in-depth. After analysis of 16 interviews with 12 different patients, no significant new 
codes emerged. Conduction and analysis of five additional interviews confirmed saturation. 
Results
Study population
Sixteen patients participated in the study. Three patients did not complete the follow-up 
period: one patient died, and two patients withdrew because they experienced difficulty with 
storytelling to the video camera or the burden of comorbidity. Two participating patients did 
not experience any changes in care. Thirteen patients and one personal caregiver (replacing 
the patient who had died during the study period) were interviewed about a total of 34 
changes in care. Some patients were interviewed more than once because they experienced 
changes at different moments. A total of 21 interviews were conducted, each taking between 
60 and 90 minutes.
The patients’ mean age at the start of the study was 68 years (SD 6.0) (Table 2). Most patients 
were male (n = 11). The majority had an H&Y stage of 2 or less (n = 12), and two patients had 
an H&Y stage of 4.
Experienced changes in care
Patients experienced a variety of changes in care such as changes in the level of unpaid care 
to prepare meals, the purchase of tools such as an adapted cup or the modification of PD-
related pharmacotherapy because of hallucinations. Two patients were admitted to hospital 
acutely, and one patient experienced a planned admission for further investigation (Table 2).
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Patient
Code
(A-P)
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Sex
Male
Female
Male
Male
Male
Male
Male
Male
Female
Male
Female
Male
Female
Female
Male
Male
Age at start of 
study (years)
65
58
59
76
63
67
65
79
75
73
70
72
70
64
65
72
Severity of 
disease
Mild-to-
severe 
(H/Y stage 
1-4)
1
1.5
1.5
2
2
1.5
1.5
4
1
2
4
2.5
1
2.5
1.5
2
Experienced change(s) in care
(Each line represents a separate 
interview and shows the discussed 
changes in care)
 - Modification of PD-related   
 pharmacotherapy  
 - Domestic adjustment
 - Purchase of a tool
 - Change in unpaid care
 - Domestic adjustment
 - Change in unpaid care
 - Modification of PD-related   
 pharmacotherapy (adverse effects)
 - Purchase of a tool
 - Domestic adjustment
 - Acute admission to hospital,  
 modification of PD-related   
 pharmacotherapy
 - Involvement of a speech therapist
 - Consultation of GP, consultation of  
 neurologist, modification of   
 PD-related pharmacotherapy 
 - Acute admission to hospital 
 - Consultation of GP, planned   
 admission to hospital
 - Consultation of neurologist,   
 modification of PD-related   
 pharmacotherapy 
 - Domestic adjustment, modification  
 of PD-related pharmacotherapy 
 - Consultation of neurologist
 - Consultation of GP, consultation of  
 neurologist, modification of   
 PD-related pharmacotherapy
 - Modification of PD-related   
 pharmacotherapy
 - Consultation of GP, ENT specialist  
 and neurologist, modification of  
 pharmacotherapy (laxative)
 - Consultation of neurologist,   
 consultation of GP, modification of  
 pharmacotherapy (laxative)
Follow-up 
period
(months)
12
12
12
12
12
12*
12
12*†
6
6
6
6*
6
6
6
6
Table 2. Characteristics of the participating patients with Parkinson’s disease  
- including an oversight of the experienced changes in care -
*Did not finish follow-up,  †Deceased during follow-up
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Themes influencing patients’ experiences and coping
We identified three themes that had a major influence on patients’ experiences, their coping 
with changes in care and their acceptance of post-change results: anticipating change; self-
managing change; and managing expectations. These themes will be explored below and will 
be illustrated with quotations.
Anticipating change 
Changes in care that were not foreseen by patients could be overwhelming for them. A 
patient who had been admitted to hospital acutely realized that admission was inevitable 
but felt that his wishes had not been attended to, which contributed to his experiencing lack 
of control at the moment of the change. 
I had the idea that Parkinson’s caused my complaints...I told him [the GP] 10 times: “That is 
what I believe.”…but he persisted and then I had to go to hospital. (Male, 67 years, H&Y 1.5)
Patients who expected a change to occur were mostly able to anticipate it and to – for 
example – make domestic adjustments or purchase a tool. Patients would then feel they 
were in control and it was less complicated for them to accept any possible impairments 
that remained despite the change. Anticipating change was easier for patients if they had 
sufficient knowledge of the disease.
Well, it [encountering a change in care] isn’t difficult. […] I know it’s a progressive disease. […] 
I anticipate. (Male, 63 years, H&Y 2)
Self-managing change
Patients preferred to solve the problems they encountered themselves, for example by 
making a domestic adjustment or by searching for a proper balance between the therapeutic 
and adverse effects of PD-related pharmacotherapy. Loss of this ability to self-manage would 
lead to feelings of anger, grief and dependence.
Sometimes I’m angry that I’m no longer able to do it myself. […] At those moments, I’ve got 
the feeling I should still be able to do it. Yes, it makes me sad. (Female, 58 years, H&Y 1.5)
It’s hard to be dependent. I’m not used to needing help. […] I prefer doing things myself. When 
you need help, it means you depend on other people. (Male, 65 years, H&Y 1)
Asking a relative to help was very difficult, and patients’ experiences differed depending on 
the person they asked for help.
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I think that’s a matter of embarrassment again. What will she [my neighbor] think of me? 
Will she think that I can’t do anything on my own anymore? [...] I don’t have that with my 
husband, because he is so familiar. [...] When I ask my neighbor, I feel like I’m a whiner. 
(Female, 58 years, H&Y 1.5)
If patients were able to solve their problems independently, they considered themselves to 
be the manager of the change in care, which led to a sense of control over the change itself 
and the situation after the change.
Nowadays I take my medication more knowingly, taking into account that if I take my medi-
cation now, I’ll have my ‘low’ in two hours’ time. I have the feeling that I’m less affected by it 
because I manage the situation. […] It’s the feeling that you’re the master of your own fate. 
(Male, 76 years, H&Y 2)
If the help of a health care provider was inevitable, patients emphasized the importance of 
shared decision-making as this allowed them to still be involved and to maintain control over 
the change in care. 
During the consultation with the neurologist we decided together to change the medication 
dose. (Female, 70 years, H&Y 4)
One patient, however, stressed that, if a health care provider was involved, she did not want 
to be the one making the decision.
I don’t want to do that [make the decision]. […] In my opinion, when a health care provider 
[neurologist] tries to help you, you should just listen and do what he says. (Female, 75 years, 
H&Y 1)
Managing expectations
If a health care provider initiated a change in care, for example the modification of PD-related 
pharmacotherapy when symptoms got worse, patients had unrealistically high expectations 
of its results. As these expectations were usually not met, patients were disappointed and 
felt uncertain. 
Yesterday I took the pills at 10 pm. At 11 pm my husband switched off the light. When I 
wanted to turn over in bed, I was barely able to do it. But I had just taken those pills! I should 
have been able to do that [turn over] by then, shouldn’t I? (Female, 64 years, H&Y 2.5)
Moreover, they had difficulties accepting the impairments that remained after the change.
The effects I expected of the modification of my medication failed to happen...for example 
fewer dips or a shorter period; that I would experience less trouble due to dips. Actually, that 
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I’d just feel better. […] However, looking back at the past few weeks, I’m disappointed about 
the effect. (Male, 65 years, H&Y 1)
If patients came up with their own solutions to the problems they faced, however, they had 
realistic expectations of the change, which helped them accept the post-change situation, 
even if their impairments were not remedied. 
Well, I wanted something [an electric shaver] that would be more comfortable, so I didn’t 
have to be afraid of cutting myself with a razor. (Male, 63 years, H&Y 2)
Discussion
Main findings
Community-dwelling PD patients experience a variety of changes in care such as changes 
in the level of unpaid care, the purchase of tools, modification of pharmacotherapy or 
admission to hospital. Three themes influence patients’ experiences and their acceptance 
of impairments remaining after change: anticipating change; self-managing change; and 
managing expectations. Being able to anticipate change enhances patients’ self-management 
and feeling of control. Patients prefer to self-manage changes in care, and if they succeed in 
doing so, they have realistic expectations and can accept impairments that remain despite 
the change. If a change is initiated by a health care provider, however, expectations are often 
unrealistically high and unmet.
Strengths and limitations
To the best of our knowledge this is the first study that explores community-dwelling PD 
patients’ experiences and coping with the changes in care in the course of their disease. 
The design of this study has several advantages. The monthly visits of the research assistant 
enabled us to respond quickly to changes in care and to interview patients shortly after 
these turning points in life, thereby limiting the risk of recall bias. Moreover, the interview 
prompts, based on patients’ videos, contributed to questioning in-depth. All interviews were 
performed by the same skilled interviewer, who had no professional relationship with the 
patients and who was also part of the analyzing team. We feel confident that we were able to 
make a valid contribution to the knowledge of the experiences of most community-dwelling 
patients with PD and their coping with changes in care.13
However, some limitations need to be taken into account. Despite purposive sampling, we 
included more men and patients with mild-stage disease. The use of technical equipment 
and the long duration of data collection might have influenced this. The (expected) burden 
of making videos was a frequently mentioned reason not to participate or to withdraw early 
and it is possible that sampling bias occurred as a result of this; patients willing and able to 
use technical equipment – such as the patients included in this study - might for example be 
more inclined to self-manage. Our population, finally, came from a single regional setting in 
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the Netherlands with well-developed specialized PD care. Patients in different areas might 
have different care experiences.
Interpretation in relation to existing literature
Our study shows that community-dwelling PD patients frequently experience changes in care 
that occur in their personal context. These changes may be a direct result of PD alone, but 
they are more likely to be the cumulative effect of the disease and patient-related factors such 
as comorbidity, ageing, personal circumstances and the ability to adapt and cope. Domestic 
adjustments, for example, depend on a patient’s living situation. Informal care, moreover, 
will only be offered if a patient has relatives who are willing to provide it. In addition, coping 
with the impairments of PD by buying a tool reflects a patient’s ability to adapt.
Self-management is acknowledged to be an essential part of coping with a chronic disease14, 
and it is frequently described as patients’ competence to deal with the symptoms, treatment 
and consequences of a disease while maintaining quality of life.15, 16 If people develop 
successful coping strategies to deal with the problems they face in their daily lives, their 
subjective well-being does not have to be affected by new impairments.9, 17 Resilience is 
crucial in this. Huber et al. criticize the 1948 World Health Organization’s (WHO) definition of 
health and propose to view health as ‘the ability to adapt and to self-manage’.17 Studies show 
that resilience and self-management can contribute to patients’ well-being and experienced 
health.14, 16 Self-management, furthermore, is known to empower chronically ill patients and 
to add to patients’ self-efficacy, independence and feelings of control over life.14, 16, 18 Our 
results are in line with this. If patients are able to self-manage the changes in care they 
face, they feel in control. The loss of this ability, on the other hand, leads to anger, grief and 
feelings of dependence.
Just like patients with multiple sclerosis (MS), PD patients are challenged in their self-
management by the progressive nature of the disease and the fluctuating expression of 
symptoms.2, 19, 20 Self-management is closely related to the ability to think ahead and plan 
changes, taking into account personal boundaries.18, 19 MS patients mention they look for 
knowledge of the disease to be able to anticipate changes.20 Our study contributes to this 
by showing that knowledge of potential changes in care is important as well. Patients who 
realize that their disease will progress and that changes in care are inevitable at some point 
are able to anticipate and even initiate changes at a moment and in a way that suits them. 
This leads to a feeling of control and helps them to have realistic expectations of changes in 
care and to accept possible remaining post-change impairments. 
Implications for clinical practice 
Health care providers can contribute to community-dwelling PD patients’ well-being by 
stimulating and facilitating self-management and by providing information about the disease, 
treatment options and potential changes in care. As GPs offer most of the disease-specific 
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care, they are already experienced in providing self-management support to patients with 
common chronic conditions such as COPD and diabetes mellitus.21, 22 Although PD is a less 
prevalent disease and disease-specific care is provided by specialized health care providers, 
GPs can still offer self-management support. After all, the changes in care that PD patients 
face are likely to be the cumulative effect of the disease itself and patient-related factors, 
which GPs are well acquainted with. Their knowledge of facilitating and complicating factors 
in their patients’ situation, moreover, enables GPs to offer help in establishing realistic self-
management goals.23 
Conclusion
PD patients face a variety of changes in care they prefer to self-manage. If patients succeed 
in doing so, they have realistic expectations and can accept impairments that remain despite 
the change. Being able to anticipate a change enhances self-management. Expectations of 
changes initiated by health care providers are often unrealistically high and unmet.
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Abstract
Background: Specialized Parkinson’s disease (PD) care offers advantages to patients. 
However, specialized health care providers may be unaware of patients’ personal context 
and comorbidity, leading to conflicting treatment regimens. Patients may benefit from a 
more holistic approach.
Objective: To clarify the role community-dwelling PD patients see for general practitioners 
(GPs) in PD care and to clarify the role GPs see for themselves. 
Methods: Qualitative interview study with 16 community-dwelling PD patients and 12 GPs in 
the Netherlands, using a constant comparative approach to analysis. 
Results: Patients expressed a preference for self-management and autonomy in decision-
making. GPs chose a limited, reactive position in early-stage PD care to stimulate patient 
autonomy. Moreover, GPs felt insufficiently competent to extend their role. Patients also 
felt GPs lack expert knowledge and skills; they focus on their neurologist for PD care. In 
addition, GPs observed patients might not realize what accessory role the GP could have, 
a role GPs described as essential in being aware of patient’s well-being. Patients did not 
describe additional roles for the GP in more advanced disease, whereas GPs mentioned a 
shift towards a more proactive and extended role.  
Conclusion: Patients and GPs see a limited role for the GP in early-stage PD care because of 
patient autonomy and GP’s lack of specific knowledge and skills. However, GPs should feel 
more confident of the added value of their generalist approach to care for patients with a 
complex chronic disorder as PD. If generalist and specialized care reinforce each other, PD 
patients benefit.  
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Introduction
Parkinson’s disease (PD) is a complex neurodegenerative disorder that varies considerably 
in clinical presentation and rate of progression.1-3 The majority of all patients with PD live 
at home, where the general practitioner (GP) offers care. In the Netherlands, all citizens 
are registered with a personal GP, who has a central position in the health care system.4 
Amongst other tasks, GPs play an important role in chronic disease care. They are well 
trained in providing everyday care for common chronic conditions such as diabetes mellitus 
and chronic obstructive pulmonary disease.5, 6 Knowledge of the patient’s personal context 
facilitates and enhances the quality of this care.7 
However, in case of PD and other complex chronic conditions – conditions with uncommon 
presentations or complicated treatment regimens – care is often best provided by specialized 
health care providers with expert knowledge and skills.7, 8 On the other hand, patients with PD 
frequently suffer from more than one chronic condition.9 Involvement of various specialized 
health care providers, each focused on one condition and unaware or unconsidered of the 
patient comorbidity, could lead to conflicting treatment regimens.9, 10 
Moreover, community-dwelling PD patients encounter many care transitions in their home 
environment. These transfers in the amount or type of care that is offered include for example 
domestic adjustments or the purchase of tools.11, 12 Such transitions and the impact on the 
patient context usually stay out of sight of specialized health care providers.
Community-dwelling PD patients may therefore benefit if care is not exclusively provided by 
specialized health care providers. For example, there may be a role for the GP in PD care as 
well. However, it is unknown whether PD patients and GPs themselves recognize a role for 
the GP in PD care. We therefore aim to clarify the role community-dwelling PD patients see 
for their GP in PD care. Moreover, we want to clarify the role GPs see for themselves.
Methods
Recruitment
Between September 2013 and June 2015, a longitudinal qualitative study was performed.13 
A purposive sample of GPs of nine general practices in and around Nijmegen – a city in 
the eastern part of the Netherlands – were asked to select patients who met the following 
criteria: a diagnosis of PD (established by a neurologist according to accepted criteria); 
community-dwelling; no apparent cognitive dysfunction; and capable of handling a video 
camera with instructions. A purposive sample of these patients, based on age, gender and 
severity of PD according to Hoehn and Yahr (H&Y)14, were approached by their GP (Figure 1). 
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Figure 1. Flowchart from recruitment of patients with Parkinson’s disease and 
their general practitioners to analysis
15 general practices 
approached to participate
9 general practices 
approached 41 patients
35 patients approached by 
researcher
3 practices did not respond to approach
3 practices had no patients who matched the inclusion criteria
6 patients refused to be approached by researcher
19 patients refused participation because of:
- the burden of PD
- the expected burden of making videos
- personal circumstances
1 patient did not finish follow-up, did not encounter transitions 
and was not interviewed
excluded from the results
1 patient finished follow-up, but did not encounter transitions 
and was not interviewed
excluded from the results
1 patient did not finish follow-up, but encountered transitions, 
yet died
1 patient did not finish follow-up, but encountered transitions
14 patients included
13 patients were interviewed
12 general practitioners of 13 patients approached for interviews
1 general practitioner refused an interview
patient interview excluded from the results
11 general practitioners of 12 patients were interviewed
Included in the results: 11 patients interviews, 1 caregiver interview and 12 general practitioner interviews
1 caregiver was interviewed
1 patient encountered a transition not as a 
consequence of PD, yet planned when diagnosed 
patient interview excluded from the results
16 patients included
12 patients finished 
follow-up and encountered 
transitions
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When a patient agreed to participate, the researcher (AP) gave more information and asked 
the patient for informed consent. Initially patients were asked to participate for a period 
of 1 year. After inclusion of six patients, we reduced the study period to 6 months because 
patients mentioned 1 year was rather long. 
We chose a qualitative research design and purposive sampling of GPs (based on gender and 
location of the practice) and patients to gain wide and in-depth insight into the role patients 
and GPs see for the GP. We expected that inclusion of 15 patients and their GPs would lead 
to saturation.
Data collection
Patients made a video once a fortnight. Each video contained the same items: a grade 
between 0 and 10 (0 being the worst imaginable, 10 the best), reflecting the patient’s feelings 
in the 2 weeks before the recording; two tests for neurological signs of PD; a description of a 
situation that went very well, a situation that did not work out as planned and a situation in 
which the patient needed help; and the possibility to add free comments.13 Once a month, 
a research assistant collected the videos and explored whether a transition had taken place. 
The definition of a transition used in this study is the transfer of a patient between different 
levels of professional or non-professional care within the same location or between different 
locations of care.11 We focused on a number of specific transfers that are likely to occur as a 
consequence of PD (Table 1).
Care transitions
 - A change in the extent of domestic help that is provided
 - A change in the extent of personal care help that is provided
 - A domestic adjustment (such as a bracket on the toilet or shower)
 - The purchase of a specific tool (such as a walker or adapted cutlery)
 - A modification of pharmacotherapy
 - The involvement of a health care provider (including for example the physical   
 therapist and speech therapist), who was not involved before
 - Consultation of the general practitioner or medical specialist, if not part of routine   
 follow-up
 - Adaptation of working hours or type of work
 - Admission to specialized day care or hospital
Table 1. Care transitions as a consequence of Parkinson’s disease, included in the study
Processed on: 18-4-2017
509581-L-bw-plouvier
98
Parkinson’s disease in primary care | A joint journey of patients and general practitioners
Patients were questioned by the researcher (AP) in a semi-structured interview once they 
encountered a transition, rather than at predetermined moments. A brief topic guide was 
used that focused on the role of the GP in PD care (Table 2). Information from the videos was 
used to customize the topic guide and to provide prompts, for example by referring to the 
described situation in which the patient needed help or a patient’s considerations regarding 
consultation of the GP. The patient’s GP was asked for informed consent and interviewed by 
the researcher (AP) on the same subject (Table 2). All interviews were recorded on tape for 
the purpose of transcription.
We refer to the study protocol for more detailed information on recruitment and data 
collection.13
Interviewee
Patient/caregiver
General practitioner
Topic
A
B
C
A
B
C
Questions 
What kind of change in care did you face?
Which health care providers are involved in your care?
Did you discuss the change with your general practitioner 
or neurologist?
Why/Why not?
What did you expect of them?
What do you expect in general from the health care 
providers involved in PD care?
What role do you see for each one of them?
Do you know what change in care your patient faced?
Did you have a role in this change?
Do you see a role for yourself?
Do you feel that you were able to guide the patient in 
this change? 
Why/Why not?
What role do you see in general for the GP in PD care?
What do you think the patient expects from you?
Table 2. Topic guide for semi-structured patient and general practitioner interviews 
concerning the role of the general practitioner in Parkinson’s disease care
Data analysis
All recorded interviews were transcribed verbatim and made anonymous for analysis. 
Software program ATLAS.ti 7 was used for detailed coding in qualitative data analysis. In 
order to refine and focus the interview topic guide, analysis of the interviews started as 
soon as the first interviews were transcribed. Data analysis was an iterative process using 
a constant comparative approach.15 Two researchers (AP, CV) familiarized themselves with 
the transcripts and independently applied codes to meaningful words and sentences. Codes 
were discussed, seeking agreement for their content. Results of the analysis of interviews 
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of patients and GPs were compared. After analysis of 10 patient interviews and 8 GP 
interviews, no significant new codes emerged. Conduction and analysis of two additional 
patient interviews and four additional GP interviews confirmed saturation. Codes were then 
grouped into themes that were discussed and agreed upon by the supervisory committee 
(ToH, AL). 
Results
A total of 35 patients from nine general practices were approached to participate, of whom 
19 refused. Finally, 16 patients and 12 GPs participated. Three patients did not complete the 
follow-up period: one patient died, another was over burdened by comorbidity and the third 
patient had difficulties with storytelling to the camera (Figure 1). 
Thirteen patients and the caregiver of the deceased patient were interviewed about 34 
encountered transitions, varying from the purchase of a tool to hospital admission. GPs of 12 
patients were interviewed as well: one GP was interviewed twice, concerning two different 
patients. Interviews lasted 30 to 90 minutes. Only those cases in which both patient and GP 
were interviewed were included in the results (n = 12 patients, n = 11 GPs; Table 3) (Figure 1).
The mean age of the included patients at the start of the study was 69 years (SD 6.0). Most 
patients were male (n = 8). The majority had mild stage disease (H&Y ≤ 2) (n = 10), two 
patients had an H&Y stage of 4. 
Most participating GPs were male (n = 7) and worked in the city (n = 7). All GPs worked in a 
group practice (Table 3).
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Role of the GP in PD care
A total of 36 codes concerning the role of the GP in PD care were identified in the analysis. 
These codes were grouped into 10 different themes: self-reliance and autonomy; diagnosing 
PD; follow-up prescriptions; acute care; lack of expert knowledge and skills; awareness of 
experiences and well-being; careful monitoring; patient’s personal situation; optimizing care 
and palliative care. The analysis gave insight into two different roles for the GP, depending on 
the stage of PD (Additional file 1).
Patients described a few specific roles for the GP in PD care in the early stages of the 
disease. GPs reiterated these roles and added others. Patients did not express any specific 
roles in more advanced-stage PD, whereas GPs mentioned additional roles in case of 
disease progression.
Limited, reactive role in early-stage PD care
Patients preferred and often succeeded to self-manage the care transitions they encountered.
I don’t go to the GP for every little thing. If I can solve it myself, then I’ll just do it. (Patient XII, 
male, 72 years, H&Y 2)
GPs underlined the importance of self-reliance and autonomy in decision-making. 
I think it’s good if people take the initiative; I believe self-reliance is after all very important. 
So, if people do that, I can only encourage it. (GP of Patient II, female, rural)
As long as someone is of sound mind, and can say what he wants to say, I think it borders on 
patronizing to try and take over. […] It has to do with instinct and autonomy and things like 
that. (GP of Patient XII, male, rural)
Patients described a few specific roles for the GP in the early stages of PD. One task both 
patients and GPs agreed on is recognition of the disease, although they acknowledged that 
this could be difficult. 
First of all, he [the GP] has to be able to diagnose [PD]…and he wasn’t able to do that when I 
went. […] It’s really difficult for the GP, because PD isn’t a disease where you see patients with 
all the same symptoms. (Patient XII, male, 72 years, H&Y 2)
The most important role is to recognize it, to diagnose. […] The start of Parkinson’s is often 
very vague and it is important for a GP to recognize it in time. (GP of Patient X, male, rural)
Furthermore, patients stated that they expect their GP to provide follow-up prescriptions for 
PD medication. 
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The medicine is finished after three months, so that’s when I have a reason and I plan to visit 
the GP. (Patient I, male, 65 years, H&Y 1)  
GPs added a role in pharmacosurveillance to this. 
I want to know what medication a patient is taking, so I know the correct dose if I write a 
repeat prescription […] but also to have a good overview of the possible interactions or side 
effects. (GP of Patient I, female, city)
In addition, patients indicated that they would turn to their GP in case of an acute care 
transition. 
If something happens, if I fell off this chair, then she [the GP] will probably come. Not the 
specialist, that one stays where he is. (Patient VIII, Male, 73 years, H&Y 2)
For all other PD-related questions and transitions, patients preferred not to contact the GP, 
since they felt that the GP lacked expert knowledge and skills. Patients chose to turn to 
specialized care directly. 
If I want my shoes fixed, I will go to the shoemaker. So, now I have Parkinson’s, I go to the 
neurologist. (Patient III, male, 76 years, H&Y 2)
She [the GP] knows of Parkinson’s but doesn’t know that much about it; she’s not an expert 
so I don’t want to trouble her. (Patient I, male, 65 years, H&Y 1)
In line with this, GPs expressed reluctance to be involved in PD care, because they did not 
feel competent. 
I: What’s the difference between Parkinson’s and other chronic disorders, where you do have 
a central position as GP?
GP: The prevalence. I think Parkinson’s is quite a complex disease with different 
manifestations […]. It’s complicated in terms of pharmacotherapy […]. It’s something I don’t 
have much experience with; there are plenty of things I feel more familiar with. So, I figure, 
if the neurologist can handle it well, then I prefer to leave it to him. (GP of Patient XII, male, 
rural)
Although GPs described their role in the early stages of PD as limited and reactive, they also 
mentioned that patients might not realize what accessory role the GP could have.
I suppose he [the patient] is content with the current care, and just doesn’t realize [what role 
the GP could have]. (GP of Patient V, male, city)
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GPs illustrated their role by mentioning the importance of being aware of patient’s 
experiences and well-being. 
The GP doesn’t have a big role in the treatment of PD, but you have to be aware of what is 
happening […], there’s more to the patient than just PD. (GP of Patient IX, male, rural)
Therefore, GPs emphasized that it was important to stay in touch with the patient at any time 
during the course of the disease.  
The GP should stay in touch with PD patients, since the consequences of the ‘care’ part […], 
especially for patients with more progressed disease, are considerable. (GP of Patient V, 
male, city)
Extended, proactive role in advanced-stage PD care
Patients with mild-stage PD did not express specific roles for the GP in case of progression of 
the disease. In addition, the patient with severe disease and the caregiver of the deceased 
patient (H&Y 4) did not describe roles for the GP other than the above-mentioned. GPs 
however mentioned a shift in their role.   
In the beginning of Parkinson’s, everything can be easily handled by the neurologist and the 
specialized nurse. But when people develop more incapacitating complaints…you know, a 
neurologist doesn’t do home visits…So I think, the more the disease progresses, the more 
important our role will become. (GP of Patient VII, female, rural)
GPs mentioned careful monitoring and paying attention to possible care transitions as 
important tasks. Moreover, they described a proactive role in discussing possible solutions 
for signaled problems, while taking into account the patient’s care preferences. 
I notice things that in my opinion could be better. I explain that to them and it is discussed. 
Then it is up to them to do something with it or not. (GP of Patient III, male, city)
In addition, GPs expressed they would consider possible benefits from a home visit, such as 
insight into patient’s living circumstances.
Sometimes a home visit can be very enlightening, to get insight into the possibilities at home. 
[…] Or if people really want a private conversation out of the medical setting… […]. Then I 
have the idea that that improves the quality of care, because it reinforces the trust of the 
relationship. (GP of Patient V, male, city)
Moreover, GPs saw an important task in coordinating health care providers and in fine-tuning 
care with the neurologist. 
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If more care is needed, then it is my experience that I get called on more often, […] to instigate 
things, to coordinate. (GP of Patient V, male, city) 
If palliative care became necessary, GPs no longer felt reluctant to be involved in PD care. 
They felt they were the most important health care provider then.  
The palliative part […] we can of course offer that in the home situation as no other can. (GP 
of Patient XII, male, rural)
Discussion
Summary of the main findings
Patients express a preference for self-management of care transitions and autonomy in 
decision-making. GPs choose to stimulate this behavior by taking a limited, reactive position 
in early-stage PD care. Moreover, they feel insufficiently competent to extend their role. 
Patients also feel GPs lack expert knowledge and skills; they focus on their neurologist for PD 
care. In addition, GPs observe that patients might not realize that GPs could have an accessory 
role in being aware of patient’s well-being. Although patients do not report additional roles 
for the GP in advanced-stage disease, GPs describe a more extended role as monitor and 
coordinator of care. Moreover, they feel more confident in their role in progressed disease, 
especially when palliative care becomes necessary.
Comparison with existing literature
The patients in our study express a favor for self-management of care transitions. Self-
management in chronic disease can be described as the degree to which a patient is able and 
willing to control daily life through management of symptoms, treatment and consequences 
of a disease.16 This definition points out the influence of patient’s context and comorbidity 
on self-management. 
If self-management is not possible, patients prefer to turn to health care providers specialized 
in PD care. The focus on expert health care providers for disease-specific care is in line with 
other research.17, 18 However, patients’ expectations of their GP differ from holistic care for 
cancer patients17 to a role limited to providing follow-up prescriptions and offering prompt 
access to care for patients with cystic fibrosis (CF).18 The limited role description of CF patients 
corresponds with our results. 
The GPs in our study also see a limited position for themselves in early-stage PD care. On 
the one hand, this is a purposely chosen position to stimulate patients’ self-reliance and 
autonomy. On the other hand, it is the result of two factors. GPs suggest that patients might 
not realize that GPs could have an accessory role. The GPs emphasize the importance of being 
aware of patient’s experiences and well-being, thereby describing the GP’s role in care as 
one focusing on person-centeredness. At the same time, GPs are reluctant to fulfill this role. 
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They seem to be intimidated by the low prevalence and diversity of manifestations of PD. 
The pharmacological treatment regimen of PD, which is experienced by GPs as complex up 
until the moment of palliative care, adds to GPs’ reluctance. However, these disease-specific 
characteristics do not particularly influence person-centered care, yet they accentuate the 
importance of involvement of health care providers specialized in PD.7 
Person-centered care provided by the GP could add to PD care as well by offering self-
management support, thus contributing to patient’s autonomy.16 GPs can use the regular 
visits of patients to repeatedly invite them to voice their care preferences, preferences that 
may change over the course of the disease and as a consequence of changes in personal 
circumstances. Awareness of the patient context and comorbidity allows the GP to help 
patients prioritize their preferences and to personalize care.7 This way patients build 
confidence and feel empowered to voice their preferences in different care settings as well19, 
what is especially important since patients nowadays have a central role in decision-making 
in specialized PD care as well.20 Moreover, attention for patient care preferences and personal 
context facilitates the GP in providing person-centered care in more advanced-stage PD 
as well.
Therefore, community-dwelling PD patients benefit from shared care in which generalist 
and specialized care reinforce each other and offer personalized care based on patient 
preferences.7 
Strengths and limitations of the study
To the best of our knowledge this is the first study that explores what role community-
dwelling PD patients and their GPs see for the GP in PD care. The design of the study has 
several advantages. The monthly visits of the research assistant enabled us to quickly respond 
to encountered transitions and to interview patients and GPs shortly after the transition, 
thereby limiting the risk of recall bias. Moreover, the interview prompts, based on the 
patient videos, facilitated recall if necessary and contributed to questioning in more detail. 
All interviews were performed by the same skilled interviewer, who took the information 
from the patient interview into account when interviewing the GP. The interviewer had no 
professional relationship with the GPs or patients, was experienced in qualitative research 
and was also part of the analyzing team. Data collection and analysis continued until 
saturation was reached. We feel confident that we were able to gain comprehensive and in-
depth insight into patient and GP perspectives on the role of the GP in PD care. 
However, some limitations need to be considered as well. Despite of our effort to collect 
longitudinal data, our results do not enable description of changes in time of patients’ 
opinion concerning the role of the GP. The decision to reduce the follow-up period from 1 
year to 6 months may have contributed to this. Interviews at predetermined moments would 
likely have resulted in more interviews per patient. However, it is uncertain if a longer follow-
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up period or interviews at fixed moments would have led to different results. Furthermore, 
despite purposive sampling we included more men and patients with mild-stage disease. 
Although we did include women and patients with advanced-stage disease, it is possible 
that the roles these groups see for the GP in PD care are not fully explored. Our population, 
finally, came from a single region in the Netherlands with well-organized specialized PD care, 
possibly influencing the role patients see for the GP. 
In conclusion
Patients and GPs describe a limited role for the GP in early-stage PD. However, community-
dwelling PD patients would benefit from shared care in which generalist and specialized care 
are valued for their specific qualities of person-centeredness and disease-specific expertise. 
GPs should realize the added value of their generalist approach to care for patients with a 
complex chronic disorder as PD and fulfill their role with confidence.  
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Stage of disease
Early
Advanced
Role of the 
GP
Limited 
Reactive 
Reactive 
Reactive 
Reactive 
Reactive 
Limited 
Limited 
Proactive 
Proactive 
Extended 
Extended 
Extended 
36 codes 
(Initially) limited
Being easily accessible
Responding to request for help
Considering reactive or proactive role
Considering consulting GP
Considering patient’s ability to initiate and manage
Role depends on patient’s coping
Discussing pro’s and con’s of patient’s coping
Discussing role of the GP with patient
Physical examination for new symptoms
Recognizing possible PD
Providing follow-up prescriptions
Pharmacosurveillance
Providing acute care
Ensuring continuity of care
Not for PD-related pharmacotherapy decisions
No expert
Feeling of incompetence 
Depends on knowledge and experience
Stay in touch with the patient
Being informed
Paying attention to experiences and well-being
Showing compassion/empathy/support
Considering reactive or proactive role
Being aware of comorbidity
Monitoring of PD and possible care transitions
Discussing solutions to signaled problems 
Taking into account patient’s care preferences
Considering benefit of home visit
Paying attention to patient’s personal context
Paying attention to the patient-doctor relationship
In dialogue with the neurologist
Knowledge of care possibilities
Offering help in care decisions
Coordinating health care providers
Main role in palliative care
Terminal care
10 themes
Self-reliance 
and autonomy
Diagnosing PD
Follow-up 
prescriptions 
Acute care
Lack of expert 
knowledge and 
skills
Awareness of 
experiences 
and well-being
Careful 
monitoring
Patient’s 
personal 
situation
Optimizing care
Palliative care
Expressed 
by 
Pt, GP
Pt, GP
Pt
GP
Pt
GP
GP
GP
GP
GP
Pt, GP
Pt, GP
GP
Pt, GP
Pt, GP
Pt, GP
Pt
GP
GP
Pt, GP
Pt
Pt, GP
Pt, GP
GP
GP
GP
GP
GP
GP
GP
GP
Pt, GP
GP
Pt, GP
GP
GP
GP
Additional files
Additional file 1 
Oversight of all codes and themes concerning the role of the general practitioner in 
Parkinson’s disease care as expressed by patients and general practitioners.
Pt = patient, GP = general practitioner
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The aim of this thesis was to both examine and contribute to patient-centered quality 
care for community-dwelling patients with Parkinson’s disease (PD), starting from the first 
recognizable symptom and extending into advanced-stage disease. For this, we needed to 
gain insight into patient experiences before, during and after the diagnosis, as well as the 
challenges that general practitioners (GPs) are confronted with in providing care to these 
patients. In this final chapter, we will first give a brief summary of the main results, before 
discussing these results in light of patient-centered primary care. Subsequently, the chosen 
methods will be reviewed critically and future perspectives will be discussed. 
Overview of main findings
Towards the diagnosis of Parkinson’s disease
The qualitative analysis of a purposive sample of patient essays about the pathway from 
the first recognizable symptom to the diagnosis of PD presented in Chapter 2, clarifies that 
patients experience difficulties recognizing the symptoms as their knowledge of PD is usually 
limited to the image of the disease that is presented in the media. This image is generally 
based on public figures with advanced-stage PD. Because the symptoms that patients 
experience in early-stage disease are often limited and not very disease-specific, patients 
tend to find other explanations for them and frequently do not seek help. A patient’s 
decision to seek professional help if symptoms do not resolve or if they progress over time is 
influenced by a variety of factors such as the involvement of significant others, the patient’s 
previous positive or negative experiences with health care providers and the patient’s fear 
that the GP might think he/she is dramatizing. After the consultation with the GP, patients 
describe different referral experiences, varying from immediate referral to the neurologist to 
consultation of several health care providers. 
The quantitative analysis of all patient essays, described in Chapter 3, reveals the possible 
consequences of the difficulties GPs may have referring PD patients, due to the often non-
disease-specific prodromal symptoms: one in every seven PD patients explicitly mentions they 
are dissatisfied with the experienced diagnostic pathway. Patients who feel that their doctor 
caused delay run a greater risk of being dissatisfied than patients who feel their pathway was 
not delayed. In addition, the quantitative analysis shows that patients’ dissatisfaction with 
the diagnostic pathway is related to a low level of education, to one patient’s request for a 
second opinion and to female sex.
We used data from the Continuous Morbidity Registration (CMR) database to compare the 
experienced symptoms and medical consumption of people who were later diagnosed with 
PD with that of healthy controls. In Chapter 4 we present the results of this study in which we 
found that PD patients consult the GP more often in the 2 years prior to the diagnosis with 
symptoms such as constipation, hyperhidrosis and sleep disorders and that over half of these 
patients present with more than one prodromal symptom in that period. In addition, these 
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patients are more often diagnosed with Medically Unexplained Physical Symptoms (MUPS) 
than the controls. Patients also tend to be referred more than usual in the period leading up 
to their diagnosis.
Changes in care after the diagnosis of PD
In Chapter 5, we describe the design of the longitudinal study on the changes in care 
encountered by community-dwelling PD patients. We followed patients for 6 months to 1 
year and asked them to make video’s describing their current physical and mental state. 
The content of these videos was used to customize the topic guide for the interviews that 
took place after every encountered care change. In these interviews, we not only asked the 
patients what changes they experienced and how they coped with them, but also asked 
them to describe what they expected of their GP. Subsequent to the patient interviews, we 
interviewed the GPs, to clarify the role they saw for themselves in PD care. 
Patients’ experiences and coping strategies with changes in care are presented in Chapter 
6. The patients prefer to solve the problems they encounter themselves. Patients’ self-
management is facilitated by their ability to anticipate changes, which is easier if patients 
have sufficient knowledge of the course of the disease and the related care changes. Being 
able to self-manage a change gives them a sense of control. Moreover, self-management 
is related to realistic expectations and acceptance of the post-change situation, even if 
impairments are not remedied. 
Chapter 7 illustrates the roles patients and GPs see for the GP in PD care. Patients expect their 
GP to recognize PD and refer correctly. Moreover, they rely on their GP in case of an acute 
care need, and turn to their GP for follow-up prescriptions for PD medication. For all other 
PD-related questions and changes in care, patients turn to specialized caregivers directly as 
they feel that GPs lack expert knowledge and skills. The GPs agree on assuming a limited role 
for themselves in early-stage disease. On the one hand, they purposely choose this position 
to stimulate patients’ self-reliance and autonomy. On the other hand, their limited role is the 
result of GPs’ reluctance to be involved more. The GPs do mention that, despite their limited 
role, it is important to stay in touch with PD patients at any time during the course of the 
disease and to take patients’ preferences into account because of the considerable impact of 
the disease on patients’ lives. The GPs describe a more extended, proactive role in advanced-
stage disease, consisting of careful monitoring, signaling problems such as upcoming changes 
in care, discussing possible solutions and coordinating health care providers. Finally, the GPs 
mention they are the most important health care providers when it comes to palliative care.
Patient-centered primary care for PD: reflections on the findings
Based on the results described above, we identified four related themes with important 
implications for care in all stages of Parkinson’s disease: the stereotyped image of PD; the 
diagnostic uncertainty related to PD; the added value of generalism to PD care; and the 
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importance of a trusting patient-doctor relationship. These themes will be discussed in 
greater detail below.
The stereotyped image of PD
As a consequence of the limited representation of PD, such as described by the patients in 
our essay study, lay persons and health care providers may have a stereotyped image of the 
disease. An earlier study showed that the general population mainly relates PD to tremor 
and stiffness, and that there is a widespread belief that the disease presents in older male 
patients, progresses rapidly and can only be partially controlled by treatment.1 Moreover, lay 
people considered their own chances of developing PD as minimal.1, 2 It is understandable 
that such a stereotyped image can have a negative effect on help-seeking behavior.2 A 
retrospective study amongst PD patients showed that the time from symptom onset to 
the diagnosis of PD was longer for women than for men.3 The authors mentioned many 
factors that might have contributed to this difference, including a possible difference in the 
experience of prodromal symptoms and the possibility that physicians have a predisposed 
perception that PD is more likely to occur in men.3 As we focused on patient dissatisfaction, 
we do not know if there are differences in experienced delay between the men and women 
in our essay study, yet we did find that women are more likely to be dissatisfied with their 
diagnostic pathway. It is possible that underlying this dissatisfaction is the initial response 
of family, friends and health care providers to normalize female patients’ complaints, giving 
them the feeling they are not being taken seriously. In addition, the belief that the diagnosis 
of PD will only be made from a certain age onwards may cause difficulty in younger patients 
to accept this diagnosis, the more so as they will be facing people’s prejudice about their 
inabilities although they might be able to function at near comparable level for years if they 
are treated adequately.1 Fortunately, famous young PD patients such as the American actor 
Michael J. Fox and the English football player Ray Kennedy are helping to break this stigma.4 
PD can limit patients’ abilities to communicate non-verbally. With progression of the disease, 
patients’ volume of speech may become weaker, and facial masking is likely to appear.5, 6 
Patients’ limited ability for non-verbal communication may be incorrectly interpreted as 
antisocial, cold, uninterested or incompetent.5-7 The impact of facial masking on intimate 
relationships, however, differs between men and women.7 This is understandable when 
taking into account the existing gender role beliefs that are rather similar across cultures.8 
Women are believed to be more emotionally expressive and socially oriented than men.7, 8 
Therefore, female PD patients’ inability to express social involvement non-verbally due to 
facial masking is more inconsistent with people’s expectations and will be interpreted more 
negatively than the same inability would in males.7, 8 Although knowledge and understanding 
of the disease is greater in GPs and other health care providers, research has shown that they 
may also have difficulty realizing that their initial assessment of a PD patient’s abilities, based 
on their first impression of the patient, may not be reliable.5, 6 Knowing that a significant 
part of newly diagnosed PD patients already manifest cognitive dysfunction and that PD 
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patients without dementia may already have trouble with medical decision-making, a first 
non-verbal impression of incompetence can, without further consideration, contribute to 
the underestimation of PD patient’s ability to self-manage. However, our study shows that 
community-dwelling PD patients in early stages of their disease are able to self-manage 
changes in care. Health care providers, therefore, should be aware of the risk that their 
assessment of PD patients’ abilities may be prejudiced and take this into account.6
The diagnostic uncertainty related to PD
The caseload in a general practice is usually undifferentiated and unorganized.9 Every 
patient has a small but real chance of suffering from a serious condition, and patients 
generally present diseases in non-textbook ways.10, 11 For GPs it is a challenge to deal with 
the diagnostic uncertainty that is part of their daily work.9, 10 For patients, the uncertainty 
involved in awaiting diagnosis can have a tremendous impact on their daily life, as we know 
from a study of dementia patients and their caregivers.12
Wray describes two types of diagnostic uncertainty: informational uncertainty and 
intrinsic uncertainty.13 Informational uncertainty is the type of uncertainty that is related 
to shortcomings in disease-specific knowledge and skills and to a flawed patient-doctor 
relationship, lacking insight into patients’ care preferences.13 The results presented in this 
thesis already described that recognizing a pattern of symptoms pointing to PD may be 
difficult for GPs because they have limited knowledge of the prodromal and early-stage 
symptoms of the disease. The importance of a trusting patient-doctor relationship will be 
discussed below.
Intrinsic uncertainty is the uncertainty that exists because the clinical course of a disease 
cannot be predicted, as diseases may present and progress in markedly different ways in 
different patients.13 The initial presentation and the clinical course of PD are highly variable: 
some patients with classic PD symptoms are diagnosed straightaway, whereas others 
experience a long and difficult diagnostic pathway. Although uncertainty about the PD 
diagnosis cannot be taken away completely until after death – after all, the diagnosis can only 
be fully ascertained post-mortem – the GPs’ response can make a difference. GPs may turn 
to overdiagnosing presented symptoms for fear of missing a serious condition 14, and if they 
do so for only one or two of the symptoms instead of creating an overview, this could lead 
to tunnel vision in the wrong direction.11 The difference we found in the MUPS diagnoses 
between the patients and the controls in our case-control study may, in fact, not reflect a 
difference in MUPS prevalence but may reflect GPs’ diagnostic uncertainty with symptoms 
that are difficult to grasp, such as symptoms of autonomic dysfunction. Patients with cancer 
and Amyotrophic Lateral Sclerosis describe over-reassurance as another response of GPs: 
‘Don’t worry; there is nothing wrong with you’.15-17 As a result, they get false hope whenever 
an examination excludes a worrisome diagnosis and tend to normalize new symptoms or 
attribute them to an initially benign diagnosis.15-17 Cancer patients also mention the possibility 
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of under-support and its consequences: patients who initially had the experience they were 
sent away or were not being taken seriously, feel uncertain if and when to present their 
symptoms again since they do not want to appear to be hypochondriacs.16 Over-reassurance 
and under-support are also described in our study, causing the risk of diagnostic delay.
There is extensive research on strategies to deal with diagnostic uncertainty in a way that 
prevents delay as much as possible.9, 10, 13, 16, 18 In all strategies, patient-doctor communication 
is essential. Diagnostic safety netting is one of these strategies.10, 16, 18 It refers to an approach 
of openly sharing the uncertainty of the diagnosis with the patient and indicating that more 
visits to the GP might be necessary before the signs and symptoms of the condition become 
more evident.16, 18 Multiple studies show that patients value health care providers who 
recognize the limits in their own knowledge and skills and act upon it.17, 19 However, the way 
in which diagnostic uncertainty is shared needs to be carefully considered. An explicit verbal 
expression, such as ‘I don’t know’, is known to undermine patients’ confidence although 
physicians generally underestimate this effect.9, 13, 20 In addition, adding some reassurance 
might be helpful to reduce patients’ stress while facing an uncertain situation.13 An important 
feature of diagnostic safety netting is the instruction to patients to return to their GP 
whenever they are worried or, if possible, when symptoms develop in a certain direction.10, 
16, 18 This way, patients are empowered to reconsult, and the experience of under-support can 
be minimized.18 The fact that the lower educated patients in our essay study are more likely 
to be dissatisfied with their diagnostic pathway than the higher educated patients, however, 
might reflect the difficulties low-educated patients have with understanding their GPs’ 
explanation and acting upon it. In the case of a complex clinical disease course, therefore, 
GPs should take the patients’ level of health literacy into account in either aiming to fully 
explain the course of the disease or mainly to focus on sharing the diagnostic uncertainty. In 
addition, it is essential for GPs to keep an open mind on any possible diagnosis in order to 
recognize if patients present new symptoms or if symptoms develop in a way that does not 
suit the first diagnostic idea.11
A strategy that can be used in combination with diagnostic safety netting, especially in 
the case of a slowly developing disease without life-threatening symptoms such as PD, is 
watchful waiting.9, 10, 16 GPs are in the position to use this approach as patients will generally 
first present their symptoms in a consultation in general practice. The symptoms presented 
in subsequent visits can then be combined into one image that is clear enough to consider 
referral, as in the case of Mrs P.D. described in the preface. As it is known that cancer 
patients feel uncertain and anxious if referral is not sufficiently explained to them and that 
PD patients’ dissatisfaction with the way the diagnosis is expressed affects their experienced 
quality of life, it is clear that referral should be discussed with patients, with an explanation 
of the considerations that is tailored to patients’ level of health literacy.9, 21-23 A study among 
patients with MUPS shows that watchful waiting, if applied in a proper way, does not have to 
lead to patient dissatisfaction.24 The same strategy might also prevent patient dissatisfaction 
with the diagnostic pathway of PD.
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The added value of generalism to PD care
It seems fair at first that the patients in our longitudinal study focus on the movement 
disorder specialist. After all, the medical specialist has the specific knowledge and skills that 
are essential for treating a complex disease such as PD, with a diverse expression and a 
complicated treatment regimen.25-28 Patients with cancer and Multiple Sclerosis also feel that 
their disease should be treated by a medical specialist 29, 30, but they also mention another 
role for the GP that is at least as important and is an essential component of chronic disease 
care: the GP should take care of the patient as a whole person.29-31 Although the patients in 
our study do not describe this role, the GPs do: ‘there’s more to the patient than just PD’. 
GPs may not be experts in PD-specific care, but they are experts in whole person medicine.32
The expertise of generalism has three clear characteristics: a continuous rather than an 
episodic view; the integration of biomedical knowledge and knowledge of the patient’s 
unique situation; and the possibility to support decisions that recognize health as a resource 
for living rather than as an end in itself.25, 32 A GP’s continuous view, the first characteristic of 
generalism, offers the advantage of the watchful waiting strategy, described above, during 
the diagnostic pathway of PD. Moreover, it allows for continuity of care. Freeman describes 
two types of continuity of care.33 One is relationship continuity or personal continuity, which is 
most valued in general practice and helps patients to build trust in their GP.19, 34 The other type 
of continuity is management continuity, for which communication of relevant information 
and cooperation between the health care providers involved are essential.33, 34 Patients with 
PD do not experience their care needs in episodes of care or in different care settings.33 
For them, the changes in care and related health care needs that come with progression of 
the disease are continuous.35 Management continuity, therefore, is indispensable. Patients 
generally prefer one health care provider to coordinate care, and earlier research in the 
Netherlands showed that chronically ill patients appreciate it if their GP fulfils this role.36 The 
patients in our study do not explicitly describe such a role for the GP, but the GPs underline 
their role in management continuity and also describe a role in care planning. 
The added value of the GP as the coordinator of the health care providers involved in PD care 
lies in the second characteristic of generalism: the integration of knowledge of a patient’s 
disease and his/her unique situation.33 The position of Dutch GPs as family doctors gives them 
insight into the past and current physical and mental state of patients and family members 
and into the contextual circumstances that influence their well-being.37 GPs also have the 
possibility of making home visits, which is especially valuable for PD patients as there is 
a known discrepancy in performance of patients in the complex living situation at home 
and in the well-lit and wide corridors of a hospital.38 In case of the need for coordination of 
care, GPs can use their insight into the patient as a whole person to integrate general care 
and disease-specific care into personal patient-centered care that prioritizes problems.26, 39, 
40 Their long-term knowledge of patients also facilitates their assessment of patients’ ability 
to adapt, which is important, as this ability to adapt and to self-manage determines their 
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experienced health.41 Moreover, the ability to adapt is assumed to influence the need for 
health care interventions more than the disease itself.42 The results of our study are in line 
with this. 
The GPs’ holistic view also allows them to support their patients in formulating self-
management goals that are not disease-oriented but focus on what is most meaningful to 
patients, the final characteristic of generalism.25, 43-45 Concentrating on the most pressing 
issues rather than the disease itself is relevant, as PD patients are known to differ in their 
perception of the most troublesome problems that come with the disease.39, 46, 47 In addition, 
patients are likely to have comorbidity.48 Self-management needs and goals of different 
diseases may be conflicting, necessitating a focus that goes beyond the single disease level.45, 
48-50 As understanding the patients’ needs for support may improve its effectiveness, frequent 
review of these needs is important.51 GPs have the possibility to use the consultations of their 
PD patients, regardless of the reason of consultation, to try to understand the meaning PD 
has in the patients’ lives and to invite them repeatedly to voice their needs and preferences.50 
They are able to tailor their support to a patient’s unique situation, therefore, based on the 
disease stage, comorbidity, personal context and care preferences that are relevant at that 
time.45, 50 The advantage of this approach goes beyond primary care. If patients are supported 
to formulate their self-management goals in a familiar setting with support offered by a GP 
who knows most of the relevant aspects, they may also feel empowered to do so in different 
care settings.44 This is especially important for PD patients because they now play a central 
role in decision-making in specialized PD care as well, although a recent study showed 
that patients experience difficulty mentioning their needs.52, 53 If patients are able to voice 
what problems are most pressing to them and what goals they value most, the therapeutic 
decisions made are likely to correspond with their preferences.39
The importance of a trusting patient-doctor relationship 
As described above, relational continuity is one of the characteristics of primary care. 
Relational continuity ‒ the ongoing therapeutic relationship between patients and their GPs ‒ 
is essential to effectuate the other characteristics described above.34 For such a relationship, 
physicians need to possess good communication skills and be caring.54 Showing empathy, 
in addition, contributes to openness in the relationship and to feelings of safety and trust.55 
The inherent knowledge and power imbalance that exists between patients and doctors 
underlines the importance of trust.56, 57 
PD patients will benefit from a trusting relationship with their GP from the moment they 
become aware of the first prodromal symptom. In our essay study, we describe the effect 
previous negative experiences in communication with health care providers may have on 
patients’ help-seeking behavior. In addition, empathic communication and trust in the GP leads 
to greater patient willingness to open up and express symptoms, expectations and emotions 
such as uncertainty, worry and frustration.31, 58, 59 PD patients should also trust that GPs will 
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try to understand the first symptoms, which may sometimes be confusing or misleading.9 
One patient in the essay study describes he always felt taken seriously by his GP, even though 
the symptoms he presented were vague. Moreover, a trusting patient-doctor relationship 
can empower PD patients to deal with the uncertainty that is inherent in their diagnostic 
pathway, for example, when patients feel that the GP takes the diagnostic journey together 
with them.9 From a study in cancer patients, it is also known that a trusting relationship may 
reduce fear of medical error and leads to more patient satisfaction.56 A trusting relationship 
between PD patients and their GPs can also help patients to deal with the unpredictability 
and uncontrollability associated with progression of their disease.60-62 Although the patients 
in our longitudinal study do not mention that they expect the GP to keep an eye on them, the 
GPs do express this as being one of their roles. GPs in a study of patients with multimorbidity 
mentioned that a trusting patient-doctor relationship facilitates the management of complex 
health care situations.50 Patients with multiple chronic conditions wanted their GP to stay in 
touch with them and to offer guidance during progression of the disease(s).36, 62 The same 
is true for cancer patients, who interpret absence of regular contact as a lack of interest 
of the GP.63
In line with earlier research, the patients and GPs in our study describe the importance of 
autonomy and self-management, leading to a sense of control.64 The preference for self-
efficacy in the early stages of PD could suggest that a trusting relationship between patients 
and GPs is not essential. The opposite, however, is true. A trusting relationship facilitates 
patients’ self-management.55, 58 The support GPs can offer in self-management has already 
been outlined above. PD patients may not be fully aware, however, of the added value of 
the GP in this respect, as one GP described in the interview study. With further progression 
of the disease, PD patients will increasingly experience difficulties with medical decision-
making as their ability to organize information and to understand treatment options becomes 
more and more impaired.65 Patient autonomy can then be maintained by stimulating shared 
decision-making.58 The central role of a trusting relationship with the GP in this, and, more 
explicitly, the importance of GPs’ knowledge of patients’ personal circumstances, has already 
been described by PD patients in an earlier study.54 Patients in general, however, are inclined 
to take a passive decision-making role out of fear they will annoy health care providers and 
receive lower quality care.57 Although the role of the GP may shift, therefore, from self-
management support to continuous counseling in stimulating shared decision-making, a 
trusting patient-doctor relationship remains equally important to encourage patients to 
voice their preferences.31, 39, 54, 56
Methodological considerations
The qualitative methods
We used qualitative research methods to gain insight into patients’ experiences with the 
diagnostic pathway of PD, to gain insight into the experiences and coping of community-
dwelling PD patients with changes in care encountered in the course of PD, and to clarify the 
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role these patients and their GPs see for GPs in PD care. In this section, we will discuss the 
strengths and limitations that are specific to the qualitative analysis of essays (Chapter 2) and 
the application of qualitative interviews, including the use of video diaries (Chapter 6 and 7). 
The format guiding patients in retrospectively describing their experiences of the diagnostic 
pathway of PD led to essays that were similarly structured (Chapter 2). The open questions 
used in this format, on the other hand, allowed patients to decide freely on the content and 
the amount of detail they wanted to provide. We believe that the content of the essays, 
therefore, reflects what matters most to the patients. Using an online approach allowed 
us to reach a large target group, as opposed to face-to-face interviews. As a consequence 
of this decision, patients who feel uncomfortable or are unable to use the computer are 
left out. Nevertheless, we tried to get a broad and reliable view of patients’ experiences by 
using, first, an inductive approach to our analysis of the essays of a highly variable sample of 
respondents, and, subsequently, a deductive approach to the analysis of essay contents of a 
second, purposive sample of respondents.66 
The longitudinal character of the study of community-dwelling PD patients and their GPs and 
the monthly visits of the research assistant enabled us to interview patients and their GPs at 
turning points in life, namely shortly after the patients encountered a change in care, rather 
than at fixed moments (Chapter 6 and 7).67 The risk of recall bias, therefore, is limited. In 
addition, we used information from the patient videos as interview prompts, thus allowing 
us to question patients in more detail. All interviews were performed by the same skilled 
interviewer, who could take the information from the patient interviews into account when 
interviewing GPs. Nevertheless, although we selected a purposive sample of patients to 
participate in our study, relatively few women and patients with advanced-stage disease 
were included. For practical reasons, the patients and GPs came from one single region, in 
which specialized PD care is well developed. In addition, despite the longitudinal set-up, only 
few patients encountered more than one moment of change in care during the study period. 
Therefore, our data do not allow us to describe changes in time of patients’ experiences, 
coping or opinions on the role of the GP in PD care.67 It cannot be excluded that a different 
study sample, another study region or a longer follow-up period would have led to different 
results.
The quantitative methods
A quantitative analysis approach was chosen to gain insight into factors influencing patient 
dissatisfaction with the diagnostic pathway of PD (Chapter 3) and to characterize the 
prodromal symptoms of PD presented in general practice (Chapter 4). Here we will describe 
the specific strengths and limitations of the methods used. The quantitative data that were 
collected as described in Chapter 5, are not included in this thesis. The collection methods of 
these data will therefore not be reviewed here.  
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We used an original approach to mixed methods research to enable content analysis of 
more than 900 freely written patient essays.68 The strengths of the data gathering method 
have been described above (Chapter 2), and the coding format used for the study presented 
in Chapter 3 was based on the results of the qualitative analysis. As the inter-observer 
agreement on the independent coding of patient dissatisfaction by two researchers in a 
random sample of 225 of the essays can be considered almost perfect, we are confident 
that we used a reliable data extraction method.69 However, interpreting spontaneous reports 
limits the interpretation of causality. In addition, factors that might be relevant but have not 
been described – such as earlier negative health care experiences ‒ will remain unknown.
The most important strength of the nested case-control study we performed on the prodromal 
symptoms of PD (Chapter 4) is the use of the CMR database.70 This well-documented database 
allowed us to include unselected cases of PD and match them to controls from the general 
population. In addition, information from the database is not biased by a retrospective view. 
Nevertheless, the low incidence of PD limits the number of patients that could be included, 
and the lack of presentation of prodromal symptoms by patients or reporting by GPs may 
have led to an underestimation of the actual prevalence of the prodromal symptoms studied. 
However, focussing on the symptoms patients present has improved our understanding of 
the symptoms that patients find significant enough for help-seeking and that GPs encounter 
in their everyday clinical practice. 
Future perspectives
Recommendations for clinical practice
Using a watchful waiting strategy with safety netting during the diagnostic pathway of 
PD has the potential of limiting diagnostic delay and, in particular, patient dissatisfaction. 
Because not all presented prodromal symptoms will immediately lead to a diagnosis of PD, 
and because patients with other conditions might benefit from the suggested approaches 
to diagnostic uncertainty as well, GPs should try to apply these methods in every diagnostic 
pathway where there is no acute threat to life. 
It appears valuable for PD patients to feel they make the diagnostic journey of PD together 
with their GP, as this can build a strong foundation for the trusting patient-doctor relationship 
that is much needed with progression of the disease. Although the moment PD is diagnosed 
is also the starting-point of a new therapeutic relationship between patients and medical 
specialists, GPs should be aware and feel confident of the continuing added value of their 
relationship with patients and act upon it. After all, community-dwelling PD patients benefit 
from shared care, in which generalist and specialized care professionals reinforce each 
other’s expertise and offer personalized care based on patient preferences.
Recommendations for education
Health care providers’ and lay people’s perception of PD should be modified from the 
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stereotyped image of an elderly male showing advanced-stage disease symptoms to a more 
complete representation of the disease, including a realistic view of the prodromal situation 
and awareness of the potentially incorrect assessment of PD patients’ competence. In order 
to facilitate earlier recognition of the symptom pattern of PD by health care providers, GPs, 
trainees and other health care providers potentially involved in care during the prodromal 
stage of the disease ‒ such as physical therapists or orthopedic surgeons ‒ should receive 
further education on the prodromal presentation of PD. It is important to note, in this regard, 
that the medical curriculum has so far paid little attention to prodromal PD, as this is a rather 
novel concept.71 Moreover, GPs and trainees should be taught about the potential changes 
in care encountered by their PD patients, in order to be able to guide them.
Knowledge of PD and its early stages should also – and perhaps particularly ‒ be improved 
in the general population. Not only will this help patients to recognize the seriousness of 
their symptoms, but it may also help family and friends to encourage patients’ help-seeking 
behavior. To improve public knowledge of PD in the prodromal stage, information campaigns 
– for example by the government, by professional organizations involved in PD care or by 
the Parkinson’s Disease Association - should be considered. Given the impact television 
potentially has on image-making, the media can also play an educational role by showing a 
more representative picture of the disease.
In addition, PD patients should be more effectively educated about the course of their 
disease and the changes in care they are likely to encounter, as this will help them to think 
ahead and to have more realistic expectations of the future. The information already existing 
on www.thuisarts.nl should be enhanced, therefore, to include information on the potential 
care changes and the role GPs can play in offering support. In addition, patients should be 
taught to voice what is most meaningful to them and what support needs they have. This 
way, self-management support is more likely to fit their needs, and care decisions made in 
shared responsibility between patients and health care providers are more likely to align 
with patients’ preferences. 
Recommendations for research
The difficulties PD patients can experience in (non-verbal) communication and medical 
decision-making may prevent them from expressing their needs for self-management 
support and may affect their ability to participate in shared decision-making. Merely inviting 
patients to share their needs and preferences may not be enough to overcome these specific 
obstacles. Research should be performed into the difficulties PD patients experience in 
voicing what is important to them, and into how these patients feel they could be trained. 
Moreover, specific attention should be paid to gender differences in that regard.
Although we were able to gain in-depth insight into community-dwelling PD patients’ 
experiences and coping with changes in care in the early stages of their disease, the results 
may not represent the experiences and coping strategies of patients with advanced stages 
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of PD. Such patients may also have different views on the role of their GP. As the general 
population is ageing and government decisions on health care force patients to live at home 
for longer periods of time, it is to be expected that GPs will increasingly be facing changes in 
care of patients with late-stage PD. Insight into their support needs would be valuable to be 
able to provide tailored care to these patients. Moreover, patients living in different regions 
with less developed specialized PD care facilities may well have different expectations of 
their GPs, and the GPs in such a region may differ in their feeling competent to provide care 
to PD patients. Performing a similar study in a different region with a larger study population 
including patients with more advanced-stage disease, therefore, would be advisable. 
For Dutch GPs, there is a Parkinson’s Disease Guideline that can support them in providing 
care to PD patients.72 However, none of the GPs we interviewed mentioned this guideline, 
underscoring the well-known challenge of guideline implementation into clinical practice. 
As the number of PD patients per general practice is likely to increase in the near future, 
research should be performed on GPs’ awareness of this guideline and on the best way of 
implementing it in their daily clinical practice. Moreover, the factors facilitating and hindering 
the use of this guideline may help us understand how GPs can be supported in offering their 
PD patients the care they need.
Conclusion
The challenging and sometimes lengthy diagnostic pathway of PD leads to uncertainty for 
both patients and GPs. During the time it takes for the signs and symptoms of PD to become 
more evident, diagnostic uncertainty should be shared with patients. Using a watchful 
waiting strategy will allow GPs to recognize a pattern in the symptoms that are presented 
over time and to suspect PD as soon as possible, while taking care to avoid tunnel vision 
towards the first diagnostic idea and making sure that patients are offered continuous 
support and are encouraged to reconsult with new complaints or worries. This way, patients 
and GPs experience the diagnostic pathway together, which may strengthen the trusting 
relationship between them. 
After the diagnosis has been made, the GPs’ role will shift, but the importance of a trusting 
relationship and the GPs’ involvement in PD care do not diminish. Patients prefer to remain 
autonomous for as long as possible, and self-management of changes in care appears to be 
possible in early-stage disease. However, GPs continue to play an important role by offering 
support to patients in formulating self-management goals that are not disease-oriented 
but focus on what is most meaningful to patients. Knowing the patient as a whole person 
facilitates this. This knowledge and  GPs’ possibility to repeatedly invite patients to express 
what problems are most pressing and what goals are valued most, moreover, allow them to 
tailor their self-management support to the needs that constantly change with progression 
of the disease. 
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The PD patients’ ability to participate in medical decision-making will decrease with further 
disease progression. In order to maintain autonomy for as long as possible, the GPs’ role will 
then shift towards a counseling role in shared decision-making. A trusting patient-doctor 
relationship remains equally important during this stage, to encourage patients to voice their 
preferences. The GPs’ knowledge of their patients’ disease and unique situation allows them 
to coordinate all health care providers that are involved in care, and to integrate care in a 
patient-centered manner by prioritizing problems in line with patients’ preferences.
It is clear, therefore, that Parkinson’s disease in primary care should be a joint journey 
of community-dwelling patients and their GPs, in which a trusting relationship is of vital 
importance to offer much-needed personalized support.
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Summary
Chapter 1 General introduction
In Chapter 1 the rationale, aims and outline of this thesis are described. 
Years before patients are being diagnosed with Parkinson’s disease (PD), they may already 
be suffering from –so called prodromal- symptoms. These symptoms are usually not disease-
specific. It may be difficult for patients to recognize that the symptoms need medical 
attention and for general practitioners (GPs) that PD is the common cause of the presented 
symptoms. Consequently, the diagnostic pathway of PD can be lengthy and uncertain and 
may negatively affect the patient-doctor relationship. Progression of PD will, in addition, 
inevitably lead to changes in care that patients have to cope with. Although these changes 
might be experienced without the involvement of professional health care providers, patients 
may still benefit from support. GPs are experienced in offering such support to patients with 
prevalent chronic conditions. 
PD patients may benefit from early intervention and treatment. A trusting patient-doctor 
relationship is indispensable to offer personalized support during changes in care and to 
enable shared decision-making. Knowledge of the factors that influence the course of the 
diagnostic pathway of PD and the experiences of patients during this pathway is however 
scarce. Moreover, most studies on the prodromal symptoms of PD are hospital-based, while 
GPs are consulted earlier, when symptoms are usually still limited. Furthermore, in order 
to provide personalized support, our knowledge of PD patients’ experiences with changes 
in care and their expectations of the GP need to be increased. This thesis aims to provide 
more insight into patients’ experiences before, during and after the diagnosis of PD, as well 
as the challenges GPs are confronted with in providing care to these community-dwelling 
PD patients. 
Towards the diagnosis of Parkinson’s disease
The patient’s perspective
Chapter 2 Time intervals in diagnosing Parkinson’s disease: the patients’ views
In order to gain more insight into patients’ experiences of the pathway from the first 
recognizable symptom to the diagnosis of PD, we performed a qualitative study (Chapter 
2) of essays about the diagnostic pathway, written by 902 patient members of the Dutch 
Parkinson’s Disease Association. A purposive sample of 52 essays was analyzed independently 
by two researchers in an iterative process. Saturation in data analysis was reached. We found 
that the diagnostic pathway of PD is an iterative process that can be divided into three time 
intervals: recognizing the symptoms; deciding to seek help; and the process of diagnosing 
PD. Patients described that recognizing the prodromal symptoms of PD can be challenging 
as their knowledge of the disease is generally based on public figures with advanced-stage 
PD. The decision to seek professional help if symptoms do not resolve or progress over 
time is influenced by a variety of factors including the involvement of significant others and 
the patient’s attitude toward health care. Patients also described they had the feeling that 
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GPs experience difficulties recognizing PD. We conclude that effort is required to increase 
recognition of the prodromal symptoms of PD by lay people and health care providers in 
order to facilitate an earlier diagnosis and timely therapeutic intervention. 
Chapter 3 The diagnostic pathway of Parkinson’s disease: a cross-sectional survey study 
of factors influencing patient dissatisfaction
In Chapter 3 we present the results of the analysis of all 902 patient essays mentioned in 
Chapter 2. Based on the qualitative analysis, a coding format was developed to examine 
the content of the essays. Two researchers independently coded more than 150 essays, 
initially to create consensus on the coding method, and later to discuss doubts in coding. 
The other essays were coded by one researcher. The focus of the study was the relationship 
between dissatisfaction and demographic characteristics, duration of the diagnostic 
pathway, communication with the GP and neurologist, the number of involved health care 
providers, whether or not a second opinion had taken place and whether diagnostic delay 
was experienced by the patient. A subgroup analysis was performed to gain insight into sex-
related differences. Of all patients, 16.4% explicitly described they were dissatisfied with 
the diagnostic pathway, whereas 4.8% were very satisfied. The chance of dissatisfaction 
increased with a lower level of education, the involvement of more than one health care 
provider other than the GP or neurologist, a second opinion initiated by the patient and 
delay caused by a health care provider. When only the GP and the neurologist were involved, 
women were more likely to be dissatisfied than men. We conclude that GPs can positively 
influence patients’ experiences and contribute to a trusting patient-doctor relationship if 
they are aware of these risk factors for patient dissatisfaction and pay extra attention to 
communication and shared decision-making. 
The general practitioner’s perspective
Chapter 4 Prodromal symptoms and early detection of Parkinson’s disease in general 
practice: a nested case-control study
The nested case-control study presented in Chapter 4 was performed in order to characterize 
the prodromal symptoms of PD presented in general practice. For this study we used 
data from the Continuous Morbidity Registration (CMR) database. This database contains 
information of all health problems that a population of approximately 12 000 patients from 
four general practices presented to the GP. We included 86 patients diagnosed with PD and 
78 matched controls and found that in the 2-year period prior to the diagnosis, PD patients 
more often presented with functional somatic symptoms, constipation, hyperhidrosis 
and sleep disorders than controls. Patients also more frequently experienced more than 
one prodromal symptom and were more often referred within the primary care team or 
to a medical specialist. We conclude that GPs should be alert when patients present 
with multiple symptoms in a 2-year period, especially considering the possible benefits of 
early intervention. 
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Changes in care after the diagnosis of Parkinson’s disease
Chapter 5 Transitions in Parkinson’s disease in primary care: protocol of a longitudinal 
mixed methods study
Chapter 5 contains the protocol of a longitudinal study on changes in care encountered by 
community-dwelling PD patients. It describes recruitment, data collection and data analysis 
in detail. A purposive sample of GPs in and around Nijmegen, the Netherlands, and their 
community-dwelling PD patients without cognitive dysfunction were planned to participate 
in the study for a period of 1 year. During that year, patients would make a video diary once 
a fortnight to give a verbal and non-verbal impression of their well-being. Every month, a 
research assistant would collect these videos and ask the patients if they had encountered 
any change in care. If so, patients would be questioned on their experiences and coping with 
the change and on the role they saw for the GP in PD care, using information from the videos 
to customize the interview topic guide. Patients’ GPs would also be interviewed in-depth, 
focusing on their role in PD care during the encountered change in care and in general. 
The anonymous, verbatim transcripts of the interviews would be analyzed according to the 
principles of constant comparative analysis. Inclusion of GPs and patients, data collection 
and data analysis was planned to continue until saturation in data analysis was reached. 
The patient’s perspective
Chapter 6 Being in control of Parkinson’s disease: a qualitative study of patient  
experiences
Chapter 6 describes the experiences and coping with changes in care of community-dwelling 
PD patients, based on the interviews with a purposive sample of 16 community-dwelling 
PD patients, who participated in the study described in Chapter 5. We found that patients 
experienced a variety of changes in care such as changes in the level of unpaid care, the 
purchase of tools, modification of pharmacotherapy or admission to hospital. Three themes 
had a great influence on patients’ experiences and their acceptance of impairments 
afterwards: anticipating change; self-managing change; and managing expectations. 
Unforeseen changes in care could be overwhelming for patients, while being able to 
anticipate change enhanced patients’ self-management and feeling of control. Patients 
preferred to solve the problems they encountered themselves, and if they succeeded in doing 
so, they had realistic expectations and could accept impairments that remained despite the 
change. If a change was initiated by a health care provider however, expectations were often 
unrealistically high and unmet. We conclude that the changes in care PD patients experience 
are closely related to their personal context. Even when disease-specific care is offered 
by specialized health care providers, self-management support and help with establishing 
realistic self-management goals can therefore be offered by GPs, who are well acquainted 
with the facilitating and complicating factors in their patients’ situation. 
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The general practitioner’s perspective
Chapter 7 Parkinson’s disease: patient and general practitioner perspectives on the role 
of primary care
In Chapter 7 we clarify the role PD patients and their GPs see for the GP in PD care. In order 
to do this, the interviews of the earlier described 16 community-dwelling PD patients and 
12 of their GPs were independently coded by two researchers and analyzed according to 
the principles of constant comparative analysis. We found that patients preferred self-
management of changes in care and autonomy in decision-making. GPs chose to stimulate 
this behavior by taking a limited, reactive position in early-stage PD care. Moreover, they 
felt insufficiently competent to extend their role. Patients also felt that GPs lack expert 
knowledge and skills; they focus on their neurologist for PD care. In addition, GPs observed 
patients might not realize what accessory role the GP could have, a role GPs described as 
essential in being aware of patient’s well-being. Although patients did not report additional 
roles for the GP in advanced-stage disease, GPs described a shift towards a more proactive 
and extended role. We conclude that, although patients and GPs see a limited role for the GP 
in early-stage PD care, GPs should feel more confident of the added value of their generalist 
approach to care for patients with a complex chronic disorder such as PD. If generalist and 
specialized care reinforce each other, PD patients benefit. 
Chapter 8 General discussion
In Chapter 8 we discuss the results of the performed studies in light of patient-centered 
primary care. Moreover, we review the methods used and discuss recommendations for 
clinical practice, education and research. 
We identified four related themes with important implications for care in all stages of PD: 
the stereotyped image of PD; the diagnostic uncertainty related to PD; the added value of 
generalism to PD care; and the importance of a trusting patient-doctor relationship. The 
stereotyped image of an elderly male patient with advanced-stage symptoms of PD can 
negatively affect patients’ recognition of prodromal symptoms and their help-seeking 
behavior. It may also contribute to GPs’ challenges in recognizing PD. GPs should apply a 
watchful waiting strategy with diagnostic safety netting to deal with the inevitable uncertainty 
that comes with the diagnostic pathway of PD. Moreover, GPs and patients should share 
their experienced feelings during this pathway. PD will then be diagnosed as soon as possible 
and the joint experience may strengthen the trusting patient-doctor relationship. This 
relationship is important to enable patients to express their care preferences and to offer 
support in formulating self-management goals that are not disease-oriented but focus on 
what is most meaningful to patients. Moreover, it facilitates shared decision-making. GPs’ 
expertise in whole person medicine furthermore, allows them to coordinate all health care 
providers involved and to integrate care in a patient-centered manner by prioritizing problems 
in line with patients’ preferences. Parkinson’s disease in primary care should thus be a joint 
journey of community-dwelling patients and their GPs, in which a trusting relationship is of 
vital importance to offer much-needed personalized support.
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The most important recommendations for clinical practice are the use of a watchful waiting 
strategy with safety netting during the diagnostic pathway and the need for awareness and 
confidence of GPs of the continuing added value of their care to community-dwelling PD 
patients. The focus for education should lie in creating a more representative image of the 
early presentation of PD, both for lay people and health care providers. Health care providers 
should also be taught the potential changes in care encountered by PD patients in order for 
them to be able to guide and educate their patients. Patients, in addition, should be taught 
to voice what is most meaningful to them and what support they need. Research should be 
performed in the way patients can best be educated in this, as merely inviting PD patients 
to share their needs and preferences may not be enough to overcome the difficulties they 
experience in communication and medical decision-making. As the general population is 
ageing and patients live at home for longer periods of time, the experiences and care needs 
of PD patients with advanced-stage disease and the way GPs can be supported to offer the 
care their PD patients need should also be the focus of research.
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Samenvatting
Hoofdstuk 1 Algemene inleiding
In Hoofdstuk 1 beschrijven we de achtergrond, doelen en opbouw van dit proefschrift. 
Al jaren voordat patiënten gediagnosticeerd worden met de ziekte van Parkinson kunnen 
ze klachten hebben, zogeheten prodromale symptomen. Deze symptomen zijn meestal 
niet ziektespecifiek. Voor patiënten kan het lastig zijn om te herkennen dat ze met hun 
klachten aandacht van zorgverleners nodig hebben en voor huisartsen is het lastig om te 
herkennen dat de aspecifieke klachten veroorzaakt worden door de ziekte van Parkinson. Als 
gevolg daarvan kan het traject tot de diagnose lang en onzeker zijn en negatieve gevolgen 
hebben voor de arts-patiënt relatie. Als de ziekte voortschrijdt treden er veranderingen op 
in de zorgbehoefte, veranderingen waar patiënten mee om moeten gaan. Ook al maken 
patiënten deze veranderingen van zorg misschien door zonder de betrokkenheid van 
professionele zorgverleners, zij kunnen nog altijd baat hebben bij ondersteuning. Huisartsen 
zijn ervaren in het bieden van zulke ondersteuning aan patiënten met veel voorkomende 
chronische aandoeningen. 
 
Parkinsonpatiënten kunnen baat hebben bij vroegtijdige interventie en behandeling. Een 
vertrouwensband tussen arts en patiënt is essentieel om persoonsgerichte ondersteuning te 
kunnen bieden en gezamenlijke besluitvorming te faciliteren. Echter, kennis van de factoren 
die het verloop van het traject tot de diagnose en de beleving van patiënten tijdens dit traject 
beïnvloeden is gering. Inzicht in de prodromale symptomen die bij de huisarts gepresenteerd 
worden is bovendien beperkt: studies tot dusver hebben zich vooral gericht op klachten 
die bij de neuroloog worden gepresenteerd, klachten die vaak uitgesprokener zijn dan de 
prodromale symptomen die eerder in het ziektebeloop bij de huisarts gepresenteerd worden. 
Meer kennis van de ervaringen van parkinsonpatiënten met veranderingen in de zorg en 
de verwachtingen die zij hebben van de huisarts is bovendien nodig om persoonsgerichte 
ondersteuning te kunnen optimaliseren. Met dit proefschrift hopen wij meer inzicht te 
kunnen bieden in de ervaringen van patiënten voor, tijdens en na de diagnose ziekte van 
Parkinson en in de uitdagingen waar huisartsen mee worden geconfronteerd bij het bieden 
van zorg aan thuiswonende parkinsonpatiënten. 
Op weg naar de diagnose ziekte van Parkinson
Het perspectief van de patiënt 
Hoofdstuk 2 Tijdsintervallen in het diagnosticeren van de ziekte van Parkinson: het  
perspectief van de patiënt
Om meer inzicht te krijgen in de ervaringen van patiënten tijdens het traject van de eerste 
klacht tot de diagnose ziekte van Parkinson, hebben we een kwalitatieve studie uitgevoerd 
van essays over het diagnostische traject, geschreven door 902 patiëntleden van de 
Parkinson Vereniging (Hoofdstuk 2). Een gerichte steekproef van 52 essays is in een zich 
herhalend proces door twee onderzoekers bekeken, onafhankelijk van elkaar. De analyse 
is doorgegaan tot verzadiging was opgetreden. We vonden dat het traject tot de diagnose 
ziekte van Parkinson een zich herhalend proces is wat in drie tijdsintervallen kan worden 
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opgedeeld: herkenning van symptomen; het besluit om hulp te zoeken; en het proces van 
diagnosticeren. Patiënten beschreven dat het herkennen van de prodromale klachten van 
de ziekte van Parkinson lastig is aangezien het beeld dat zij van de ziekte hebben bestaat 
uit dat van bekende personen met een vergevorderd stadium van de ziekte van Parkinson. 
Als de klachten niet vanzelf overgaan of toenemen besluiten patiënten veelal professionele 
hulp te zoeken, een besluit wat beïnvloed wordt door factoren als de betrokkenheid van 
naasten en de houding van de patiënt tegenover gezondheidszorg. Patiënten beschreven 
daarnaast dat zij het gevoel hadden dat de huisarts ook moeite had om de ziekte van 
Parkinson te herkennen. We concluderen dat het noodzakelijk is om energie te steken in 
het uitbreiden van kennis over de prodromale symptomen van de ziekte van Parkinson bij 
leken en zorgverleners om het eerder stellen van de diagnose en vroegtijdig starten van de 
behandeling mogelijk te maken. 
Hoofdstuk 3 Het traject tot de diagnose ziekte van Parkinson: een cross-sectionele survey 
studie naar factoren die van invloed zijn op patiënt ontevredenheid
In Hoofdstuk 3 presenteren wij de resultaten van de analyse van alle 902 essays van 
patiënten die we in Hoofdstuk 2 al noemden. Gebaseerd op de kwalitatieve analyse uit dat 
hoofdstuk, hebben we een methode ontwikkeld om de inhoud van de essays te coderen. 
Twee onderzoekers hebben onafhankelijk van elkaar meer dan 150 essays gecodeerd, 
initieel om tot consensus te komen over de codeermethode en later om dilemma’s in het 
coderen te bediscussiëren. De andere essays zijn gecodeerd door één onderzoeker. De 
focus van dit onderzoek was de relatie tussen patiënt ontevredenheid en demografische 
gegevens, duur van het diagnostisch traject, communicatie met de huisarts en de neuroloog, 
het aantal betrokken zorgverleners buiten de huisarts en neuroloog, of een second opinion 
plaatsgevonden heeft en of er, volgens de patiënt, vertraging opgetreden is in het traject. 
Een subgroepanalyse is verricht om inzicht te krijgen in seksegerelateerde verschillen. Van 
alle patiënten was 16.4% ontevreden met het traject tot de diagnose en 4.8% zeer tevreden. 
De kans op ontevredenheid was groter bij patiënten met een laag opleidingsniveau, bij 
betrokkenheid van meer dan één zorgverlener, bij een second opinion op verzoek van de 
patiënt en bij vertraging veroorzaakt door zorgverleners. Als alleen de huisarts en neuroloog 
betrokken waren, waren vrouwen vaker ontevreden dan mannen. We concluderen dat als 
huisartsen zich bewust zijn van de risicofactoren voor ontevredenheid van patiënten en extra 
aandacht besteden aan communicatie en gezamenlijke besluitvorming, zij de ervaringen 
van patiënten positief kunnen beïnvloeden en bij kunnen dragen aan een vertrouwensband 
tussen arts en patiënt. 
Het perspectief van de huisarts
Hoofdstuk 4 Prodromale symptomen en vroegtijdige herkenning van de ziekte van  
Parkinson in de huisartspraktijk: een nested case-control studie
De nested case-control studie die we presenteren in Hoofdstuk 4 is uitgevoerd om de 
prodromale klachten van de ziekte van Parkinson, die in de huisartsenpraktijk worden 
gepresenteerd, in kaart te brengen. Hiervoor hebben we gebruik gemaakt van de database 
van de Continue Morbiditeits Registratie (CMR). Deze database bevat informatie over 
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alle gezondheidsproblemen die ongeveer 12000 patiënten gepresenteerd hebben bij de 
huisartsen in vier praktijken. Uit deze populatie hebben we 86 parkinsonpatiënten en 78 
gematchte controles geïncludeerd. We vonden dat parkinsonpatiënten in een periode van 2 
jaar voorafgaand aan de diagnose ten opzichte van de controles vaker somatisch onvoldoende 
verklaarde lichamelijke klachten, obstipatie, hyperhidrosis en slaapproblemen presenteerden 
bij de huisarts. Patiënten hadden ook vaker last van meer dan één prodromale klacht en 
werden vaker verwezen naar eerstelijns zorgverleners of naar een medische specialist. We 
concluderen dat huisartsen alert zouden moeten zijn als patiënten meerdere symptomen 
presenteren over een periode van enkele jaren, meewegend wat het positieve effect zou 
kunnen zijn van vroege interventie. 
Veranderingen in de zorg na de diagnose ziekte van Parkinson
Hoofdstuk 5 Veranderingen in de zorg bij de ziekte van Parkinson in de eerste lijn:  
protocol van een longitudinale mixed methods studie
Hoofdstuk 5 bevat het protocol van een longitudinale studie naar veranderingen in de zorg 
die thuiswonende parkinsonpatiënten meemaken. Het beschrijft werving, dataverzameling 
en data analyse in detail. De onderzoeksopzet was om een gerichte steekproef te nemen 
van huisartsen in en rond Nijmegen (Nederland) en hun thuiswonende parkinsonpatiënten 
zonder cognitieve problemen en hen voor een periode van 1 jaar te laten participeren in 
het onderzoek. Gedurende dat jaar zouden patiënten elke 14 dagen een videodagboek 
maken om verbaal en non-verbaal een indruk te geven van hun welzijn. Elke maand zou 
een onderzoeksassistent deze video’s ophalen en informeren of er veranderingen in de zorg 
plaatsgevonden hadden. Als dat het geval was, zouden patiënten geïnterviewd worden over 
hun ervaringen en manier van omgaan met de verandering en over de rol die zij voor de 
huisarts zagen in de zorg voor parkinsonpatiënten. De informatie uit de video’s zou hierbij 
gebruikt worden om de interviewgids aan te scherpen. Ook de huisartsen van de patiënten 
zouden geïnterviewd worden met de focus op hun rol tijdens de verandering in zorg die hun 
patiënt doorgemaakt had en op hun rol in de zorg voor parkinsonpatiënten in het algemeen. 
De geanonimiseerde transcripten van de interviews zouden worden geanalyseerd in een 
proces van continue vergelijking. Inclusie van huisartsen en patiënten, dataverzameling en 
data analyse zouden doorgaan totdat verzadiging was opgetreden. 
Het perspectief van de patiënt 
Hoofdstuk 6 Controle houden bij de ziekte van Parkinson: een kwalitatieve studie naar 
patiënt ervaringen 
Hoofdstuk 6 beschrijft de ervaringen van thuiswonende parkinsonpatiënten met 
doorgemaakte veranderingen in de zorg en de manier waarop ze er mee omgegaan 
zijn. Hiervoor hebben we gebruik gemaakt van de interviews met 16 patiënten, die 
deelgenomen hebben aan de studie beschreven in Hoofdstuk 5. We vonden dat patiënten 
diverse veranderingen in de zorg meemaken zoals veranderingen in de ondersteuning van 
mantelzorgers, de aanschaf van hulpmiddelen, aanpassing van de medicatie of opname in het 
ziekenhuis. Drie thema’s zijn van invloed op de ervaringen van patiënten en op hun acceptatie 
van eventueel resterende beperkingen: het anticiperen op verandering; zelfmanagement 
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van verandering; en het omgaan met verwachtingen. Patiënten kunnen zich overvallen 
voelen door een verandering in de zorg. Als ze erop kunnen anticiperen, draagt dit echter 
bij aan zelfmanagement van de verandering en aan het gevoel van controle. Patiënten gaven 
er de voorkeur aan de problemen die ze tegenkwamen zelf op te lossen. Zelfmanagement 
ging over het algemeen gepaard met realistische verwachtingen van de verandering en de 
acceptatie van resterende beperkingen, terwijl veranderingen die geïnitieerd werden door 
een zorgverlener gepaard gingen met onrealistisch hoge verwachtingen. We concluderen dat 
de veranderingen in de zorg die parkinsonpatiënten ervaren vaak nauw verbonden zijn aan 
hun persoonlijke situatie. Zelfs als ziektespecifieke zorg door specialisten wordt verleend, 
kan ondersteuning in zelfmanagement en het formuleren van realistische doelen hiervoor 
toch geboden worden door de huisarts die goed op de hoogte is van de faciliterende en 
belemmerende factoren in de situatie van de patiënt.
Het perspectief van de huisarts
Hoofdstuk 7 De ziekte van Parkinson: het perspectief van patiënt en huisarts op de rol 
van huisartsgeneeskunde
In Hoofdstuk 7 beschrijven we de rol die de huisarts volgens patiënten en huisartsen 
zou moeten hebben in de zorg voor parkinsonpatiënten. Om dit te kunnen doen hebben 
twee onderzoekers onafhankelijk van elkaar de eerder beschreven interviews met 16 
thuiswonende parkinsonpatiënten en de interviews met 12 van hun huisartsen gecodeerd 
en gezamenlijk geanalyseerd volgens de principes van de continue vergelijking. We vonden 
dat patiënten de voorkeur gaven aan zelfmanagement van veranderingen en aan autonomie 
in besluitvorming. Om dit gedrag te stimuleren kozen de huisartsen ervoor een reactieve 
positie in te nemen bij patiënten met een nog niet vergevorderd stadium van de ziekte van 
Parkinson. Huisartsen voelden zich bovendien niet voldoende competent om hun rol uit te 
breiden. Patiënten hadden ook het idee dat de huisarts kennis en kunde tekort kwam en 
richtten zich met Parkinson gerelateerde vragen primair op de neuroloog. Huisartsen gaven 
daarnaast aan dat patiënten misschien niet goed zicht hebben op de rol die de huisarts zou 
kunnen hebben, een rol waarin huisartsen zelf het belang benadrukken van het bewaken van 
het welzijn van de patiënt. Hoewel de geïnterviewde patiënten geen extra rollen beschrijven 
voor de huisarts bij progressie van de ziekte, benoemen huisartsen een verschuiving naar een 
proactievere en uitgebreidere rol. We concluderen dat huisartsen meer vertrouwen zouden 
mogen hebben in de toegevoegde waarde van hun huisartsgeneeskundige benadering 
van de zorg voor patiënten met een complexe chronische aandoening zoals de ziekte van 
Parkinson. Parkinsonpatiënten halen er voordeel uit als huisartsen en specialisten elkaar 
aanvullen in de zorg die zij verlenen.
Hoofdstuk 8 Algemene discussie 
In Hoofdstuk 8 plaatsen we de resultaten van de beschreven onderzoeken in perspectief. 
Bovendien bespreken we methodologische kwesties en geven we suggesties voor de 
dagelijkse praktijk, onderwijs en verder onderzoek. 
We concluderen dat er vier thema’s zijn die van belang zijn voor de zorg in alle fases van de 
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ziekte van Parkinson: het stereotype beeld dat er van de ziekte bestaat; de diagnostische 
onzekerheid waarmee de ziekte van Parkinson gepaard gaat; de toegevoegde waarde van 
generalisme aan de zorg voor parkinsonpatiënten; en het belang van een vertrouwensband 
tussen huisarts en patiënt. Het stereotype beeld dat van de ziekte van Parkinson bestaat, 
dat van de oude, voorovergebogen schuifelende man, kan een negatieve invloed hebben op 
de herkenning van de prodromale symptomen van de ziekte en op het hulpzoekgedrag van 
patiënten. Daarnaast kan het huisartsen bemoeilijken om de ziekte vroegtijdig te herkennen. 
Huisartsen zouden in het omgaan met de onzekerheid die inherent is aan het diagnostische 
traject van de ziekte van Parkinson een strategie moeten toepassen van ‘watchful waiting’, 
waarbij zij gelijktijdig zeker stellen dat patiënten terugkomen als dit nodig is. Zo kan de ziekte 
van Parkinson zo snel mogelijk worden gediagnosticeerd. Patiënten en huisartsen zouden 
bovendien hun gevoelens van onzekerheid moeten delen in deze fase aangezien dit kan 
bijdragen aan de vertrouwensband tussen arts en patiënt. Deze band is belangrijk om de 
drempel te verlagen voor het aangeven van eigen voorkeuren en prioriteiten door patiënten 
en om ondersteuning te kunnen bieden in het formuleren van doelen voor zelfmanagement 
die niet ziektegericht zijn maar zich richten op wat de patiënt het belangrijkst vindt. Bovendien 
faciliteert een vertrouwensband tussen arts en patiënt gezamenlijke besluitvorming. De 
expertise van huisartsen in het bieden van ‘whole person medicine’ leidt er bovendien toe 
dat zij de zorg zo kunnen coördineren en integreren dat die gebaseerd is op de voorkeuren 
en prioriteiten die de patiënt aangegeven heeft. Thuiswonende parkinsonpatiënten en 
hun huisartsen zouden de reis, die de ziekte van Parkinson is, dan ook gezamenlijk moeten 
afleggen, waarbij een vertrouwensband essentieel is om persoonsgerichte ondersteuning 
mogelijk te maken. 
De belangrijkste aanbevelingen voor de huisartsenpraktijk zijn het gebruik van een ‘watchful 
waiting’ strategie gedurende het diagnostische traject van de ziekte van Parkinson en 
het herkennen van en vertrouwen hebben in de toegevoegde waarde van generalistische 
zorg voor thuiswonende parkinsonpatiënten. De focus voor onderwijs zou moeten liggen 
in het tot stand brengen van een representatiever beeld van de prodromale fase van de 
ziekte, zowel bij leken als bij zorgverleners. Zorgverleners zouden bovendien meer kennis 
moeten krijgen van de mogelijke veranderingen in zorg die parkinsonpatiënten kunnen 
ervaren, zodat patiënten hierover beter geïnformeerd en hierin beter begeleid kunnen 
worden. Patiënten zouden geleerd moeten krijgen om uit te spreken wat zij belangrijk 
vinden en welke ondersteuning zij nodig hebben. Onderzoek zou gedaan moeten worden 
naar de manier waarop zij dit het beste zouden kunnen leren, aangezien parkinsonpatiënten 
enkel uitnodigen om hun behoeften en voorkeuren te delen mogelijk niet genoeg is om de 
moeilijkheden die zij ervaren in communicatie en medische besluitvorming te overwinnen. 
Met de vergrijzing van de bevolking en het langer thuis wonen van hulpbehoevende ouderen 
zou eveneens onderzoek gedaan moeten worden naar de ervaringen en zorgbehoeften 
van patiënten met een verder gevorderd stadium van de ziekte van Parkinson en naar de 
manier waarop huisartsen ondersteund kunnen worden in het bieden van passende zorg aan 
hun parkinsonpatiënten. 
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Dankwoord
Ook een promotieonderzoek is een ‘joint journey’, een reis die je gezamenlijk met anderen 
aflegt. Graag wil ik dan ook iedereen bedanken die direct of indirect een bijdrage heeft 
geleverd aan de totstandkoming van dit proefschrift. Een bijzonder woord van dank ook voor 
alle patiënten en huisartsen die deel hebben genomen aan de verschillende onderzoeken, 
zonder uw bijdrage was het nooit geworden wat het nu is. Een aantal mensen wil ik graag 
met naam en toenaam noemen. 
Beste Tim, zelfs zonder financiële bijdrage sta jij op deze plek in het dankwoord :-). Wat 
ben ik blij dat jij je aanvankelijke twijfel over het copromotorschap opzij hebt gezet. Je 
bevlogenheid, je positieve instelling, je creativiteit in het bedenken van oplossingen, je 
daadkracht en het vertrouwen wat je mij gaf sloten naadloos aan op wat ik nodig had om te 
pieken en gaven me het gevoel van teamwork. Ik ben dan ook blij dat we onze samenwerking 
kunnen voortzetten.
Beste Toine, mijn eerste stappen in onderzoeksland heb ik bij jou gezet, mijn wetenschappelijke 
stage tijdens de studie Geneeskunde. Toen ik 10 jaar later opnieuw jouw kamer binnenliep 
waren we het er snel over eens: ik zou gaan promoveren. Graag wil ik je bedanken voor je 
- ik zou bijna zeggen huisartsgeneeskundige - manier van begeleiden, met veel oog voor de 
persoon achter de promovendus. Ik kijk met plezier terug op de zeer bewust gekozen boeken 
en kaarten bij verjaardagen en andere bijzondere momenten en op je belangstelling voor 
het wel en wee van mijzelf en mijn gezin. Doordat jij mij de ruimte gaf om en promovendus 
en moeder te zijn (in wisselende volgorde) kon ik de balans bewaren en de lat hoog leggen. 
Heerlijk om met iemand samen te werken die net zo snel vooruit wil als ik. Dank ook voor 
je openheid: en passant heb ik daardoor de gelegenheid gehad meer te leren over het 
politieke spel dat wetenschap ook kan zijn. Wat fijn dat ik als postdoc nog verder kan groeien 
onder jouw leiding.
Beste Chris, waar ter wereld jij je ook bevond, jouw feedback op gestuurde stukken kwam 
altijd binnen enkele uren en getuigde van kritisch lezen. Jij bewaakte dat de kracht van de 
huisarts in elk artikel goed naar voren kwam en wist altijd te zorgen voor een waardevolle 
bijdrage aan de discussie. Heel veel dank hiervoor.
Beste Bas, jouw bevlogen manier van praten over de ziekte van Parkinson zorgden 
ervoor dat mijn bijzondere interesse voor de aandoening al tijdens de opleiding tot 
specialist ouderengeneeskunde werd gewekt. Je positie in de ‘Parkinson wereld’ heeft 
tijdens dit promotieonderzoek ongetwijfeld deuren geopend die anders gesloten waren 
gebleven, maar het is vooral je aanstekelijke enthousiasme tijdens bijeenkomsten van de 
begeleidingscommissie dat me bij zal blijven. Dank je wel dat jij mijn derde (!) promotor 
wilde zijn. 
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Beste Chris, Martin en Masja, jullie waren mijn ‘andere begeleidingscommissie’. Als 
vertegenwoordigers van de Parkinson Vereniging – en daarmee van de parkinsonpatiënten 
– dachten jullie mee over de opzet, uitvoering, analyse en weergave van alle onderzoeken 
in dit boekje. Ik ben blij dat we ons samen in blijven spannen voor het welzijn 
van parkinsonpatiënten.
Beste stagestudenten en studentassistenten, zonder jullie inzet was dit promotieonderzoek 
niet mogelijk geweest. Beste Eva, Juliët en Anne, ook al zijn jullie niet door mij persoonlijk 
begeleid, toch wil ik jullie graag bedanken voor jullie bijdrage. Beste Leontien, Anne, 
Clementine en Sjoerd, ik heb veel van en met jullie geleerd en heb genoten van de inzichten 
die de samenwerking met jullie bracht. Beste Esmée, Lotte, Simone en Lorraine, heel erg 
bedankt voor jullie hulp bij allerhande klussen. En - last but not least - Annelies en Olga, 
zonder wiens hulp dit boekje was blijven steken op een paar hoofdstukken. Beste Annelies, 
uren heb je door weer en wind in en rond Nijmegen gefietst om video’s op te halen bij 
patiënten. Jouw persoonlijke contact heeft de deelnemers ongetwijfeld goed gedaan. Beste 
Olga, wat heerlijk om met iemand samen te werken die precies begrijpt wat je bedoelt en 
ook nog kritisch meedenkt. Wat ben ik blij voor jou dat jij jezelf bijna dokter mag noemen.
Beste (oud-)collega’s van de afdeling Eerstelijnsgeneeskunde, jullie zijn een belangrijke factor 
in mijn werkplezier, misschien zonder dat jullie je er bewust van zijn. Vanaf de allereerste 
dag heb ik me thuis gevoeld op de afdeling en ik hoop dat dat nog lang zo blijft. Een speciaal 
woord van dank aan Hans Bor en Ron Hameleers. Beste Hans, dank je wel voor het eindeloze 
geduld waarmee jij statistische analyses in Libelletaal aan mij hebt uitgelegd. Beste Ron, jij 
zorgde voor een vliegende start van dit promotieonderzoek, dank je wel.
Beste oud-collega’s van de ouderengeneeskunde, Lareb en de afdeling Anesthesiologie, 
Pijn en Palliatieve Geneeskunde. Jullie gaven mij de ruimte om me te ontwikkelen als 
mens en in te zien waar mijn kwaliteiten en uitdagingen liggen. Zonder die inzichten en de 
kansen die ik kreeg om te kijken of ‘onderzoek doen mijn ding was’, was ik nooit aan een 
promotieonderzoek begonnen. 
Lieve familie, schoonfamilie en vrienden, heel veel dank voor jullie interesse in de voortgang 
van mijn promotie, voor de (misschien onbewuste) tips en trucs en voor de afleiding die jullie 
boden. Waar collega’s het werkplezier kunnen bepalen, dragen jullie bij aan mijn welzijn in 
het ‘gewone’ leven. 
Lieve paranimfen, dank jullie wel dat jullie mij bij willen staan.
Lieve Elza, ook al zijn we nog zo verschillend, ik heb veel aan je gehad als kamergenoot. Heel 
veel dank voor je luisterend oor, zowel op werkgebied als privé. Genoten heb ik ook van je 
TrashWorks creaties, waardoor onze kamer heel eigen is. Hoe moet dat nu straks met de 
flexibele werkplekken?
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Lieve Luc, broertje, hoewel jij niks met geneeskunde en met onderzoek hebt, wist ik direct 
dat ik jou als paranimf naast me zou willen. Van de rust die jij uitstraalt hoop ik tijdens de 
promotie stiekem ook iets te voelen. Van jouw vermogen om bewust je mond te houden, 
maar de spijker op de kop te slaan als het erop aankomt, kan ik nog veel leren. Ik hoop dat 
we de komende jaren vaker samen de tijd kunnen vinden voor een goed gesprek.
Lieve Lisette, als zusje heb ik altijd op je kunnen bouwen. Ik vind het fijn dat we elkaar de 
afgelopen jaren ook steeds beter zijn gaan begrijpen en waarderen. Heel erg bedankt dat 
jij, ondanks je drukke bestaan, de vormgeving van dit boekje voor je rekening hebt willen 
nemen en er zo voor gezorgd hebt dat het eruit springt tussen al die anderen.
Lieve pappa, toen ik nog heel klein was zei jij al dat ik vast professor ging worden. Dat 
professorschap lijkt me vooralsnog onwaarschijnlijk, maar een eerste stap de goede richting 
in is gezet. 
Lieve mamma, ik vind het heel bijzonder dat jij elke letter van dit proefschrift met even grote 
belangstelling gelezen hebt.
Dank jullie wel dat jullie mij het vertrouwen hebben gegeven om mijn plek te zoeken, zelfs als 
dat niet altijd strookte met de verwachting. Bedankt dat jullie er altijd zijn!
Lieve, lieve, lieve kindjes, er bestaat geen betere afleiding van werk dan jullie.
Lieve Janne, dit is dan het boekje wat ik aan het maken was. Niet echt een leuk leesboek hè? 
Met jouw nieuwsgierigheid en niet aflatende enthousiasme zou je ook weleens een goede 
onderzoeker kunnen worden. Ik hoop dat je altijd zo jezelf blijft als je nu bent.
Lieve Siem, geen steentje in jouw bouwwerken heeft een toevallige plek, achter alles zit een 
plan. De vragen die jij stelt laten ook zien hoe goed je over alles nadenkt. Ik ben benieuwd 
waar jou dat ooit gaat brengen.
Lieve Jet, ik geniet ervan om te zien hoe jij elke dag iets nieuws ontdekt en leert. Ik kijk nu al 
uit naar de gesprekken aan tafel als ook jij je er inhoudelijk mee gaat bemoeien.
Allerliefste Jouke, woorden schieten te kort om te zeggen wat jij voor mij betekent. Samen 
staan we sterk.
Lieve alle vier, ik ben blij dat ik dit proefschrift niet af hoef te sluiten met de zin ‘ik heb nu 
eindelijk weer tijd voor jullie’. Volgens mij zijn we er samen goed in geslaagd om te zorgen 
dat die tijd er ook tijdens mijn promotieonderzoek was. Misschien heb ik nu wel meer rust ;-) 
Ik hou van jullie!
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aan de Radboud Universiteit in Nijmegen. In 2005 rondde ze deze studie af. Vanwege haar 
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De theoretische achtergrond bleek echter beter bij Annette te passen dan de praktijk. Tussen 
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